KOL | Rikard HolmdahlNational and Local Joint Engineering Research Center of Biodiagnosis and Biotherapy, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China | Medical ... |
Currículum de kol para Rikard Holmdahl
| Year | |
|---|---|
| 2022 | National and Local Joint Engineering Research Center of Biodiagnosis and Biotherapy, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China Medical Inflammation Research, MediCity Research Laboratory, University of Turku, Turku, Finland |
| 2021 | The Second Affiliated Hospital of Xi’an Jiaotong University (Xibei Hospital), Xi’an, China Department Medical Biochemistry and Biophysics, Division Medical Inflammation Research, Karolinska Institute, 171 77 Stockholm, Sweden;, (M.A.);, (X.C.);, (B.X.);, (G.F.L.);, (M.Y.B.);, (Y.H.);, (L.B.) Division of Medical Inflammation Research, Dept. of Medical Biochemistry and Biophysics, Karolinska Institute, Stockholm, Sweden |
| 2020 | Dept. of Medical Inflammation Research, Section of Medical Biochemistry and Biophysics, Karolinska Institute, Stockholm Section for Medical Inflammation Research, BMCI11, Lund University, Lund, Sweden National & Local Joint Engineering Research Center of Biodiagnosis and Biotherapy, The Second Affiliated Hospital, Xi'an Jiaotong University, 710004 Xi’an, China Karolinska Institutet |
| 2019 | Section for Medical Inflammation Research, Department of Medical Biochemistry and Biophysics, Karolinska Institute, Solnavägen 9, 171 65, Solna, Sweden Center for Medical Inflammation Research, Southern Medical University, Guangzhou, China R. Holmdahl and C.I. Svensson contributed equally to this paper. |
| 2018 | School of Pharmaceutical Science, Southern Medical University, Guangzhou, China Medical Inflammation Research, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm 17177, Sweden. Electronic address: Karolinska University Hospital, Karolinska Institutet, Stockholm, Sweden Medicity Research Laboratory, University of Turku, Turku, Finland |
| 2017 | Karolinska Institutet Division of Medical Inflammation Research Stockholm Sweden Center for Medical Immunopharmacology Research, Southern Medical University, 510515 Guangzhou, China. Medicity Research Laboratory, University of Turku, Turku, Finland, . |
Rikard Holmdahl: Estadísticas de influencia
Sacar un reporte
| Concept | World rank |
|---|---|
| cageeffects | #1 |
| arthritis development severity | #1 |
| cii peptide molecules | #1 |
| dancf1da rats | #1 |
| m1j | #1 |
| cells chronic arthritis | #1 |
| findings new therapy | #1 |
| haplotype ltab | #1 |
| chromosome arthritis severity | #1 |
| hladr1transgenic mice | #1 |
| genetic control pia | #1 |
| function nox2 | #1 |
| arthritis ncf1 allele | #1 |
| cia experimental autoantibodies | #1 |
| proteolipoprotein peptide | #1 |
| susceptible cia | #1 |
| position ros production | #1 |
| mutation ptdins3pbinding site | #1 |
| cd68‐expressing cells | #1 |
| cii mhc | #1 |
| eae2 | #1 |
| rat type collagen | #1 |
| neonatal mortality milk | #1 |
| pepsin lewis | #1 |
| pc4 pc8 | #1 |
| acute phase arthritis | #1 |
| rat pia | #1 |
| oestrogen induced | #1 |
| arthritis tlr3 upregulation | #1 |
| phosphatase 22 | #1 |
| transgenic tolerance tlymphocytes | #1 |
| mice chronic arthritis | #1 |
| innate immunity mip | #1 |
| pia4 | #1 |
| ztmrhd | #1 |
| cii matrix protein | #1 |
| phytol rna | #1 |
| function p47phox | #1 |
| congenic fragment | #1 |
| epitope cartilage | #1 |
| autoantibodies collagen | #1 |
| strains polychondritis | #1 |
| chronic development | #1 |
| drb10401positive | #1 |
| 270 peptide | #1 |
| cii antibody | #1 |
| cia caia model | #1 |
| incidence arthritis | #1 |
| rat pristaneinduced arthritis | #1 |
| animal models acpa | #1 |
| m2139 ciic1 | #1 |
| chronic relapsing arthritis | #1 |
| aq class | #1 |
| arthritis protection | #1 |
| cii treatment | #1 |
| dependent autoimmune arthritis | #1 |
| c3hnb mice | #1 |
| 2 months beta | #1 |
| treatment physiological doses | #1 |
| cia recognition | #1 |
| manifestations lupus disease | #1 |
| ciiglycopeptides | #1 |
| immunization heterologous | #1 |
| collagen citrullination | #1 |
| injection lewis rat | #1 |
| comp mabs | #1 |
| spread induced psoriasis | #1 |
| mhc genetic region | #1 |
| cix cii | #1 |
| nzw parental strain | #1 |
| collagen chains antibody | #1 |
| regulates severity | #1 |
| glycoprotein alpha1microglobulin | #1 |
| inability collagen | #1 |
| cii lewis | #1 |
| inflammation living mice | #1 |
| ccp2 negative | #1 |
| ncf1m1j mice ncf1 | #1 |
| expressions cyp7a1 | #1 |
| daf2cross | #1 |
| cia rat | #1 |
| cia pathogenesis | #1 |
| resistance collageninduced arthritis | #1 |
| cia molecular basis | #1 |
| b10q dba 1f1 | #1 |
| rabeximod inflammatory cells | #1 |
| ccp positive patients | #1 |
| m2139 arthritogenic mab | #1 |
| oia induction | #1 |
| autoimmune accelerating | #1 |
| igg2a vivo | #1 |
| cartilage stability cartilage | #1 |
| suppression collagen | #1 |
| immunization autologous peptide | #1 |
| ncf1 mutant | #1 |
| nodp nod | #1 |
| biodegradation cryogels | #1 |
| citrullinated collagen arthritis | #1 |
| inbred strains cia | #1 |
| genetic association ncf1 | #1 |
| rns type collagen | #1 |
| wo2012127214 | #1 |
| human α‐enolase | #1 |
| tlr3 synovium | #1 |
| methodspurified | #1 |
| ciiinduced | #1 |
| mhc cii | #1 |
| elimination carbohydrates | #1 |
| cii experimental autoantigens | #1 |
| pia cia | #1 |
| arthritogenic mabs cii | #1 |
| arthritogenic mabs | #1 |
| diagnostic accuracy acpa | #1 |
| cryogel column antibodies | #1 |
| glycopeptide stimulation | #1 |
| cia12 pia4 | #1 |
| impact topoisomerase antagonist | #1 |
| experimental collagen type | #1 |
| h2q h2r | #1 |
| fumia | #1 |
| polymorphism ncf1 | #1 |
| hladrbound peptides | #1 |
| cix cartilage | #1 |
| compsufficient mice | #1 |
| b10q1 | #1 |
| aplec locus | #1 |
| mice b10q | #1 |
| animal models polychondritis | #1 |
| ros ncf1 | #1 |
| ncf1 spread | #1 |
| cii comp | #1 |
| skg mutation | #1 |
| therapeutic cleavage | #1 |
| cia swr mouse | #1 |
| leukosialin rats | #1 |
| argltgrpgda | #1 |
| cii mouse | #1 |
| breeding capacity | #1 |
| major role rp | #1 |
| caia monoclonal | #1 |
| 256 270 | #1 |
| innate rats | #1 |
| chemical collagen | #1 |
| nox2 complex–derived ros | #1 |
| models rheumatoid arthritis | #1 |
| dimethyl6n | #1 |
| mab cb268 | #1 |
| ul1 ciif4 | #1 |
| cii swr mice | #1 |
| chondrocytes kgf | #1 |
| plasminogen deficiency cia | #1 |
| congenic arthritis | #1 |
| rats phytol | #1 |
| arthritis rabeximod | #1 |
| ncf1da | #1 |
| animal genes cia | #1 |
| arthritis immunization | #1 |
| cia experimental arthritis | #1 |
| cells arthritis progression | #1 |
| peptide agonist fmlf | #1 |
| nox2derived ros mice | #1 |
| ciilysdnp | #1 |
| hla–dr1 | #1 |
| region ncf1 | #1 |
| periodontitis pristaneinduced arthritis | #1 |
| susceptibility cia | #1 |
| citrullinated cii | #1 |
| cartilage explants m2139 | #1 |
| gene ncf1 | #1 |
| dba mouse epitopes | #1 |
| cix disease | #1 |
| animal histocompatibility | #1 |
| eae3 chromosome | #1 |
| eae2 locus | #1 |
| induce arthritis | #1 |
| physiological doses development | #1 |
| u1 antibodies patients | #1 |
| immunization heterologous peptide | #1 |
| nodq nod | #1 |
| mouse chromosome eae39 | #1 |
| mbpc5a | #1 |
| presence mhv | #1 |
| qtl chip | #1 |
| rats severity | #1 |
| collagen antibody arthritis | #1 |
| mem lglutamine | #1 |
| nonglycosylated peptide | #1 |
| effector phase arthritis | #1 |
| experimental arthritis antibodies | #1 |
| mbq mouse macrophages | #1 |
| functional nox2 | #1 |
| mgpi325 | #1 |
| acute arthritis neutrophils | #1 |
| cxi comp | #1 |
| developed severe | #1 |
| illness cia | #1 |
| b10q mice authors | #1 |
| normal cartilage arthritis | #1 |
| ros rheumatoid humans | #1 |
| genes ncf1 | #1 |
| rt1l haplotypes | #1 |
| denidritic cells | #1 |
| myelomonocytic arthritis interleukin2 | #1 |
| arthritis pnipaam | #1 |
| macrophages mannans | #1 |
| ciif4 mab | #1 |
| mbq mouse | #1 |
| cii immunization treatment | #1 |
| ifn signature mice | #1 |
| severe arthritis immunization | #1 |
| cells synthetic glycopeptides | #1 |
| chronic arthritis mice | #1 |
| cd4 treatment | #1 |
| nod loci genes | #1 |
| phase arthritis | #1 |
| g6pi acute arthritis | #1 |
| comp experimental autoantibodies | #1 |
| mir144 tlr2 expression | #1 |
| ncf1m1j mutation | #1 |
| region eae2 | #1 |
| ros experimental arthritis | #1 |
| cii mabs | #1 |
| cholera toxin study | #1 |
| anticii autoantibodies | #1 |
| rats rheumatoid | #1 |
| ncf1 mutation mice | #1 |
| mhc‐congenic mouse strains | #1 |
| ifnbeta arthritis | #1 |
| idd5 loci | #1 |
| rfig lambda | #1 |
| chemiluminescent probe l012 | #1 |
| cia ul1 | #1 |
| functional ncf1 macrophages | #1 |
| cxiia | #1 |
| cia antigens haplotypes | #1 |
| arthritis synovial tlr3 | #1 |
| arthritis arthritis loci | #1 |
| humans animals arthritis | #1 |
| chromosomes eae loci | #1 |
| arthritis susceptibility rats | #1 |
| comp arthritis models | #1 |
| cia40 | #1 |
| tissue attack | #1 |
| suppressive development | #1 |
| encephalomyelitis arthritis | #1 |
| collagen antibodies | #1 |
| function single | #1 |
| nox2 function | #1 |
| single bout hiit | #1 |
| mab ciif4 ciic1 | #1 |
| ncf1 association | #1 |
| rat comp | #1 |
| cii olive oil | #1 |
| liver histone deacetylase | #1 |
| synovial membranes joints | #1 |
| rat comp arthritis | #1 |
| arthritis male | #1 |
| mice ncf1 | #1 |
| cii cells | #1 |
| nod nss1 | #1 |
| cii anticd4 treatment | #1 |
| cia5 cia21 | #1 |
| susceptibility collageninduced arthritis | #1 |
| cia rat cii | #1 |
| b10dr4ncf1 mice | #1 |
| cii immunodominant | #1 |
| eae39 locus cia | #1 |
| induction postpartum flare | #1 |
| non‐mhc genes | #1 |
| 22 variant r620w | #1 |
| topoisomerase antagonist | #1 |
| collagen arthritis iii | #1 |
| 6 cii | #1 |
| cia locus | #1 |
| bb2bb3 | #1 |
| cii cxi | #1 |
| ncf1 sle | #1 |
| hyaluronanreceptor cd44 | #1 |
| lewis rat cia | #1 |
| pregq2 fragment | #1 |
| 371115tetramethyl2hexadecene1ol | #1 |
| collagen epitopes | #1 |
| mab ecm | #1 |
| il10 cia | #1 |
| nodq locus | #1 |
| critical restriction site | #1 |
| oestradiol exacerbation | #1 |
| pathogenesisis | #1 |
| arthritis autoantibody | #1 |
| cb268 | #1 |
| bb2bb3 regulation | #1 |
| aq glycopeptide | #1 |
| tlr3 expression fls | #1 |
| mhc influence | #1 |
| caia experimental arthritis | #1 |
| mbp c5a | #1 |
| mcii707 | #1 |
| specific cii | #1 |
| pv cd4 cells | #1 |
| nox2complex | #1 |
| tracheolaryngeal | #1 |
| ncf1 mutated | #1 |
| arthritis mutant strains | #1 |
| peritonitis transgenic | #1 |
| response splenocytes | #1 |
| double deficiency qa2 | #1 |
| cb268 cii | #1 |
| dba 1 | #1 |
| m1j mice | #1 |
| response cii | #1 |
| sle‐prone mrl | #1 |
| cia opportunities | #1 |
| hydrocarbon oil structure | #1 |
| genes arthritis | #1 |
| cells mgps | #1 |
| cia2 cia9 | #1 |
| ros mip | #1 |
| collagen type‐ii epitope | #1 |
| polymorphism autoimmune diseases | #1 |
| ncf4 | #1 |
| pc8 pc117 | #1 |
| arthritis pepsin | #1 |
| pia cia13 pia7 | #1 |
| b10qacb | #1 |
| disease lew | #1 |
| eae2 eae3 | #1 |
| type collagen cia | #1 |
| antiidiotypic antibodies cd4 | #1 |
| pathogenesis cia | #1 |
| type collagens rats | #1 |
| ciid3 | #1 |
| cii ciif4 | #1 |
| cii cartilage | #1 |
| disease th1 immunity | #1 |
| mice c3h background | #1 |
| eae39 | #1 |
| ncf1 polymorphisms | #1 |
| protective alleles eae2 | #1 |
| arthritis multiple | #1 |
| effects cia | #1 |
| tlr2 tlr2 regulation | #1 |
| b10qnss1 | #1 |
| qa2 gene clusters | #1 |
| tumors immunosuppressive leukocytes | #1 |
| ncf1 polymorphism | #1 |
| animal models complexity | #1 |
| cuiiidaligands | #1 |
| disease arthritis | #1 |
| cii 6 | #1 |
| hydrolyzed igg | #1 |
| arthritis injection | #1 |
| synovial cells macrophages | #1 |
| disease suggestive locus | #1 |
| identification genetic regions | #1 |
| type cii | #1 |
| induction phase cia | #1 |
| cii mab | #1 |
| cia compdeficient mice | #1 |
| rats rt1f mhc | #1 |
| swr nfr | #1 |
| phenotypes ncf1m1j mice | #1 |
| thymectomy transgenes | #1 |
| presence sex hormones | #1 |
| collagen langerhans cells | #1 |
| cii256 270 | #1 |
| development pristaneinduced arthritis | #1 |
| human immunopeptidome lung | #1 |
| rats pia9 alleles | #1 |
| cia32 | #1 |
| pristaneinduced arthritis | #1 |
| f1 males influence | #1 |
| immune cartilage | #1 |
| fecq4 fragment | #1 |
| cii256 | #1 |
| cxi chronic arthritis | #1 |
| rheumatoid arthritis complexity | #1 |
| nasal treatment ctbcii | #1 |
| rat cii cii | #1 |
| cia rheumatoid arthritis | #1 |
| nephritis nodq | #1 |
| loci cia2 | #1 |
| arthritis toe stiffness | #1 |
| δ228 | #1 |
| induced relapsing | #1 |
| pia cix | #1 |
| ciic1 mab ciif4 | #1 |
| ctbcii | #1 |
| mice salt intake | #1 |
| inbred dba cii | #1 |
| disease susceptibility castration | #1 |
| tolerance immunodominant | #1 |
| arthritis estrogen | #1 |
| c57bl 10q | #1 |
| ciic1scfv | #1 |
| arthritis antibody | #1 |
| mhc mbp | #1 |
| caia induced | #1 |
| adjuvanticity autoimmunity | #1 |
| pia blocking arthritis | #1 |
| tracheolaryngeal cartilage | #1 |
| mice burkholderia cepacia | #1 |
| tlr3 pristane | #1 |
| glycosylated epitope | #1 |
| aq molecule | #1 |
| cii severity | #1 |
| monoclonal cartilage cattle | #1 |
| genome b10riii | #1 |
| antibodies consensus motif | #1 |
| ciif4 adverse effects | #1 |
| autoimmune arthritis activation | #1 |
| tlr3 expression tnfα | #1 |
| induced arthritis | #1 |
| autoantibodies cartilage | #1 |
| gergaagiagpk | #1 |
| pia experimental chromosomes | #1 |
| cia13 pia7 | #1 |
| anti type | #1 |
| stromal cells osteoclasts | #1 |
| mice cryogels | #1 |
| major locus cia | #1 |
| hg6pi | #1 |
| congenic | #1 |
| sod3 peritonitis | #1 |
| rat cb10 cb11 | #1 |
| representative swedish | #1 |
| glycosylated determinant peptides | #1 |
| tolerance arthritis susceptibility | #1 |
| myeloid effector functions | #1 |
| induced arthritis rats | #1 |
| arthritis animals | #1 |
| cia mip | #1 |
| multiple sclerosis rabeximod | #1 |
| hybridomas multispecific antibodies | #1 |
| mutant p47phox | #1 |
| immunization mouse | #1 |
| polymer adjuvant activity | #1 |
| cii peptides | #1 |
| aq molecules | #1 |
| arthritis collagen | #1 |
| lys264 | #1 |
| complex aq molecules | #1 |
| tolerance arthritis protection | #1 |
| recombinant vaccine inflammation | #1 |
| rats pristane | #1 |
| ncf1 genes | #1 |
| cia mhc | #1 |
| selfcii | #1 |
| cartilage explants ciic1 | #1 |
| w33t | #1 |
| immunization lathyritic cii | #1 |
| glut4dependent glucose transport | #1 |
| cxi rats | #1 |
| chronic pristane | #1 |
| immunospecific reactions | #1 |
| cia eae39 | #1 |
| arthritis humans | #1 |
| mediate pulmonary inflammation | #1 |
| pristaneinduced arthritis pia | #1 |
| lower capacity ros | #1 |
| major cii | #1 |
| cartilage damage vivo | #1 |
| arthritis b6n mice | #1 |
| comp cii | #1 |
| dominant susceptibility loci | #1 |
| activation cii | #1 |
| ethylene isostere | #1 |
| cryogel matrix cells | #1 |
| estrogen manifestations | #1 |
| 4 histone deacetylases | #1 |
| functional ncf1 | #1 |
| carbohydrates cii | #1 |
| arthritis congenic | #1 |
| patients china cohort | #1 |
| tlr3 expression flss | #1 |
| kupffer cells mir144 | #1 |
| models collagen | #1 |
| socalled collagen antibody | #1 |
| disease transgenic models | #1 |
| ciic1 ciif4 | #1 |
| disease glycoproteins | #1 |
| copy variation ncf1 | #1 |
| sialadenitis strains | #1 |
| rats synthetic peptide | #1 |
| arthritis adjuvants | #1 |
| cii induce | #1 |
| fecq4 | #1 |
| deficient ncf1 | #1 |
| pristane tlr3 expression | #1 |
| chromosome 17 mhc | #1 |
| pristane hydrocarbon oils | #1 |
| pia8 | #1 |
| cia antibody response | #1 |
| arthritis autoimmune | #1 |
| synovium pia rats | #1 |
| cia collagen | #1 |
| rt1u lew1w | #1 |
| susceptible strain cross | #1 |
| spe acute phase | #1 |
| b10qc5δ | #1 |
| ifa cii ifa | #1 |
| c1iii type collagen | #1 |
| backcrosses nzb mice | #1 |
| predominant selection | #1 |
| b10qbalb | #1 |
| daxlewf1 | #1 |
| partial advanced | #1 |
| spleen cluster | #1 |
| oils induce | #1 |
| arthritis castration | #1 |
| mice salt concentrations | #1 |
| innate‐associated disease | #1 |
| b10q | #1 |
| antigen presentation cii | #1 |
| immunization heterologous cii | #1 |
| autoimmunogenic hydrocarbon oils | #1 |
| b10q mice | #1 |
| rats ncf1 | #1 |
| maintenance arthritis | #1 |
| kgf thymus | #1 |
| reduced oxidative burst | #1 |
| b10q b10riii | #1 |
| inbred dba pepsin | #1 |
| autologous peptide cells | #1 |
| monoclonal arthritis arthritis | #1 |
| rheumatoid collagen | #1 |
| pristaneprimed cells | #1 |
| disease cd8 deficiency | #1 |
| ros adaptive immunity | #1 |
| arthritis cia | #1 |
| development chronic arthritis | #1 |
| reactivity cb268 | #1 |
| cii cb fragments | #1 |
| arthritis genetics | #1 |
| autoantibody formation cia | #1 |
| arthritis pia | #1 |
| genetic variants ncf1 | #1 |
| pia11 | #1 |
| rt1f haplotype | #1 |
| kgf treatment onset | #1 |
| collageninduced arthritis loci | #1 |
| cartilage antibody | #1 |
| rheumatoid drug evaluation | #1 |
| anti cii acpa | #1 |
| h2p h2q haplotype | #1 |
| cia reduction | #1 |
| presence arthritogenic mabs | #1 |
| rat rt1ba genes | #1 |
| pristane primed | #1 |
| autoantibodies cii | #1 |
| data act389949 | #1 |
| methods | #1 |
| nss1 | #1 |
| cia2 arthritis | #1 |
| sialadenitis cell phenotypes | #1 |
| cia oestrogen | #1 |
| polymorphic fragment | #1 |
| ciic1 mabs | #1 |
| dendritic cells collagen | #1 |
| superovulation rate | #1 |
| maintained pregnancy levels | #1 |
| nrc ova | #1 |
| glycosylation hla | #1 |
| cells dba mouse | #1 |
| bqncf1m1j | #1 |
| nod nss1 loci | #1 |
| comp cxi | #1 |
| psiechch | #1 |
| nonglycosylated epitope | #1 |
| increased salt exposure | #1 |
| rheumatoid arthritis autoimmunity | #1 |
| cia development | #1 |
| headache paradigm | #1 |
| cii antibodies | #1 |
| genetic regions | #1 |
| ros antigens | #1 |
| ncf1 copy variation | #1 |
| compdeficient mice | #1 |
| ym1deficient mice | #1 |
| heterologous peptide response | #1 |
| tlr3 upregulation flss | #1 |
| autoimmunity mineral oils | #1 |
| ros continental ancestry | #1 |
| rats antibody response | #1 |
| mucosal tolerance cii | #1 |
| antitlr3 antibody | #1 |
| disease collagen | #1 |
| collagen arthritis hyaluronanreceptor | #1 |
| mice darkness | #1 |
| mip cia | #1 |
| periodontitis rats pia | #1 |
| autologous cii | #1 |
| arthritis gene regions | #1 |
| beta 10b mrl | #1 |
| wt ncf1 | #1 |
| pristane macrophages | #1 |
| hg6pi325 | #1 |
| macrophage ros | #1 |
| peritonitis sod3 | #1 |
| arthritis estrus cycle | #1 |
| active arthritis complex | #1 |
| oestrogen‐induced suppression | #1 |
| oestrogen cia | #1 |
| locus arthritis | #1 |
| rheumatoid arthritis immunization | #1 |
| cb11 sequence cii | #1 |
| protein ncf1m1j mice | #1 |
| mannan mice | #1 |
| polychondritis mice | #1 |
| polymorphism mitochondrial genome | #1 |
| cia21 lymph nodes | #1 |
| genetic background rats | #1 |
| antibody responses cii | #1 |
| eae b10riii mice | #1 |
| collageninduced arthritis | #1 |
| ros rns inflammation | #1 |
| dr4 glycopeptides | #1 |
| cia cells | #1 |
| oestradiol dth | #1 |
| cells cb11 | #1 |
| cia9 | #1 |
| controlling onset | #1 |
| arthritis intraperitoneal injection | #1 |
| cii vivo | #1 |
| cia olive oil | #1 |
| β1helix | #1 |
| lack arthritis | #1 |
| cxi 6 | #1 |
| 339 polymorphism | #1 |
| hexadecane induce arthritis | #1 |
| cii caia | #1 |
| chromosome cia | #1 |
| immunization type | #1 |
| disease affinity | #1 |
| mice arthritis | #1 |
| arthritis naive mice | #1 |
| protective role cia | #1 |
| hladrβ10402 | #1 |
| etoposide topoisomerase antagonist | #1 |
| cartilage explants mabs | #1 |
| ncf1 mice wt | #1 |
| nadph activation | #1 |
| sensitive wkymvm | #1 |
| spleen pristane injection | #1 |
| siliac | #1 |
| caia gene segments | #1 |
| treatment cii immunization | #1 |
| bond requirements | #1 |
| cii molecule | #1 |
| antibody induced | #1 |
| tcell hybridomas cells | #1 |
| native cii | #1 |
| ncf1m1j mice | #1 |
| chick cii cii | #1 |
| modified glycopeptides | #1 |
| ncf1mutation | #1 |
| impact etoposide | #1 |
| eae39 study | #1 |
| positional identification | #1 |
| transient joint inflammation | #1 |
| dth dba 1 | #1 |
| antibody binding vivo | #1 |
| oxa nzb mice | #1 |
| lew1w rt1u | #1 |
| arthritis anticii abs | #1 |
| ciic1 m2139 | #1 |
| development cia | #1 |
| toxin‐1‐producing staphylococci | #1 |
| phagocytic nox2 complex | #1 |
| genes congenic | #1 |
| constant light order | #1 |
| genes animal models | #1 |
| lew mol strain | #1 |
| promoter regions antigens | #1 |
| cii response | #1 |
| arthritis animal mice | #1 |
| inconsistent susceptibility | #1 |
| joint proteins | #1 |
| antibodies citrullinated peptide | #1 |
| mice th1 cytokines | #1 |
| arthritis traits | #1 |
| arthritis qtl chip | #1 |
| susceptible collagen | #1 |
| rats ncf1 allele | #1 |
| new therapy arthritis | #1 |
| acpas specificity | #1 |
| driven psoriatic arthritis | #1 |
| dominant hypersensitivity | #1 |
| estrogenmediated suppression | #1 |
| homologous type pia | #1 |
| placental mhc class | #1 |
| mice h2q | #1 |
| rat cii | #1 |
| recognition lysine | #1 |
| cii rats | #1 |
| specific antibody protection | #1 |
| phemagelatin | #1 |
| cii recognition | #1 |
| rat congenic data | #1 |
| controlling collagen | #1 |
| differences ncf1 | #1 |
| function ncf1 gene | #1 |
| role nox2derived ros | #1 |
| cii epitopes | #1 |
| cii responsiveness | #1 |
| injection adjuvant oils | #1 |
| insulitis strains | #1 |
| chronic active arthritis | #1 |
| dth response mrl | #1 |
| strains developed | #1 |
| citrullinated type collagen | #1 |
| cii immunization | #1 |
| arthritis loci | #1 |
| eae2 chromosome | #1 |
| chronic intervention | #1 |
| arthritis induced | #1 |
| publication animals arthritis | #1 |
| fpr1 agonist neutrophils | #1 |
| autoantibody responses cii | #1 |
| eae chromosomes | #1 |
| isolated fragment chromosome | #1 |
| cia comp | #1 |
| ifnbeta deficiency | #1 |
| caia cia | #1 |
| ciif4 ciic1 | #1 |
| type collagen cii256−270 | #1 |
| carcinoma tumors ros | #1 |
| b10riii | #1 |
| development humanized models | #1 |
| receptor γ pparγ | #1 |
| heterologous cii | #1 |
| congenic polymorphism illness | #1 |
| arthritis ncf1 | #1 |
| concentrations rat cii | #1 |
| arthritis development cross | #1 |
| development inflammatory attack | #1 |
| position cii256270 | #1 |
| eae39 control disease | #1 |
| melatonin release pinealectomy | #1 |
| dba 1j | #1 |
| genetically segregating crosses | #1 |
| valphachain | #1 |
| emulsions induction | #1 |
| naive experimental chromosomes | #1 |
| citrullination cii | #1 |
| mhc aq | #1 |
| rats terpenes | #1 |
| arthritis encephalomyelitis | #1 |
| arthritis amino | #1 |
| cb11 fragment | #1 |
| models rheumatoid | #1 |
| arthritis severity rats | #1 |
| cia model strains | #1 |
| re04001activatedfpr1 | #1 |
| new loci controlling | #1 |
| ros nox2 complex | #1 |
| nod incidence | #1 |
| congenic cia40 | #1 |
| developed arthritis | #1 |
| mice mutated type | #1 |
| nox2 agonists | #1 |
| pristane cell death | #1 |
| disease c4bp | #1 |
| nodq nod nodp | #1 |
| h2w3 | #1 |
| mediating arthritis | #1 |
| 237 females | #1 |
| epitopes cb11 fragment | #1 |
| rats comp | #1 |
| ncf1 mutant mice | #1 |
| arthritis control mice | #1 |
| cii256−270 | #1 |
| genetic control sialadenitis | #1 |
| congenic strains rats | #1 |
| respiratory burst severity | #1 |
| formation arthritis | #1 |
| igg response cii | #1 |
| satellite encephalomyelitis autoimmune | #1 |
| ltabncr3 | #1 |
| cii experimental arthritis | #1 |
| homologous type collagen | #1 |
| role ncf1 | #1 |
| rats congenic arthritis | #1 |
| macrophages hladr1transgenic mice | #1 |
| da1f | #1 |
| chronic arthritis development | #1 |
| chromosome f1 males | #1 |
| cells caia | #1 |
| rabeximod | #1 |
| nucleotide reactive | #1 |
| polychondritis autoimmune disease | #1 |
| chlorophyll component | #1 |
| ncf1 | #1 |
| e3xda | #1 |
| cia f1 males | #1 |
| clec4b | #1 |
| strains nodq | #1 |
| dba 1jpfp cia | #1 |
| mice interferon gamma | #1 |
| collagen arthritis progesterone | #1 |
| phytol molecular pathways | #1 |
| position 264 | #1 |
| cia homologous cii | #1 |
| cii lewis rats | #1 |
| 2 nox2 | #1 |
| phytol arthritis | #1 |
| illness terpenes | #1 |
| arthritis caia | #1 |
| ciispecific cell responses | #1 |
| arthritis mhc | #1 |
| caia lps | #1 |
| ncf4 nox2 complex | #1 |
| recombinants rt1u | #1 |
| ncf1 339 | #1 |
| cia animal models | #1 |
| antibody response cii | #1 |
| tlr3 rna interference | #1 |
| oxidases polymers | #1 |
| idiotype‐specific binding | #1 |
| mice functional ncf1 | #1 |
| mip ncf4 | #1 |
| animal genetic predisposition | #1 |
| chemical cartilage | #1 |
| swr mice immunization | #1 |
| cells arthritogenicity | #1 |
| peripheral cells alphachains | #1 |
| existence periodontitis | #1 |
| g6pi chronic arthritis | #1 |
| severity ides | #1 |
| arthritis tlr3 | #1 |
| cii260‐270 | #1 |
| disease monitoring rats | #1 |
| glycosylated cii | #1 |
| riiis alleles eae2 | #1 |
| dapia6 | #1 |
| lew ztm ncf1 | #1 |
| mabs monoclonal arthritis | #1 |
| tcell congenic arthritis | #1 |
| vivo treatment | #1 |
| cell tolerance cii | #1 |
| h2p mice cia | #1 |
| ciispecific cells day | #1 |
| cia animal epitopes | #1 |
| collagen hybridomas | #1 |
| tlr3 tlr3 expression | #1 |
| estrogen immune responses | #1 |
| dominant traits | #1 |
| fpr act389949 | #1 |
| animal models arthritis | #1 |
| c4bp alternative pathway | #1 |
| major epitopes | #1 |
| mmc transgene | #1 |
| flss tlr3 expression | #1 |
| region eae3 | #1 |
| psich2nh2 | #1 |
| cia mtx | #1 |
| mouse cii | #1 |
| ftirm mice | #1 |
| vivo imaging l012 | #1 |
| clec4b ncf1 | #1 |
| injection mannan | #1 |
| tolerance arthritis | #1 |
| citrullinated type | #1 |
| model rheumatoid | #1 |
| autoimmune priming | #1 |
| rats antibody cartilage | #1 |
| emission tomography mannan | #1 |
| cia cii | #1 |
| arthritis males | #1 |
| prevents arthritis | #1 |
| salivary glands antigen | #1 |
| cia31 | #1 |
| endos hydrolyzed igg | #1 |
| terpenes toll | #1 |
| rats pristaneinduced arthritis | #1 |
| ul1 vivo | #1 |
| congenic c57bl mice | #1 |
| pepsin immunization | #1 |
| experimental autoantibodies | #1 |
| oxidative burst disease | #1 |
| obs electrophoresis | #1 |
| immunologic animals arthritis | #1 |
| cd2 human cells | #1 |
| function acpas | #1 |
| cia ul1 mab | #1 |
| gia expansion | #1 |
| citrulline collagen | #1 |
| cii u1 | #1 |
| complex cia | #1 |
| liver contributes hfdmets | #1 |
| pristane induced | #1 |
| severe polyarthritis | #1 |
| cia ifa | #1 |
| ifa rats | #1 |
| galactosylated peptide | #1 |
| b10dr4ncf1 mice cii | #1 |
| arthritogenic antibodies | #1 |
| p47phoxv232 | #1 |
| differential susceptibility cia | #1 |
| qa2 natural mutations | #1 |
| rats adjuvant oil | #1 |
| disease genotype immunoglobulin | #1 |
| protein expression genes | #1 |
| cartilagespecific protein | #1 |
| pregq2 | #1 |
| realtime pcr flss | #1 |
| cells cii | #1 |
| act389949 fpr2 | #1 |
| chronicity arthritis | #1 |
| effects ciif4 | #1 |
| ym1 pneumonitis | #1 |
| beta 10b beta | #1 |
| anticii response | #1 |
| caia kgf | #1 |
| lathyritic cii | #1 |
| cii induced arthritis | #1 |
| cii259 273 | #1 |
| features arthritis | #1 |
| cii cia | #1 |
| satellite encephalomyelitis | #1 |
| h2w17 | #1 |
| male mice arthritis | #1 |
| alpha type collagen | #1 |
| cia b10q | #1 |
| phase cia | #1 |
| ii‐induced arthritis | #1 |
| ncf1 gene | #1 |
| alphachains cell surface | #1 |
| arthritis pristane | #1 |
| vivo monoclonal mouse | #1 |
| experimental autoantigens | #1 |
| hfdmets | #1 |
| ciic1 fab | #1 |
| ncf4 mip | #1 |
| model rheumatoid arthritis | #1 |
| dnp epitopes lysine | #1 |
| enhanced autoimmunity | #1 |
| oxoethyl6h | #1 |
| ym1 alternative activation | #1 |
| ciispecific | #1 |
| fibroblasts ifnbetadeficient mice | #1 |
| vivo monoclonal | #1 |
| upregulation tlr3 | #1 |
| b10q mice ncf1 | #1 |
| ncf1 allele | #1 |
| native comp | #1 |
| elisagenetyping | #1 |
| u1 epitope | #1 |
| arthritogenicity cells | #1 |
| ox8 antibodies | #1 |
| eae mtx | #1 |
| arthritis onset severity | #1 |
| anticii abs | #1 |
| 17βestradiolregulation | #1 |
| 1 ncf1 | #1 |
| treatment pia | #1 |
| pc117 extracellular structures | #1 |
| peptides aq | #1 |
| development collagen | #1 |
| pathway arthritis | #1 |
| cia il10 | #1 |
| congenic mice genes | #1 |
| rats arthritis | #1 |
| concentrations cii | #1 |
| mab mab ciic1 | #1 |
| collagen reactivity cxi | #1 |
| glycosylation cell recognition | #1 |
| position ciilysdnp | #1 |
| arthritis monoclonal arthritis | #1 |
| haplotypes h2q | #1 |
| h2r h2q | #1 |
| pepsin arthritis | #1 |
| arthritis immunisation | #1 |
| bal cells work | #1 |
| rat placenta uterus | #1 |
| arthritis transfer | #1 |
| collagen cii | #1 |
| ncf1deficient mice | #1 |
| cia ros | #1 |
| pinealectomy exposure | #1 |
| heterologous collagen | #1 |
| rats pia | #1 |
| presentation cii | #1 |
| experimental chromosomes | #1 |
| minimal glycopeptide core | #1 |
| avridine arthritis | #1 |
| tolerance cia | #1 |
| flss polyi | #1 |
| adjuvant oils | #1 |
| anticii antibody response | #1 |
| macrophages cii degradation | #1 |
| pia model | #1 |
| cii rheumatoid autoantibodies | #1 |
| mcaia | #1 |
| cia12 | #1 |
| caia mab | #1 |
| reproductive performance identification | #1 |
| new arthritis therapy | #1 |
| pia7 | #1 |
| cell recognition carbohydrates | #1 |
| homologous cii | #1 |
| caia riiis segment | #1 |
| cii h2p | #1 |
| rheumatoid disease models | #1 |
| ncf1 knockout | #1 |
| immunization cii | #1 |
| mice ros | #1 |
| act389949 | #1 |
| hyaluronanreceptor | #1 |
| lpscaia | #1 |
| dba1 mice | #1 |
| b10q strain | #1 |
| severity pia | #1 |
| h2q mice | #1 |
| anti collagen | #1 |
| epitopes collagen | #1 |
| collagen iiinduced arthritis | #1 |
| inflammatory tissue attack | #1 |
| p47phox ncf1 | #1 |
| cii h2q | #1 |
| type collagen cxi | #1 |
| antigenic adjuvant | #1 |
| congenic polymorphism | #1 |
| immunization mouse cii | #1 |
| c3hnb h2p | #1 |
| drb10401 col2259 | #1 |
| caia effects | #1 |
| rat cii arthritis | #1 |
| arthritogenic mab ciic1 | #1 |
| arthritis‐susceptibility loci | #1 |
| surface redox levels | #1 |
| cells rat cii | #1 |
| cells galactosylated peptide | #1 |
| c3hq mice | #1 |
| cartilage‐specific antibodiesis | #1 |
| enhanced autoimmunity arthritis | #1 |
| cia congenic arthritis | #1 |
| cia5 qtl | #1 |
| arthritis independent | #1 |
| eae strains severity | #1 |
| psoriasis spread | #1 |
| oestrogen‐induced | #1 |
| wild type ncf1 | #1 |
| presentation arthritis | #1 |
| oestrogen treated | #1 |
| disease dba 1jpfp | #1 |
| hufcgammariia | #1 |
| plasminogendeficient mice arthritis | #1 |
| collagen dendritic cells | #1 |
| polyi arthritis | #1 |
| mcaia ncf1 | #1 |
| pia3 chromosome | #1 |
| polyi pia rats | #1 |
| macrophages cii | #1 |
| animals arthritis | #1 |
| spread psoriasis | #1 |
| immunisation cells | #1 |
| 15a11 | #1 |
| loci controlling diabetes | #1 |
| concentrations mouse cii | #1 |
| rheumatoid arthritis eae | #1 |
| cii immunization mice | #1 |
| arthritis suppression | #1 |
| pia cii | #1 |
| targeted mutation ncf4 | #1 |
| dth nzb | #1 |
| cii256270 | #1 |
| dba 1 mouse | #1 |
| histology vaccination | #1 |
| citc1iiip | #1 |
| ncf1 deficient | #1 |
| genistein collagen | #1 |
| cia caia | #1 |
| arthritis aim | #1 |
| tnfα tlr3 expression | #1 |
| arthritis cell | #1 |
| rats hfdmets | #1 |
| fibroblast induced arthritis | #1 |
| cia11 | #1 |
| h2g7 haplotype nod | #1 |
| visual signs arthritis | #1 |
| disease development effects | #1 |
| caia acute arthritis | #1 |
| cell determinants cii | #1 |
| specificity arthritis | #1 |
| lewis rats pepsin | #1 |
| dth dominant hypersensitivity | #1 |
| vridine‐induced arthritis | #1 |
| genetic encephalomyelitis autoimmune | #1 |
| cathelicidin expression blood | #1 |
| ecm mab | #1 |
| genetic crossbreeding | #1 |
| cii pepsin | #1 |
| cnbr‐fragment | #1 |
| arthritis driven | #1 |
| mice l012 | #1 |
| fcγr3 | #1 |
| abetachains | #1 |
| caia model | #1 |
| pia disease | #1 |
| cells heterologous cii | #1 |
| pia model rats | #1 |
| emerging glyco‐based strategies | #1 |
| preformed cartilage | #1 |
| c3bireceptors | #1 |
| h2q c3hnb | #1 |
| cia induced arthritis | #1 |
| rats cxi | #1 |
| suggestive locus chromosome | #1 |
| collagen autoantibody | #1 |
| antibody cartilage blymphocyte | #1 |
| pia4 chromosome | #1 |
| increased incidence cia | #1 |
| l012 vivo imaging | #1 |
| c3hnb | #1 |
| humanized models disease | #1 |
| deficient neonatal | #1 |
| cii cartilage explants | #1 |
| ftirm cii | #1 |
| adaptive immunity fcγrs | #1 |
| immunization rat cii | #1 |
| loci eae39 | #1 |
| arthritogenic antibody | #1 |
| cii human | #1 |
| kgf cia | #1 |
| cartilage‐specific | #1 |
| marginal ankylosis | #1 |
| development aureus arthritis | #1 |
| anticlever1 antibody treatment | #1 |
| ciif4 cartilage explants | #1 |
| ciispecific monoclonal | #1 |
| ncf1m1j mice function | #1 |
| cii 256270 peptide | #1 |
| pia2–8 | #1 |
| nox2derived ros | #1 |
| congenic fragments | #1 |
| therapeutic c4bp | #1 |
| arthritis development immunisation | #1 |
| beta 812 | #1 |
| immunodominant cii | #1 |
| contrast nodq | #1 |
| lpr mice granulocytes | #1 |
| striking phenotypic similarities | #1 |
| dth nzb mice | #1 |
| serum chromosome | #1 |
| transgenic nadph | #1 |
| ncf1 lyme arthritis | #1 |
| cia cartilage | #1 |
| sialadenitis arthritis | #1 |
| oxa backcrosses | #1 |
| rat cb11 immunization | #1 |
| animal epitopes injections | #1 |
| ciiderived | #1 |
| cartilage specific | #1 |
| experimental collagen | #1 |
| stages arthritis | #1 |
| ppt medium | #1 |
| pepsin cii | #1 |
| chromosome pia | #1 |
| ciilysdnp mice | #1 |
| expression liver receptor | #1 |
| cii261 | #1 |
| ncf1 ros | #1 |
| cia22 | #1 |
| cii acpa | #1 |
| collagen epitope expression | #1 |
| tregs ros | #1 |
| c57bl strains loci | #1 |
| mice anticd4 treatment | #1 |
| collagen type cii | #1 |
| major epitopes patients | #1 |
| damage type collagen | #1 |
| qtl positional cloning | #1 |
| arthritis promoting | #1 |
| restricted role fcγr | #1 |
| cxi collagen fibers | #1 |
| pia rats tlr3 | #1 |
| cii259273 peptide | #1 |
| antibodies pc4 | #1 |
| cia21 cia22 | #1 |
| established arthritis | #1 |
| fecq4 locus | #1 |
| c3hq mice cii | #1 |
| nox2 complex | #1 |
| oxazolone inflammatory response | #1 |
| cxi | #1 |
| collagen ii‐induced | #1 |
| psicoch2 | #1 |
| rats mhc genes | #1 |
| immune priming events | #1 |
| cells cia | #1 |
| ncf1 p47phox | #1 |
| psoriasis single locus | #1 |
| m1s1a | #1 |
| cii 256 | #1 |
| female preponderance development | #1 |
| congenic strains cia | #1 |
| experimental arthritis articular | #1 |
| ros autoimmune diseases | #1 |
| col2259 | #1 |
| mice mutated cii | #1 |
| function targeted deletion | #1 |
| murine psoriasis model | #1 |
| hdac3 pparγ | #1 |
| psa mip | #1 |
| dominant hypersensitivity dth | #1 |
| single monoclonal | #1 |
| rt1bβ | #1 |
| tumor models ncf1 | #1 |
| cia melatonin | #1 |
| ciispecific cells | #1 |
| sialadenitis congenic mice | #1 |
| pia experimental arthritis | #1 |
| oestradiol suppression | #1 |
| ncf4 gene | #1 |
| ftirm ciic1 | #1 |
| autoimmune diseases cnvs | #1 |
| cia rheumatoid autoantibodies | #1 |
| plcpip | #1 |
| tolerance collagen | #1 |
| genes antibodies | #1 |
| synthetic peptides cii | #1 |
| signaling characterization | #1 |
| fecq3 | #1 |
| cii sera | #1 |
| ncf1m1j m1j mice | #1 |
| major antigenic epitope | #1 |
| rheumatoid arthritis cii | #1 |
| c3hq | #1 |
| arthritis rheumatoid arthritis | #1 |
| role eosinophilia | #1 |
| lnchc cholesterol metabolism | #1 |
| arthritis epitopes | #1 |
| collagen‐induced arthritis | #1 |
| rt1ba | #1 |
| fcbinding | #1 |
| frequency chronic arthritis | #1 |
| oestrogen lupus disease | #1 |
| oxidative burst inducers | #1 |
| elevated th17 cells | #1 |
| targeted deletion ncf1 | #1 |
| arthritis monoclonal | #1 |
| pc117 | #1 |
| comp lack | #1 |
| tlr3 flss | #1 |
| ncf1m1j | #1 |
| expression ncf1 | #1 |
| ability gut protection | #1 |
| chromosome caia | #1 |
| cii cross reactivity | #1 |
| environments mice | #1 |
| cii severe arthritis | #1 |
| keratinocytes dth reaction | #1 |
| pia5 | #1 |
| arthritis experimental | #1 |
| arthritis estrogen treatment | #1 |
| cii antigen presentation | #1 |
| b10qnfr | #1 |
| experimental autoimmunity cells | #1 |
| ncf4 mice | #1 |
| mouse cii reactivity | #1 |
| transgenic nadph oxidase | #1 |
| estrogen physiological doses | #1 |
| position mouse cii | #1 |
| cii monoclonal arthritis | #1 |
| cii cix | #1 |
| collagens antibody | #1 |
| caia cii | #1 |
| reactivity cii | #1 |
| therapeutic cleavage igg | #1 |
| ros immunohistochemistry implants | #1 |
| development collageninduced arthritis | #1 |
| heterologous cii cells | #1 |
| loci sialadenitis | #1 |
| pia rats arthritis | #1 |
| interacting subloci | #1 |
| hiit nox2 activity | #1 |
| arthritismodulating | #1 |
| new arthritis | #1 |
| nodq×b10q | #1 |
| olive oil cii | #1 |
| peptide characterisation | #1 |
| nzw parental | #1 |
| mrl mice estrogen | #1 |
| chromosome congenic strains | #1 |
| ciipeptide | #1 |
| cii cell | #1 |
| autoimmune diseases identification | #1 |
| pristane stimulation | #1 |
| collagen immunization | #1 |
| nzb dth | #1 |
| rabeximod arthritis | #1 |
| cell recognition cii | #1 |
| ciispecific antibodies | #1 |
| increase ncf1 | #1 |
| ala261gly262 | #1 |
| daiu | #1 |
| role major epitopes | #1 |
| rats ncf1 gene | #1 |
| anticii antibodies | #1 |
| cii histocompatibility complex | #1 |
| functional nox2 complex | #1 |
| cells ncf1 | #1 |
| ncf1 nos2 | #1 |
| pparγ cbrh7919 cells | #1 |
| autoimmune response cii | #1 |
| ncf1 ncf1 mice | #1 |
| scarce clinical samples | #1 |
| glycosylated epitope structures | #1 |
| cartilage cii | #1 |
| chronic stage arthritis | #1 |
| downregulating oestradiol | #1 |
| mice cii epitopes | #1 |
| cii development | #1 |
| anticardiolipin antibodies p005 | #1 |
| b10b | #1 |
| epitopes arthritis | #1 |
| ciipeptide cells | #1 |
| pc4 pc117 | #1 |
| fls ppt medium | #1 |
| day ciispecific cells | #1 |
| inflammatory phase arthritis | #1 |
| thps cii | #1 |
| pia9 | #1 |
| collagen reactive | #1 |
| insulitis nodq | #1 |
| arthritis collagen arthritis | #1 |
| cii pia | #1 |
| da1u rat liver | #1 |
| cia tsc transgenic | #1 |
| decreasing activation | #1 |
| ides treatment severity | #1 |
| snat proteins | #1 |
| inflammation caia | #1 |
| arthritis rat | #1 |
| cii rat cii | #1 |
| mechanism autoimmune | #1 |
| cii immunisation | #1 |
| transgenic mice mhcii | #1 |
| c1iii | #1 |
| minor cartilage proteins | #1 |
| h2q haplotype | #1 |
| b10q h2q | #1 |
| sialadenitis nodq | #1 |
| cia13 | #1 |
| pia rheumatoid arthritis | #1 |
| dth mice trait | #1 |
| strains b10q | #1 |
| tlr expression synovium | #1 |
| nox2 complex ncf4 | #1 |
| mhc cia | #1 |
| nox2 functionality | #1 |
| oxidases receptors | #1 |
| established sialadenitis | #1 |
| homologous type | #1 |
| ciic1 antibody | #1 |
| ncf1 mutation | #1 |
| experimental carcinogens | #1 |
| h‐2b | #1 |
| autologous type collagen | #1 |
| h‐2q mice | #1 |
| cii dendritic cells | #1 |
| collagen 256 | #1 |
| vpba pnipaam | #1 |
| mannan joints | #1 |
| denatured cii | #1 |
| intracellular processing cii | #1 |
| arthritis animal | #1 |
| evokes peptide | #1 |
| ciiinduced arthritis | #1 |
| loci arthritis | #1 |
| cia pia | #1 |
| estrogen differential outcome | #1 |
| riiis segment chromosome | #1 |
| sterically privileged | #1 |
| lewis oia | #1 |
| rats rt1 | #1 |
| lps caia | #1 |
| dba 1jpfp | #1 |
| fab2 ciic1 | #1 |
| inflammatory arthritis assessment | #1 |
| nox2 complex addition | #1 |
| rats established pia | #1 |
| citrullinated variants | #1 |
| muscle nox2 | #1 |
| type epitopes | #1 |
| da1u rats expression | #1 |
| antibody ciic1 | #1 |
| pia3 pia4 | #1 |
| il10 mmc | #1 |
| cells autologous cii | #1 |
| g6pi peptide | #1 |
| eae2 resistant locus | #1 |
| arthritis susceptibility mice | #1 |
| cii arthritis | #1 |
| animal immunosuppressive agents | #1 |
| streptococcal endo | #1 |
| cell specificity cii | #1 |
| ncf1339 allele | #1 |
| established pia disease | #1 |
| congenic arthritis rats | #1 |
| hfdmets expression | #1 |
| cii heterologous cii | #1 |
| cia5 region | #1 |
| joint inflammatory phase | #1 |
| cii259 | #1 |
| ncf1 ptpn22 | #1 |
| p47phox mutant | #1 |
| cia induced | #1 |
| tumor colonization | #1 |
| ul1 ciif4 mab | #1 |
| cii ros | #1 |
| serum interferon activity | #1 |
| urokinase enzyme | #1 |
| cartilaginous joints | #1 |
| cii vaccination | #1 |
| cii induced | #1 |
| inclusion negative predictive | #1 |
| act389949 fpr | #1 |
| cartilage collagen type | #1 |
| estrogeninduced suppression | #1 |
| locus cia development | #1 |
| cii citrullinated | #1 |
| greater osteoclasts | #1 |
| olive oil arthritis | #1 |
| mabs cii | #1 |
| f1 hybrids disease | #1 |
| antitype collagen | #1 |
| cii polymer | #1 |
| acpa general population | #1 |
| cia chromosome | #1 |
| kgf chondrocytes | #1 |
| arthritis chronic | #1 |
| celldependent disease | #1 |
| arthritis ul1 | #1 |
| citrullinated collagen | #1 |
| tcell experimental cartilage | #1 |
| mice deficient ncf1 | #1 |
| h2p cia | #1 |
| milk titers | #1 |
| cxi cii | #1 |
| large numbers hybridomas | #1 |
| dba 1 background | #1 |
| animal epitopes | #1 |
| epitope type | #1 |
| dependent autoimmune | #1 |
| mhv runting neonates | #1 |
| cii specific | #1 |
| substrains ztmrhd | #1 |
| type disease | #1 |
| tolerance induction cii | #1 |
| h‐2q | #1 |
| cia h2p | #1 |
| clever1 type macrophages | #1 |
| t‐cell epitope cii260‐270 | #1 |
| collagen induced | #1 |
| arthritis mcaia | #1 |
| bcell activities | #1 |
| ifnbeta experimental arthritis | #1 |
| mice developed | #1 |
| relapsing arthritis | #1 |
| severity cia | #1 |
| comp disease monitoring | #1 |
| cii | #1 |
| anticd4 treatment immunization | #1 |
| rat cii response | #1 |
| act389949 agonist | #1 |
| collagen cxi | #1 |
| congenic mice vdr | #1 |
| confers arthritis susceptibility | #1 |
| frequency igaproducing cells | #1 |
| inbred dba prolactin | #1 |
| arthritis darkness | #1 |
| day acute arthritis | #1 |
| clec4b activation | #1 |
| cii triple | #1 |
| induction oia | #1 |
| authors hgpi325339 peptide | #1 |
| cii major epitope | #1 |
| beta haplotype | #1 |
| mice ncf4 | #1 |
| epitopes cb10 fragment | #1 |
| ncf1 ncf1m1j mutation | #1 |
| incidence nod | #1 |
| engagement fcgammar | #1 |
| ciif4 cartilage damage | #1 |
| spontaneous tissue inflammation | #1 |
| cxi pia | #1 |
| arthritis incidence | #1 |
| mutated ncf1 | #1 |
| dth antibody response | #1 |
| cell‐deficient mice | #1 |
| igg1 igg2b isotypes | #1 |
| b10riii riiis | #1 |
| exacerbation arthritis | #1 |
| development oia | #1 |
| extraarticular cartilage | #1 |
| inbred strains severity | #1 |
| cells mouse cii | #1 |
| early onset development | #1 |
| partial advanced intercross | #1 |
| severity arthritis | #1 |
| lew avridineinduced arthritis | #1 |
| ox8 monoclonal | #1 |
| arthritis locus | #1 |
| cii carbohydrates | #1 |
| strong response epitopes | #1 |
| diabetes sialadenitis | #1 |
| arthritis | #1 |
| csfspecific | #1 |
| saline arthritis | #1 |
| cii epitope | #1 |
| inflammatory phase cia | #1 |
| cxb10qf2 | #1 |
| arthritis qtl pia7 | #1 |
| vivo experimental arthritis | #1 |
| cii260 | #1 |
| cii disease | #1 |
| mannaninduced | #1 |
| cia21 | #1 |
| mumt mice oestrogen | #1 |
| compia | #1 |
| severe arthritis | #1 |
| mice cii immunization | #1 |
| arthritis b10q mice | #1 |
| functional selective fpr1 | #1 |
| caia mutant mice | #1 |
| cia7 chromosome | #1 |
| pristane hexadecane | #1 |
| nzb mice trait | #1 |
| ncf1 mice | #1 |
| onset animals arthritis | #1 |
| j1 epitope | #1 |
| rats chronic disease | #1 |
| day cii immunisation | #1 |
| susceptibility collagen | #1 |
| cxi arthritis | #1 |
| nfr origin | #1 |
| glycosylated cii259 | #1 |
| mannan immune | #1 |
| suppression collagen arthritis | #1 |
| experimental arthritis autoimmune | #1 |
| blocking arthritis | #1 |
| proteins gay | #1 |
| clonal expansion arthritis | #1 |
| macrophages autoimmune priming | #1 |
| selected anti‐t‐cell | #1 |
| anticcp2negative patients | #1 |
| administration antibodies hyaluronanreceptor | #1 |
| rs201802880 | #1 |
| arthritis incidence severity | #1 |
| rats clec4b | #1 |
| mcia1 | #1 |
| immunization rat | #1 |
| dapia3 | #1 |
| chronic arthritis rats | #1 |
| b10dr4ncf1 | #1 |
| immunological transmitter | #1 |
| cia dominant epitope | #1 |
| cii saline | #1 |
| autoimmune arthritis apcs | #1 |
| specificity ros rns | #1 |
| immune response mbp | #1 |
| lymphocytes collagen | #1 |
| acpa discriminate | #1 |
| qtl animal genes | #1 |
| cia oia | #1 |
| molecule aq | #1 |
| sialadenitis incidence | #1 |
| cd43expressing cells | #1 |
| rp autoimmune disease | #1 |
| cii chronic | #1 |
| fecq3 locus | #1 |
| pia eae | #1 |
| defined polymeric adjuvant | #1 |
| epitopes vivo | #1 |
| mhc class injections | #1 |
| post‐partum exacerbation | #1 |
| pia3 | #1 |
| rat recombinants | #1 |
| paamcryogel | #1 |
| cii ncf1 | #1 |
| qa2 ncf1 | #1 |
| healthy nzw | #1 |
| rabeximod treatment | #1 |
| ros glucose transporter | #1 |
| mice ncf1m1j mutation | #1 |
| epitopes cii | #1 |
| effects fab2 | #1 |
| cii ecm | #1 |
| arthritis ides | #1 |
| anti comp | #1 |
| cd200 btla | #1 |
| h2p susceptibility | #1 |
| human cii cartilage | #1 |
| h2p h2q | #1 |
| cia vivo priming | #1 |
| cia lysine | #1 |
| collagen‐induced | #1 |
| ll37 rcramp | #1 |
| arthritis rat strains | #1 |
| ncf1 m1j | #1 |
| lymphocytes cartilage | #1 |
| human gpi protein | #1 |
| cii articular cartilage | #1 |
| pristaneinduced arthritis rats | #1 |
| mir144 tlr2 | #1 |
| cia | #1 |
| rheumatoid arthritis cia | #1 |
| induced arthritis cia | #1 |
| induction cii | #1 |
| melatonin cia | #1 |
| antibodies cii | #1 |
| phagocyte oxidative burst | #1 |
| potent disease accelerator | #1 |
| antibodies fibß62 | #2 |
| psychosocial stress hpaaxis | #2 |
| alterations neuroendocrine profile | #2 |
| comp cia | #2 |
| c2ta genetic | #2 |
| cpg2088 | #2 |
| sle nadph oxidase | #2 |
| hiit skeletal | #2 |
| ptpn22 protein disulfide | #2 |
| mrl joints stages | #2 |
| rats arthritogenic challenge | #2 |
| h2q response | #2 |
| igg glycosylation arthritis | #2 |
| oestradiol cia | #2 |
| models autoimmune | #2 |
| fil307 | #2 |
| homologous cia | #2 |
| antibody response development | #2 |
| beta 10b | #2 |
| collageninduced arthritis mice | #2 |
| conditions igke promoter | #2 |
| ptpn22 c129s | #2 |
| ros peroxide | #2 |
| arthritis oia | #2 |
| fpr1 neutrophils | #2 |
| mice bacterial infections | #2 |
| tolerance cii | #2 |
| ovx ncf1 mice | #2 |
| increased severity development | #2 |
| shared epitope cxi | #2 |
| dxea strain tgfbeta | #2 |
| oxidation c129s | #2 |
| mycobacteria granulomas | #2 |
| intrinsic tolerance | #2 |
| osteoclasts flow cytometry | #2 |
| autoimmune recognition | #2 |
| fibα580 | #2 |
| liver histone | #2 |
| citcii | #2 |
| mab cii | #2 |
| new immunomodulatory drug | #2 |
| animal granulomatous disease | #2 |
| rats utility | #2 |
| collagen citrullination adhesion | #2 |
| tcells recognition | #2 |
| rats lymphocytes | #2 |
| cartilage‐specific autoimmunity | #2 |
| cii ciic1 | #2 |
| l10d9 antibody | #2 |
| fibroblast induced | #2 |
| m2139 ciif4 | #2 |
| antileukoproteinase alp | #2 |
| cell dependent | #2 |
| oestradiol induction phase | #2 |
| l10d9 | #2 |
| dr4 cii259 | #2 |
| adjuvant oils arthritis | #2 |
| matrilin vivo | #2 |
| 18fbicyclo610nonyne | #2 |
| caia | #2 |
| arthritogenic | #2 |
| epitope‐specific recognition | #2 |
| rats ifngamma | #2 |
| c2ta mhcii expression | #2 |
| mhc congenic | #2 |
| cii citrullination | #2 |
| igke promoter expression | #2 |
| synovial immune reactions | #2 |
| early onset severity | #2 |
| 12 590 | #2 |
| macrophagespecific nox2 | #2 |
| glut4dependent | #2 |
| transgenic oxidases zymosan | #2 |
| genotypes ovx | #2 |
| citcii311 | #2 |
| incidence insulitis | #2 |
| fibα563 | #2 |
| antibody‐mediated arthritis | #2 |
| lymphocytelike | #2 |
| positive anticcp2 test | #2 |
| sera rheumatoid arthritis | #2 |
| maintenance induced resistance | #2 |
| oxidation increased severity | #2 |
| derived ros | #2 |
| circulating medium | #2 |
| congenic polychondritis | #2 |
| das28 values p001 | #2 |
| h12919 | #2 |
| rp animal ear | #2 |
| p47phoxmutated | #2 |
| mice susceptible | #2 |
| antipan | #2 |
| aetiology2–4 | #2 |
| smash recommendations | #2 |
| arthritis female | #2 |
| tgfbeta spinal cord | #2 |
| cd19 cells egfp | #2 |
| 18ffluoromannan | #2 |
| genetic encephalomyelitis | #2 |
| cytosolic ros production | #2 |
| cia day | #2 |
| hladr2dq6 | #2 |
| species susceptible haplotypes | #2 |
| dxea strain | #2 |
| igkeegfp lentivirus expression | #2 |
| b10g | #2 |
| exclusive reactivity | #2 |
| induction cia | #2 |
| celldependent phase | #2 |
| binding cartilage | #2 |
| comp cartilage | #2 |
| multiple antibody reactivities | #2 |
| ccp2 diagnostic accuracy | #2 |
| agonist study | #2 |
| ß62 | #2 |
| congenic mice autoimmune | #2 |
| arthritis heterologous cia | #2 |
| myelin ppd | #2 |
| ere activation treatment | #2 |
| mbp89 peptides | #2 |
| immunization mouse collagen | #2 |
| cia mice mice | #2 |
| prophylactic treatment linomide | #2 |
| citrullinated peptides development | #2 |
| genetic regions psoriasis | #2 |
| igkeegfp lentivirus | #2 |
| mph induction | #2 |
| sle cgd | #2 |
| snp position | #2 |
| antibodies disease onset | #2 |
| percentage peripheral cells | #2 |
| ncf1gene | #2 |
| arthritis scoring | #2 |
| anticcp2negative | #2 |
| collagen ii‐induced arthritis | #2 |
| ala261 | #2 |
| antitoxin immunoglobulin | #2 |
| disease promoting | #2 |
| mice genistein treatment | #2 |
| glycopeptide complexes | #2 |
| tracheolaryngeal cartilage rp | #2 |
| c57bl 10 background | #2 |
| sialadenitis animals | #2 |
| m2139 | #2 |
| eae caia | #2 |
| endoglycosidase treatment | #2 |
| mhciii | #2 |
| chromosome rats | #2 |
| antibodies development | #2 |
| cells arthritis | #2 |
| autoimmune membrane proteins | #2 |
| induction p47phoxmutated mph | #2 |
| b10qncf1 mice cia | #2 |
| etoposide serum concentrations | #2 |
| granulomas ros | #2 |
| hkatpasecontaining vesicles | #2 |
| cell tolerance c5a | #2 |
| influence chromosome | #2 |
| chronic autoimmune polyarthritis | #2 |
| dxeb strain immunization | #2 |
| ros source | #2 |
| dancf1da | #2 |
| b10qf1 | #2 |
| nadph oxidase 2 | #2 |
| psoriatic disease models | #2 |
| disease development presence | #2 |
| higher levels anas | #2 |
| severity collagen arthritis | #2 |
| cep1 fibß62 | #2 |
| mph ros | #2 |
| oestrogen pregnancy | #2 |
| rats heterologous cii | #2 |
| anticii antibody | #2 |
| pristane rats | #2 |
| binding sites autoimmune | #2 |
| murine locus eae2 | #2 |
| severity collagen | #2 |
| eae protein rna | #2 |
| utility comp | #2 |
| arthritis fb | #2 |
| pia rat | #2 |
| experimental cloning | #2 |
| putative vulnerability locus | #2 |
| adjuvant rats | #2 |
| citc1359 | #2 |
| immunological requirements | #2 |
| autoimmune congenic arthritis | #2 |
| paws mice | #2 |
| mbp peptide eae | #2 |
| cxi l10d9 antibody | #2 |
| toe stiffness | #2 |
| arthritis mice | #2 |
| transgenic protein processing | #2 |
| chronic arthritis treatment | #2 |
| allelic variant type | #2 |
| g6pi arthritis | #2 |
| gender rats | #2 |
| chronic relapsing disease | #2 |
| titres ccp2 | #2 |
| ides treatment | #2 |
| nox2 neuropathological alterations | #2 |
| selective fpr1 | #2 |
| disease cyclosporin treatment | #2 |
| epitopes rat | #2 |
| receptor‐specific manner | #2 |
| biologicals 24 months | #2 |
| mannan induced | #2 |
| clever1 tumor | #2 |
| suppressive oestrogen | #2 |
| raloxifene estradiol treatment | #2 |
| oestrogen myelin | #2 |
| anti cii | #2 |
| mhc iii | #2 |
| ptpn22 ncf1 | #2 |
| multiple sclerosis maps | #2 |
| osteoclastogenesis endogenous dna | #2 |
| incidence nephritis | #2 |
| immunocap isac performance | #2 |
| fibß62 | #2 |
| vaccination strategy c5a | #2 |
| fpr1 signaling | #2 |
| cia arthritis | #2 |
| cii depletion | #2 |
| fpr1 agonist | #2 |
| lack ifngamma | #2 |
| cgd mice kynurenine | #2 |
| ciif4 | #2 |
| das28 24 months | #2 |
| c1epitope | #2 |
| cia mechanisms | #2 |
| acpa reactivities | #2 |
| vivo cii | #2 |
| nadph oxidase deficiency | #2 |
| chitosanagarosegelatin | #2 |
| arthritis gender | #2 |
| ncf1 ean6 | #2 |
| ros granulomas | #2 |
| functional ncf1 variants | #2 |
| cii311 | #2 |
| sequence analysis indel | #2 |
| control subjects samples | #2 |
| mbp 87110 peptide | #2 |
| apc naïve cells | #2 |
| elastaseinduced emphysema nox2 | #2 |
| antileukoproteinase modulation | #2 |
| igke | #2 |
| monodeoxygenation | #2 |
| disease 111 | #2 |
| wildtype mice macrophages | #2 |
| cia animals | #2 |
| mhcii experimental arthritis | #2 |
| analyses comp | #2 |
| integrin‐binding‐domain | #2 |
| collagen antibody | #2 |
| ifngamma spinal cord | #2 |
| neuroendocrine profile | #2 |
| eae dxea strain | #2 |
| type collagen cii | #2 |
| mog79 | #2 |
| nodq | #2 |
| animal model arthritis | #2 |
| oestrogen suppressive | #2 |
| arthritis ethanol | #2 |
| macrophages enhances | #2 |
| arthritis g6pi | #2 |
| pnipaam vpba | #2 |
| rats disease onset | #2 |
| wtc5a | #2 |
| design glycopeptides | #2 |
| implanted melanoma | #2 |
| b10qncf1 mice | #2 |
| rt1bb | #2 |
| lymphoproliferative gene | #2 |
| c2ta genetic polymorphisms | #2 |
| eae cia | #2 |
| das28 acpa reactivities | #2 |
| arthritogenic mab cii | #2 |
| symptoms anti ccp2 | #2 |
| injection w3 13 | #2 |
| sialadenitis mice | #2 |
| igsecretors | #2 |
| pristane injection | #2 |
| caia oestradiol | #2 |
| arthritis antibody response | #2 |
| granulomas macrophages | #2 |
| epitope glycosylation | #2 |
| enhanced arthritis | #2 |
| re04 | #2 |
| arthritogenic capacity | #2 |
| l10d9 antibody cartilage | #2 |
| ean6 | #2 |
| pia rats | #2 |
| arthritis progression | #2 |
| comp titers | #2 |
| caia effector phase | #2 |
| agonist fpr2 | #2 |
| collagen arthritis immunization | #2 |
| mice collagen | #2 |
| matrilin 1 | #2 |
| tregs mph ros | #2 |
| cii injection | #2 |
| mabs collagen | #2 |
| glycan activation | #2 |
| micro dams transgenic | #2 |
| alp monoclonal arthritis | #2 |
| snecs neutrophils | #2 |
| salt intake vivo | #2 |
| staphylococcal infections mice | #2 |
| castrated mice day | #2 |
| 034positive | #2 |
| collagen arthritis cii | #2 |
| granulomas cgd mice | #2 |
| w3 13 | #2 |
| knockout illness | #2 |
| cartilage respiratory tract | #2 |
| glycopeptides histocompatibility | #2 |
| lew mol | #2 |
| cms eae | #2 |
| h2q mice mice | #2 |
| arthritogenic challenge | #2 |
| mabs comp | #2 |
| arthritis raloxifene | #2 |
| kinloch | #2 |
| rats da1u rats | #2 |
| cd8 cells incidence | #2 |
| cia disease | #2 |
| macrophagespecific nox2 development | #2 |
| skg model | #2 |
| neutrophil functions modulation | #2 |
| antibodies cartilage | #2 |
| 111 vivo treatment | #2 |
| class immunoenzyme | #2 |
| hiit skeletal muscle | #2 |
| nox2 complex sle | #2 |
| immunosuppressive leukocytes | #2 |
| lymphocytes animals | #2 |
| antibody cartilage | #2 |
| nox2 macrophages | #2 |
| da1u | #2 |
| dominant suppressive | #2 |
| chain l10d9 antibody | #2 |
| cia monkeys | #2 |
| tlymphocyte arthritis arthritis | #2 |
| mog rats | #2 |
| suggestive locus | #2 |
| i‐a molecule | #2 |
| immunization mbp89 | #2 |
| fibβ36 | #2 |
| ciic1 | #2 |
| mbp89 | #2 |
| disease humanized mice | #2 |
| cia anti | #2 |
| transgenic osteoporosis oestradiol | #2 |
| terpenes animals | #2 |
| caia eae | #2 |
| ptpn22 disulfide | #2 |
| sequences mbp89 | #2 |
| hydroxyethylene | #2 |
| raloxifene oestradiol | #2 |
| development combination | #2 |
| mrl mice stages | #2 |
| linomide homologous cia | #2 |
| egfp cd19 cells | #2 |
| diseases collagen | #2 |
| ability arthritis | #2 |
| arthritis treatment | #2 |
| lack functional nox2 | #2 |
| bmd caia | #2 |
| c5ay35 | #2 |
| granulocytes alp | #2 |
| symptoms antibodies | #2 |
| h2q | #2 |
| flow cytometry ovx | #2 |
| liver mice rna | #2 |
| disease genotype hybridization | #2 |
| arthritis models rats | #2 |
| α3xi | #2 |
| human lung nox2 | #2 |
| l10d9 antibody cxi | #2 |
| single nucleotide rats | #2 |
| anticd4 treatment | #2 |
| ncf1 oxidation | #2 |
| anticcp2negative presence | #2 |
| redox regulation ptpn22 | #2 |
| iaexpressing cells | #2 |
| nadph oxidase elevations | #2 |
| galactosyl moiety | #2 |
| immunization sch | #2 |
| ncf1 mutants | #2 |
| pathogenic igg antibodies | #2 |
| neutrophil fpr2 | #2 |
| human animal models | #2 |
| c129s mutant disulfide | #2 |
| eno5 | #2 |
| antibody fine | #2 |
| altered formation | #2 |
| tregs mph | #2 |
| microscopic scoring arthritis | #2 |
| eosinophilia arthritis | #2 |
| rats da1u | #2 |
| antibodies cep1 | #2 |
| igke promoter | #2 |
| rno12 | #2 |
| dxeb | #2 |
| oestrogen ean | #2 |
| autoimmunity autoantibodies | #2 |
| rats polymorphism | #2 |
| cartilage respiratory | #2 |
| mitochondria polymorphism | #2 |
| heterologous collagens arthritis | #2 |
| mbp peptides immunization | #2 |
| cartilage proteins sera | #2 |
| peptides chronic eae | #2 |
| rheumatoid binding | #2 |
| da1u rats | #2 |
| animal haplotypes | #2 |
| arthritis development rats | #2 |
| ros tregs | #2 |
| matrilin cartilage proteins | #2 |
| antigen monoclonal arthritis | #3 |
| anticollagen antibodies | #3 |
| type collagen vivo | #3 |
| arthritogenic mab | #3 |
| cryogel bioreactor | #3 |
| disease w3 13 | #3 |
| genotype knowledge | #3 |
| mice rheumatoid | #3 |
| cytotoxic t‐lymphocyte | #3 |
| acpapositive twins | #3 |
| ifngamma neurons | #3 |
| fibβ74 onset | #3 |
| sialadenitis | #3 |
| eae1 | #3 |
| major cell epitope | #3 |
| acpa specificities presence | #3 |
| eae17 chromosome | #3 |
| nadph oxidase complex | #3 |
| hladrb104 mann whitney | #3 |
| acpa subspecificities | #3 |
| cep1 filaggrin | #3 |
| treatment arthritis | #3 |
| osteoclasts release | #3 |
| antigen presentation mhcii | #3 |
| activated cells mice | #3 |
| cyp7a1 abca1 | #3 |
| induced immunospecific tolerance | #3 |
| pathogenesis pia | #3 |
| acpas twins | #3 |
| fibα591 | #3 |
| eae16 | #3 |
| macrophages involvement | #3 |
| acpa combination | #3 |
| dual manner | #3 |
| allopregnancy | #3 |
| autoimmunity cartilage | #3 |
| mhc class betachain | #3 |
| ncf4 rs729749 | #3 |
| rats disease | #3 |
| recombination rt1a | #3 |
| points acs | #3 |
| combination acpa | #3 |
| complex genetic control | #3 |
| citrullinated cyclic | #3 |
| rtlu | #3 |
| type c2ta | #3 |
| loci antibodies | #3 |
| subspecificities occurrence | #3 |
| levels fibα591 | #3 |
| monoclonal cartilage sections | #3 |
| nerve terminallike profiles | #3 |
| stroke cvrelated death | #3 |
| apc cia | #3 |
| acpas human serum | #3 |
| h2qbearing | #3 |
| arthritis susceptible | #3 |
| db1 treatment day | #3 |
| mice development | #3 |
| autoimmunity pia | #3 |
| pristane‐induced arthritis | #3 |
| rheumatoid autoimmune | #3 |
| h2aalpha | #3 |
| arthritis resistance | #3 |
| rheumatoid crosses | #3 |
| nox2 cgd | #3 |
| lew1f | #3 |
| female immunoenzyme | #3 |
| dxea | #3 |
| clever1 macrophages | #3 |
| human cii | #3 |
| cd4∶cd8 lineage commitment | #3 |
| lew ztm | #3 |
| citcii355 | #3 |
| mice copolymers | #3 |
| antigens keratinocytes | #3 |
| fibβ74 | #3 |
| rs729749 | #3 |
| antigens collagen | #3 |
| keratinocytes langerhans cells | #3 |
| cvrelated death adjustment | #3 |
| aureus arthritis mice | #3 |
| cii species | #3 |
| antibodies vim60 | #3 |
| pfp mice | #3 |
| vivo control mice | #3 |
| cells naïve mice | #3 |
| processing cii | #3 |
| ifnbetadeficient mice | #3 |
| mice environments | #3 |
| chromosome eae17 | #3 |
| arthritis animal model | #3 |
| fibα573 fibα591 | #3 |
| citc1iii filaggrin | #3 |
| genes disease development | #3 |
| class antigens keratinocytes | #3 |
| arthritis susceptibility | #3 |
| dancf1e3 | #3 |
| arthritogenicity | #3 |
| glycosylated type | #3 |
| endogenous ifnbeta | #3 |
| height disease | #3 |
| mnc salivary glands | #3 |
| dnfb ears | #3 |
| c2ta | #3 |
| transgenic osteoporosis | #3 |
| hdac1 rheumatoid arthritis | #3 |
| low production | #3 |
| cii elisa | #3 |
| advanced intercross eae5 | #3 |
| acpas plasma | #3 |
| c57bl mice illness | #3 |
| h2p mice | #3 |
| immunization addition | #3 |
| neutrophils eae | #3 |
| oxidase 2 | #3 |
| multiple sclerosis hladr2 | #3 |
| cia strains | #3 |
| eae5 ncf1 | #3 |
| ifngammali | #3 |
| 95 cvrelated death | #3 |
| pnippam | #3 |
| fibα573 fibβ74 | #3 |
| cia animals arthritis | #3 |
| hladrb104 cochranmantelhaenszel test | #3 |
| anticollagen antibody | #3 |
| immuniozation | #3 |
| response immune response | #3 |
| arthritis effects | #3 |
| twins acpapositive | #3 |
| differences citrullinated peptides | #3 |
| antibodies citc1iii | #3 |
| arthritis model | #3 |
| development acpas | #3 |
| wildtype mice granulomas | #3 |
| cartilage proteins | #3 |
| natural alleles genes | #3 |
| hdac1 pathogenesis | #3 |
| twins acpas | #3 |
| citrullinated peptides time | #3 |
| model arthritis | #3 |
| bcg ros | #3 |
| citrulline inflammation | #3 |
| db1 treatment | #3 |
| lupus nets | #3 |
| chronic collagen | #3 |
| cii reactive | #3 |
| dthreaction | #3 |
| cvrelated death | #3 |
| rats mog | #3 |
| hfdmets rats | #3 |
| ean mca | #3 |
| genetic influence susceptibility | #3 |
| fibα573 | #3 |
| cd8 cells ean | #3 |
| igl genes | #3 |
| dce spe | #3 |
| subspecificities associations | #3 |
| neutrophil cytosolic factor | #3 |
| antibodies specific sets | #3 |
| targeting toll | #3 |
| autoimmune models | #3 |
| 81b | #3 |
| eae31 | #3 |
| fibβ62 81b | #3 |
| occurrence subspecificities | #3 |
| ros deficiency | #3 |
| species lymphocytes | #3 |
| antibodies citrullinated | #3 |
| minimal adjuvant requirement | #3 |
| patients monoclonal chimeric | #3 |
| models arthritis | #3 |
| disease development contribution | #3 |
| ncf1 cldn4 | #3 |
| swedish patients antibodies | #3 |
| role ros | #3 |
| binding aq | #3 |
| incidence antinuclear antibodies | #3 |
| acpas genetic factors | #3 |
| macroporous gel particles | #3 |
| cystatin cdeficient mice | #3 |
| cbrh7919 cells | #3 |
| disease immunization | #3 |
| disease genotype immunity | #3 |
| mice constant light | #3 |
| cdk6 padi4 | #3 |
| fibα591 vim60 | #3 |
| eae5 pia4 | #3 |
| disease anti lymphocyte | #3 |
| rodents6 | #3 |
| citrullinated peptides multiplex | #3 |
| disease disease development | #3 |
| arthritis review | #3 |
| origin suggestive linkage | #3 |
| inflamed synovial tissues | #3 |
| crossreactive idiotope | #3 |
| experimental cell | #3 |
| mca ean | #3 |
| cvrelated death association | #3 |
| day disease duration | #3 |
| disease risk subsets | #3 |
| mmc mice | #3 |
| complex autoimmune diseases | #3 |
| arthritis autoimmunity | #3 |
| pia | #3 |
| onset combination | #3 |
| reactive idiotope | #3 |
| allogeneic pregnancy | #3 |
| carriers hladrb104 | #3 |
| total abrogation | #3 |
| isotypes acpas | #3 |
| spe dce | #3 |
| rheumatoid arthritis complement | #3 |
| acpa titers | #3 |
| rt1a tap2 | #3 |
| eae17 | #3 |
| nox2 pathogenesis | #3 |
| development collagen arthritis | #3 |
| pia6 | #3 |
| ctla4 adult mice | #3 |
| ciic1 cii | #3 |
| arthritis levels | #3 |
| rs729749 ncf4 | #3 |
| antibodies induce | #3 |
| ctla4 deletion | #3 |
| cia hdac1 | #3 |
| common mouse model | #3 |
| rheumatoid cloning | #3 |
| disease height | #3 |
| eae5r1 | #3 |
| acpas fine specificities | #3 |
| acpa multiplex | #3 |
| citc1iii fibα573 | #3 |
| development arthritis | #3 |
| cd4∶cd8 lineage | #3 |
| ifngammali neurons | #3 |
| hydrocarbon oils | #3 |
| female preponderance | #3 |
| anti‐type | #3 |
| rats rheumatoid arthritis | #3 |
| experimental arthritis | #3 |
| presence drb104 | #3 |
| vim60 | #3 |
| early phase disease | #3 |
| eae17 genetic heterogeneity | #3 |
| citc1iii | #3 |
| oxidases reactive | #3 |
| restricted role | #3 |
| rt11 rats | #3 |
| animal glycosylation humans | #3 |
| positional cloning genes | #4 |
| mrl dth | #4 |
| adjuvant oil | #4 |
| interaction monoclonal antibody | #4 |
| strain eae | #4 |
| cells maternal origin | #4 |
| subsets presence | #4 |
| mp‐lpr | #4 |
| estrogen levels levels | #4 |
| mice etoposide | #4 |
| smoking antibodies | #4 |
| genistein addition | #4 |
| mhc eae | #4 |
| endos igg | #4 |
| cathelicidins ll37 | #4 |
| congenic c57bl | #4 |
| inpp4b474r 548p | #4 |
| autoimmune mrl | #4 |
| citrullinated peptides autoantibodies | #4 |
| pathogenesis histone | #4 |
| immune response cii | #4 |
| congenic rats rats | #4 |
| cia suppression | #4 |
| cii peptide | #4 |
| estrogen cia | #4 |
| cii animal epitopes | #4 |
| krönke | #4 |
| parathyroid antibodies | #4 |
| antibody response mog | #4 |
| autoantibodies type collagen | #4 |
| affinity case | #4 |
| tnfα p38 mapk | #4 |
| c129s | #4 |
| cell response immunization | #4 |
| dth reaction | #4 |
| mip mice | #4 |
| cytosolic ros | #4 |
| type collagen autoimmunity | #4 |
| stages disease development | #4 |
| multispecific antibodies | #4 |
| arthritis comp | #4 |
| type‐ii collagen | #4 |
| arthritis mouse | #4 |
| rs12979659 | #4 |
| candidate genes rats | #4 |
| sh3gl1 | #4 |
| cia b10q mice | #4 |
| diseases rheumatoid | #4 |
| mutation ncf1 | #4 |
| bxsb chromosome | #4 |
| peptide mbp | #4 |
| k8 k8 mice | #4 |
| epitope collagen | #4 |
| catabolism kynurenine | #4 |
| rp sle | #4 |
| cells cryogel | #4 |
| locus mouse chromosome | #4 |
| synovial endothelium | #4 |
| arthritis severity | #4 |
| glend2 | #4 |
| antigen sequence deletion | #4 |
| il‐4‐deficient mice | #4 |
| ox8 | #4 |
| strains arthritis | #4 |
| dead cell remnants | #4 |
| cia lia | #4 |
| variance animals arthritis | #4 |
| antibodies citrullinated peptides | #4 |
| cia mouse | #4 |
| cb10 fragment | #4 |
| knowledge genetic association | #4 |
| fpr2 recognition | #4 |
| collagen immune | #4 |
| collagen type | #4 |
| fibβ62 | #4 |
| response arthritis | #4 |
| estrus cycling | #4 |
| fcγr regulation | #4 |
| lxrα pparγ | #4 |
| normal mouse igg | #4 |
| ethylene isosteres | #4 |
| type collagen arthritis | #4 |
| arthritis defined | #4 |
| development sialadenitis | #4 |
| tcell activation development | #4 |
| arthritis collageninduced arthritis | #4 |
| species regulate | #4 |
| type collagen rat | #4 |
| genetic association vav1 | #4 |
| pathogenic antibody | #4 |
| experimental genetic | #4 |
| cd4 cells stage | #4 |
| macrophages mycobacteria | #4 |
| autoimmune experimental phenotype | #4 |
| dae3 | #4 |
| rs682626 | #4 |
| experimental arthritis humans | #4 |
| anti‐t‐cell | #4 |
| inbred dba peptides | #4 |
| experimental arthritis cii | #4 |
| mrl b6 | #4 |
| rheumatoid arthritis rats | #4 |
| acpas serum | #4 |
| pristane‐induced | #4 |
| vav1 rheumatoid arthritis | #4 |
| collagen rheumatoid | #4 |
| shared autoimmunity | #4 |
| treg cells ctla4 | #4 |
| dth mrl | #4 |
| potent immunomodulator | #4 |
| lnchc | #4 |
| cii ifa | #4 |
| citrullinated protein antibodies | #4 |
| glands sialadenitis | #4 |
| tsc mice | #4 |
| cellular transfer | #4 |
| cyclic software | #4 |
| immunodominant cell | #4 |
| autoimmunity rats | #4 |
| cells cryogel column | #4 |
| collagen glycopeptides | #4 |
| elevated th1 | #4 |
| placental mhc | #4 |
| onset clinical arthritis | #4 |
| antitype collagen antibodies | #4 |
| experimental cattle cells | #4 |
| α1ii chain | #4 |
| elimination cd8 cells | #4 |
| immunoglobulin deficient | #4 |
| cryogel matrix | #4 |
| cia6 | #4 |
| delayed immunization rats | #5 |
| pathogenesis autoimmune arthritis | #5 |
| resistance cia | #5 |
| lethal inflammatory disorder | #5 |
| tubule cells kidney | #5 |
| igg endos | #5 |
| antileukoproteinase | #5 |
| backcrossed | #5 |
| glycopeptide fragment | #5 |
| oia | #5 |
| severe arthritis mice | #5 |
| immunological involvement | #5 |
| monoclonal antibody alpha | #5 |
| symptoms rheumatoid arthritis | #5 |
| autoimmune disease models | #5 |
| symptom onset frequency | #5 |
| oxidative radicals | #5 |
| autologous type | #5 |
| collageninduced arthritis cia | #5 |
| wellknown role | #5 |
| aureus arthritis | #5 |
| tlr3 expression | #5 |
| arthritis rats | #5 |
| rt1eu | #5 |
| interaction cartilage | #5 |
| immunization male | #5 |
| b‐cell epitope | #5 |
| biomarkers 2 polyradiculoneuropathy | #5 |
| tbb infection | #5 |
| multiplex analyses | #5 |
| mice acpa | #5 |
| pineal gland development | #5 |
| beta 11 cells | #5 |
| absence c5 | #5 |
| rats developed | #5 |
| development acpa | #5 |
| lew1n | #5 |
| α10i | #5 |
| chromosome cia7 | #5 |
| cgd hyperinflammation | #5 |
| apc cii | #5 |
| ii‐induced | #5 |
| c‐glycoside analogue | #5 |
| ovalbumin pepsin | #5 |
| multiplex array | #5 |
| raloxifene disease activity | #5 |
| severe sialadenitis | #5 |
| nox complex | #5 |
| cd8 deficiency | #5 |
| symptoms development | #5 |
| oestradiol vehicle | #5 |
| experimental breeding | #5 |
| tsst1producing | #5 |
| o2• h2o2 nox | #5 |
| immunization type collagen | #5 |
| type collagen cix | #5 |
| arthritogenic cells | #5 |
| collagen anti | #5 |
| nox o2• h2o2 | #5 |
| subsets rheumatoid arthritis | #5 |
| immunized animals controls | #5 |
| osteoclasts stromal cells | #5 |
| low dose tolerance | #5 |
| uterus cells | #5 |
| dba mouse | #5 |
| epitope cii | #5 |
| avridineinduced arthritis | #5 |
| exercise hiit | #5 |
| patients acpa levels | #5 |
| ly female | #5 |
| cia type collagen | #5 |
| overexpression hdac3 | #5 |
| citrullinated peptides ccp | #5 |
| cbrh7919 | #5 |
| commonly model | #5 |
| position type collagen | #5 |
| streptococcus pyogenes ides | #5 |
| il4deficient mice | #5 |
| nox animal models | #5 |
| asparaginelinked glycan | #5 |
| higher levels melatonin | #5 |
| dba 1 mice | #5 |
| regulating rat | #5 |
| recovery ean | #5 |
| tcell hybridomas | #5 |
| multiparous mice | #5 |
| citrullinated peptides | #5 |
| puccetti | #5 |
| painlike behavior | #5 |
| chick cii | #5 |
| field nox | #5 |
| glycopeptide | #5 |
| hydroxynorvaline | #5 |
| ros mca | #5 |
| lipidomic remodeling | #5 |
| antibodies filaggrin | #5 |
| tcell mrl | #5 |
| congenic nod | #5 |
| tlr3 macrophages | #5 |
| swr mouse | #5 |
| cartilage type | #5 |
| egfp flow cytometry | #5 |
| glycopeptidomimetics | #5 |
| mrvalues | #5 |
| classical adjuvant | #5 |
| measurement nox activity | #5 |
| ros macrophages | #5 |
| arthritis onset | #5 |
| cia model | #5 |
| smoking prior | #5 |
| eae5 | #5 |
| cgd mice | #5 |
| joints rats | #6 |
| igg autoantibodies sera | #6 |
| rheumatoid arthritis comp | #6 |
| peptides arthritis | #6 |
| tsst1 mice | #6 |
| ltab | #6 |
| rcramp | #6 |
| lys270 | #6 |
| immunization peptides | #6 |
| macrophages mph | #6 |
| cia cd4 cells | #6 |
| treatment oestradiol | #6 |
| metabolic nuclear receptors | #6 |
| autoimmune experimental genes | #6 |
| cartilage collagens | #6 |
| dominant suppression | #6 |
| relapsing polychondritis rp | #6 |
| cell recognition | #6 |
| betaoestradiol | #6 |
| pv loss | #6 |
| develop arthritis | #6 |
| ccp2 positive | #6 |
| glycoproteins nadph | #6 |
| isotypes patients | #6 |
| knockout receptors igg | #6 |
| contrasting roles | #6 |
| glycopeptide specificity | #6 |
| cd4∶cd8 | #6 |
| mrna tgfbeta | #6 |
| transgenic mice arthritis | #6 |
| data ros | #6 |
| mhcii alleles | #6 |
| affinity ligand protein | #6 |
| eae mhc | #6 |
| arthritis autoantibodies | #6 |
| acpa specificities | #6 |
| pathogenic events | #6 |
| heterogeneous stock mice | #6 |
| rheumatoid arthritis collagen | #6 |
| rheumatoid arthritis model | #6 |
| collagen cells | #6 |
| collagen arthritis | #6 |
| complex mhc | #6 |
| l3t4positive cells | #6 |
| arthritis antibodies | #6 |
| b10 mouse | #6 |
| autoimmunity arthritis | #6 |
| functional selective | #6 |
| disease protective | #6 |
| erosive polyarthritis | #6 |
| animal genetic | #6 |
| mice sialadenitis | #6 |
| anti ccp2 | #6 |
| experimental postmenopausal | #6 |
| active arthritis | #6 |
| loci controlling | #6 |
| pristane squalene | #6 |
| activity neuroinflammation | #6 |
| monoclonal encephalomyelitis autoimmune | #6 |
| staphylococcus aureus arthritis | #6 |
| recombinant rat interferongamma | #6 |
| cells affinity surface | #6 |
| pyramidal neurons loss | #6 |
| cia26 | #6 |
| controls arthritis | #6 |
| c57bl 6 background | #6 |
| mice congenic | #6 |
| female lymphocyte | #6 |
| acpa anti | #6 |
| nox2 mediates | #6 |
| collagen cia | #6 |
| mice investigated | #6 |
| arthritis models | #6 |
| induced psoriasis | #6 |
| k8 mice | #6 |
| murine loci | #6 |
| hdac1 class | #6 |
| region syntenic | #7 |
| impact cia | #7 |
| response immunization | #7 |
| cii anti | #7 |
| congenic mouse | #7 |
| rheumatoid arthritis role | #7 |
| cryogel column | #7 |
| hydrolases polymorphism | #7 |
| ciireactive cells | #7 |
| raassociated molecules | #7 |
| autoantibodies lymphocytes | #7 |
| oestrogen rats | #7 |
| cii apc | #7 |
| glycosylated collagen | #7 |
| collagen arthritis cia | #7 |
| cognate activation | #7 |
| chronic phase arthritis | #7 |
| role raloxifene | #7 |
| impaired induction | #7 |
| mice constant darkness | #7 |
| polychondritis relapsing | #7 |
| type collagen | #7 |
| arthritis genes | #7 |
| protective influences | #7 |
| arthritis strains | #7 |
| arthritis type collagen | #7 |
| rats phases | #7 |
| strains disease | #7 |
| yaa gene | #7 |
| regulatory cells macrophages | #7 |
| nonarthritogenic | #7 |
| autoimmune human | #7 |
| aplec | #7 |
| chronic experimental | #7 |
| effector phase | #7 |
| castrated females | #7 |
| periodontitis arthritis | #7 |
| citrullinated peptide antigens | #7 |
| g6pi | #7 |
| antibodies citrullinated antigens | #7 |
| collagen arthritis rats | #7 |
| 3xi | #7 |
| macrophages alternative activation | #7 |
| locus chromosome | #7 |
| collagen epitope | #7 |
| animal immunization injections | #7 |
| antibodyinduced arthritis | #7 |
| isomerase peptide | #7 |
| mediated vasculitis | #7 |
| induction arthritis | #7 |
| cia mice | #7 |
| mbp peptide | #7 |
| mouse collagen | #7 |
| transgenic class | #7 |
| autoantibodies citrullinated peptides | #7 |
| murine psoriasis | #7 |
| conventional environment | #7 |
| cia5 | #7 |
| congenic strains | #7 |
| acpa titres | #7 |
| autoimmunity collagen | #7 |
| analysis crosses | #7 |
| symptoms disease onset | #7 |
| antigens differentiation arthritis | #7 |
| responses cii | #7 |
| ean animals | #7 |
| snecs | #7 |
| psoriasiform skin disease | #7 |
| cab3 | #7 |
| clinical signs ean | #8 |
| cia animal model | #8 |
| b10 background | #8 |
| fcγr2b | #8 |
| eae genetic encephalomyelitis | #8 |
| experimental binding | #8 |
| onset day day | #8 |
| mumt mice | #8 |
| cosphox | #8 |
| antibodies acpas | #8 |
| arthritis lymphocytes | #8 |
| ptpn22620w | #8 |
| polymeric cryogels | #8 |
| chromosomes loci | #8 |
| underlying genes | #8 |
| rheumatoid autoimmunity | #8 |
| oia2 | #8 |
| diseases loci | #8 |
| autoantibodies subset | #8 |
| dominant cell epitope | #8 |
| chronic autoimmune arthritis | #8 |
| hlase alleles | #8 |
| autoantibodies collagen type | #8 |
| induced neuropathology | #8 |
| non‐mhc | #8 |
| mbp mog | #8 |
| neutrophil cytosolic | #8 |
| inflamed synovia | #8 |
| antigenspecific priming | #8 |
| lyme arthritis severity | #8 |
| ros interplay | #8 |
| treatment monoclonal | #8 |
| parathyroid glands receptors | #8 |
| autologous peptide | #8 |
| heterologous peptide | #8 |
| cia2 | #8 |
| destructive effects | #8 |
| murine locus | #8 |
| antibody vivo | #8 |
| autoimmune congenic mice | #8 |
| sialadenitis mrl | #8 |
| rats mhc | #8 |
| mice techniques | #8 |
| 297 cases | #8 |
| 42 rats | #8 |
| illness igg | #8 |
| mice ifnbeta | #8 |
| typeii collagen | #8 |
| experimental autoimmune disease | #8 |
| ifa cii | #8 |
| incidence cia | #8 |
| hladrb11001 | #8 |
| patients type collagen | #8 |
| eae3 | #8 |
| onset incidence | #8 |
| t‐cell priming | #8 |
| hdac3 expression | #8 |
| rt1f | #8 |
| medium mem | #8 |
| supermacroporous cryogel | #8 |
| haematogenously | #8 |
| persistent joint pain | #8 |
| hybridomas antibodies | #8 |
| murinised | #8 |
| rheumatoid chromosome | #8 |
| α1‐microglobulin | #8 |
| humans experimental arthritis | #8 |
| oxidized peptides | #8 |
| expression hdac3 | #8 |
| rheumatoid autoantibodies | #9 |
| pristane | #9 |
| early joint erosions | #9 |
| induced metabolic syndrome | #9 |
| arthritis skg mice | #9 |
| variants acpa | #9 |
| rt1u | #9 |
| rats rat | #9 |
| cia transgenic mice | #9 |
| mammalian disease models | #9 |
| loci rats | #9 |
| 2 nadph | #9 |
| animal models urgent | #9 |
| postmenopausal arthritis | #9 |
| antibody alpha | #9 |
| development autoimmune arthritis | #9 |
| acpas patients | #9 |
| specific nox2 | #9 |
| inbred dba mice | #9 |
| posttranslational glycosylation | #9 |
| autoimmunogenic | #9 |
| differentiation autoimmune | #9 |
| hgpi325 | #9 |
| murine collagen | #9 |
| bound carbohydrates | #9 |
| intranasal animals arthritis | #9 |
| class allele | #9 |
| disease strains | #9 |
| b10riii mice | #9 |
| mouse peptide | #9 |
| patients acpas | #9 |
| eae immunization | #9 |
| reduced arthritis | #9 |
| idiotype‐specific | #9 |
| illness receptor | #9 |
| collagen complement | #9 |
| experimental arthritis rats | #9 |
| serum interferon | #9 |
| ox19 | #9 |
| avridine | #9 |
| hitr | #9 |
| oil adjuvants | #9 |
| alpha1inhibitor3 | #9 |
| arthritis cross | #9 |
| inbred lew tlymphocytes | #9 |
| bovine cii | #9 |
| oligomeric matrix | #9 |
| rheumatoid joints | #9 |
| collagen female | #9 |
| psychological tyrosine | #9 |
| response mouse | #9 |
| effects mabs | #9 |
| histone 1 hdac1 | #9 |
| acpas | #9 |
| il10 role | #9 |
| human immunopeptidome | #9 |
| antibodies vivo | #9 |
| ean myelin | #9 |
| experimental genes | #9 |
| specific sets | #9 |
| adaptive inflammation | #9 |
| nodp | #9 |
| ifnbeta mice | #10 |
| cell‐deficient | #10 |
| native collagen type | #10 |
| pain animal models | #10 |
| alpha collagen chains | #10 |
| rheumatoid arthritis dr4 | #10 |
| collagen autoimmunity | #10 |
| immunization rats | #10 |
| oestrogen | #10 |
| knockout nadph | #10 |
| nih heterogeneous stock | #10 |
| onset chromosome | #10 |
| antibody collagen | #10 |
| cells increased production | #10 |
| dense fractions | #10 |
| mice cii | #10 |
| antibodies specific | #10 |
| stock mice | #10 |
| severe erosive | #10 |
| extracellular cartilage | #10 |
| monoclonal antigens rats | #10 |
| h2ap | #10 |
| prl effects | #10 |
| mice nadph | #10 |
| acutephase response rats | #10 |
| beta 11 | #10 |
| axotomized motor neurons | #10 |
| experimental cartilage | #10 |
| inbred dba | #10 |
| rats lewis rats | #10 |
| cartilage collagen fibrils | #10 |
| reactivity acpas | #10 |
| hlase smoking | #10 |
| tertbutylacrylamide | #10 |
| o2• h2o2 | #10 |
| genetic experiments | #10 |
| autoimmune disease humans | #10 |
| cartilage arthritis | #10 |
| animal models | #10 |
| abp gene | #10 |
| cd4 cells spleen | #10 |
| cells development | #10 |
| passive transfer experiments | #10 |
| mbp peptides | #10 |
| citrullinated antigen | #10 |
| mutated mice | #10 |
| acpa diagnosis | #10 |
| cartilage oligomeric | #10 |
| monoclonal arthritis | #10 |
| development severity | #10 |
| cii mice | #10 |
| mice genistein | #10 |
| activation male | #10 |
| presence acpa | #10 |
| endogenous collagen | #10 |
| species respiratory | #11 |
| mhc control | #11 |
| monoclonal rheumatoid factors | #11 |
| gad6 | #11 |
| cia7 | #11 |
| arthritis absence | #11 |
| chronic arthritis | #11 |
| mice mhc | #11 |
| tailbase | #11 |
| cia30 | #11 |
| antibody type collagen | #11 |
| inflammatory arthritis role | #11 |
| isotypes | #11 |
| antibodies association | #11 |
| loci regulating | #11 |
| 2xi | #11 |
| potential autoantigens | #11 |
| nodb10h2b mice | #11 |
| ptpn22 smoking | #11 |
| chondrocytes ecm | #11 |
| mice cd1 | #11 |
| dss wt | #11 |
| fragments anti | #11 |
| cells pia | #11 |
| 84–102 | #11 |
| individuals onset | #11 |
| rat arthritis | #11 |
| naïve cells cells | #11 |
| lentiviral vector expression | #11 |
| antigen variability | #11 |
| development rheumatoid | #11 |
| stromal cells macrophages | #11 |
| rat liver rats | #11 |
| liver receptor lxrα | #11 |
| rat collagen | #11 |
| genetic contamination | #12 |
| loci disease | #12 |
| mutation nadph | #12 |
| fpr2 agonists | #12 |
| psoriasis mouse model | #12 |
| autoimmune monoclonal antigens | #12 |
| major haplotype | #12 |
| immunodominant | #12 |
| pia1 | #12 |
| role arthritis | #12 |
| cell responses cii | #12 |
| lung macrophages mice | #12 |
| α1ii | #12 |
| antibodies structures | #12 |
| peptide study | #12 |
| natural polymorphism | #12 |
| structure antibodies | #12 |
| study arthritis | #12 |
| natural loss | #12 |
| animal immunohistochemistry | #12 |
| type collagen immunization | #12 |
| psoriasis arthritis | #12 |
| hydroxylysines | #12 |
| riiis | #12 |
| matrilin | #12 |
| stages pathogenesis | #12 |
| frequencies antibodies | #12 |
| mutated mouse | #12 |
| cii patients | #12 |
| reduces severity | #12 |
| rats cia | #12 |
| illness sex characteristics | #12 |
| associations antibodies | #12 |
| mice comp | #12 |
| bovine type collagen | #12 |
| increased litter size | #12 |
| onset symptoms | #12 |
| lymphoid cells development | #12 |
| backgroundantibodies | #12 |
| serum concentrations comp | #12 |
| encephalomyelitis induced | #12 |
| qa2 | #12 |
| rats expression | #12 |
| stage cia | #12 |
| myelin ean | #12 |
| treatment experimental arthritis | #12 |
| nonselfdiscrimination | #12 |
| icmediated | #12 |
| cross rats | #12 |
| chronic erosive arthritis | #12 |
| mbp response | #12 |
| species deficiency | #13 |
| l012 | #13 |
| genes mouse chromosome | #13 |
| idd5 | #13 |
| development type collagen | #13 |
| cyclic citrullinated | #13 |
| cells salivary glands | #13 |
| oxidase nox2 | #13 |
| advanced intercross | #13 |
| sequence collagen | #13 |
| behavioral alterations rats | #13 |
| mannan | #13 |
| dba molecular | #13 |
| dr1 transgenic | #13 |
| nos2derived | #13 |
| b10p | #13 |
| lew1w | #13 |
| epitope immunization | #13 |
| strains incidence | #13 |
| native type collagen | #13 |
| cell epitope | #13 |
| arthritis knowledge | #13 |
| nonobese diabetic mouse | #13 |
| expression egfp | #13 |
| citrullinated | #13 |
| major loci | #13 |
| mtec aire | #13 |
| bcelldeficient mice | #13 |
| levels nabs | #13 |
| mouse strains | #13 |
| macroscopic scoring | #13 |
| anticii | #13 |
| antibodies citrullinated proteins | #13 |
| oxidative regulation | #13 |
| ho4 | #13 |
| doses ici | #13 |
| joints blood | #13 |
| μ chain | #13 |
| 24dinitro1fluorobenzene | #13 |
| ccp2 antibodies | #13 |
| immunohistochemistry interferon | #13 |
| rfigg | #13 |
| complement complement activation | #13 |
| factor isotypes | #13 |
| hladrb1 ptpn22 | #13 |
| t‐cell epitope | #13 |
| multispecific | #13 |
| experimental interferon | #14 |
| deficient production | #14 |
| macrophages immune response | #14 |
| smallmolecule compound | #14 |
| nasal inhalation | #14 |
| humans nadph | #14 |
| collagen comp | #14 |
| antifilaggrin antibodies | #14 |
| loci rheumatoid | #14 |
| aggregated nets | #14 |
| autoimmune arthritis | #14 |
| osteoclasts vivo | #14 |
| loci interaction | #14 |
| thr233 | #14 |
| arlacel | #14 |
| cia expression | #14 |
| protein collagen | #14 |
| gut protection | #14 |
| blymphocyte female humans | #14 |
| collagen disease | #14 |
| arthritic paws | #14 |
| specific inflammation | #14 |
| autoimmunity animals | #14 |
| molecular disease models | #14 |
| peptides anti | #14 |
| immune regulators | #14 |
| presence mcv | #14 |
| candidate autoantigens | #14 |
| murine collageninduced arthritis | #14 |
| sirt1 mmp9 | #14 |
| b6n mice | #14 |
| efficient promotion | #14 |
| immunized rat | #14 |
| mhc class region | #14 |
| involvement cells | #14 |
| nodb10h2b | #15 |
| neuritis rats | #15 |
| integrated bioprocess | #15 |
| apcs macrophages | #15 |
| tflask | #15 |
| arthritis role | #15 |
| antibodies arthritis | #15 |
| immune complex formation | #15 |
| regulation adaptive immunity | #15 |
| monolithic cryogel | #15 |
| anticollagen | #15 |
| aire mtec | #15 |
| rats monoclonal antigens | #15 |
| involvement pathogenesis | #15 |
| monoclonal arthritis rats | #15 |
| rat genetics | #15 |
| rt1a | #15 |
| translationally modified | #15 |
| cdr regions | #15 |
| mice type collagen | #15 |
| arthritis development | #15 |
| exaggerates | #15 |
| cultured human chondrocytes | #15 |
| mice immunization | #15 |
| osteoporosis development | #15 |
| dcii | #15 |
| 2 weight | #15 |
| amps development | #15 |
| murine cia | #15 |
| treatment cia | #15 |
| polychondritis | #15 |
| raloxifene estradiol | #15 |
| rheumatoid arthritis presence | #15 |
| lentiviral gene delivery | #15 |
| experimental allergic neuritis | #15 |
| type collagen development | #15 |
| mhc class molecule | #15 |
| antigenic epitope | #15 |
| congenic rats | #15 |
| presence anticarp antibodies | #15 |
| citrullinated peptides patients | #15 |
| ros cii | #15 |
| pparγ lxrα | #16 |
| antinuclear autoimmunity | #16 |
| staphylococcal arthritis | #16 |
| class transplantation | #16 |
| cep1 | #16 |
| matrilin proteins | #16 |
| h2p | #16 |
| arthritis severity mice | #16 |
| anti‐t | #16 |
| nonglycosylated form | #16 |
| n305 | #16 |
| hla–drb1 shared epitope | #16 |
| levels natural antibodies | #16 |
| acute inflammation mice | #16 |
| oligomeric matrix protein | #16 |
| mhcii ciita | #16 |
| fewer osteoclasts | #16 |
| mhc genes | #16 |
| disease mice mice | #16 |
| rno10 | #16 |
| subspecificities | #16 |
| congenic mice mice | #16 |
| epitopes mice mice | #16 |
| rats experimental arthritis | #16 |
| rheumatoid arthritis genes | #16 |
| autologous collagen | #16 |
| genes animals | #16 |
| arthritis cii | #16 |
| development rheumatoid arthritis | #16 |
| males onset | #16 |
| lew1 | #16 |
| rheumatoid factor production | #16 |
| mumt | #16 |
| rt1 | #16 |
| indirect genetic predisposition | #16 |
| lethal inflammatory | #16 |
| cells female mice | #17 |
| arthritis rheumatoid autoantibodies | #17 |
| rt1av1 | #17 |
| allergic neuritis | #17 |
| leuphe | #17 |
| periodontitis antibodies | #17 |
| rats lewis | #17 |
| triplehelical conformation | #17 |
| progesterone development | #17 |
| inbred lew | #17 |
| ethanol development | #17 |
| strains lymphocytes | #17 |
| rheumatoid arthritis subsets | #17 |
| collagen induced arthritis | #17 |
| cells presenting cells | #17 |
| onset rheumatoid arthritis | #17 |
| cells collagen | #17 |
| human fcγriia | #17 |
| animals congenic | #17 |
| spleen peyers patches | #17 |
| cartilage collagen | #17 |
| genistein mice | #17 |
| nox2 derived | #17 |
| collagen specific | #17 |
| clever1 | #17 |
| skg | #17 |
| polyphosphate4 | #17 |
| native denatured | #17 |
| cab4 | #17 |
| mice rheumatoid arthritis | #17 |
| langerhans cells cells | #18 |
| cartilage type collagen | #18 |
| ros data | #18 |
| addition ros | #18 |
| h2z | #18 |
| day immunization | #18 |
| ealkene | #18 |
| anti cd44 | #18 |
| collagen autoantibodies | #18 |
| dra0101 | #18 |
| purified anti | #18 |
| disease duration onset | #18 |
| keratinocytes induction | #18 |
| adjuvant arthritis rats | #18 |
| short‐term administration | #18 |
| joint inflammatory | #18 |
| defined epitope | #18 |
| genes spleen | #18 |
| arthritis anti | #18 |
| humanized transgenic mice | #18 |
| phenotypic feature | #18 |
| salivary glands mice | #18 |
| day arthritis | #18 |
| galactose moiety | #18 |
| hybridomas mice mice | #18 |
| autoimmune illness | #18 |
| moginduced eae | #18 |
| expression lxrα | #18 |
| cuiiida | #18 |
| supermacroporous | #19 |
| vivo elimination | #19 |
| inflammatory attack | #19 |
| castrated female rats | #19 |
| future utility | #19 |
| collagen response | #19 |
| suppression dth | #19 |
| cd4 transgenic | #19 |
| rats snp | #19 |
| new avenues | #19 |
| patients polychondritis | #19 |
| mice congenic mice | #19 |
| protein comp | #19 |
| mrl mp mice | #19 |
| trimolecular complex | #19 |
| peyers patches spleen | #19 |
| blood monocytes neutrophils | #19 |
| single intradermal injection | #19 |
| mice develop | #19 |
| tbetarii gene | #19 |
| protective alleles | #19 |
| gly262 | #19 |
| elisa cia | #19 |
| beta oestradiol | #19 |
| cia eae | #19 |
| citrullinated proteins acpa | #19 |
| three‐dimensional culture | #19 |
| experimental autoimmunity | #20 |
| serm raloxifene | #20 |
| development disease | #20 |
| stress phospholipids | #20 |
| antibody treatment | #20 |
| matrilin1 | #20 |
| role nox | #20 |
| ciita mhcii | #20 |
| ncr3 | #20 |
| loci chromosomes | #20 |
| 5r5 | #20 |
| nox1deficient mice | #20 |
| knockout mice transgenic | #20 |
| fls tnfα | #20 |
| 5p14 | #20 |
| imaging reactive | #20 |
| prominent infiltration | #20 |
| underlying gene | #20 |
| monkeys rodents | #20 |
| glycosylated | #20 |
| enhanced tcr | #20 |
| inflammation mice | #20 |
| mbp rats | #20 |
| littermate | #20 |
| mice cia | #20 |
| highly susceptible | #20 |
| pvg1av1 | #20 |
| mhc class alleles | #20 |
| response mbp | #20 |
| progesterone oestrogen | #20 |
| rt1d | #20 |
| human rheumatoid arthritis | #20 |
| muscle ros | #21 |
| olahsd | #21 |
| genes controlling | #21 |
| nitratenitriteno pathway | #21 |
| diseases lymphocytes | #21 |
| α1acidglycoprotein | #21 |
| nox2 mice | #21 |
| triplehelical peptides | #21 |
| onset severity | #21 |
| nox2 activity | #21 |
| igg fcgammar | #21 |
| drb11001 | #21 |
| n141 | #21 |
| chronic relapsing | #21 |
| granule mobilization | #21 |
| arthritis pregnancy | #21 |
| rats development | #21 |
| illness autoimmune | #21 |
| n286 | #21 |
| mice mutant strains | #21 |
| pathogenesis rheumatoid | #21 |
| linomide treatment | #21 |
| cells adaptive immune | #21 |
| cia treatment | #21 |
| ean rats | #21 |
| suppressor cytotoxic cells | #21 |
| individual acpa | #21 |
| supermacroporous cryogels | #21 |
| conserved haplotype | #21 |
| experimental rheumatoid | #21 |
| positional cloning | #21 |
| serum levels comp | #21 |
| ul1 | #22 |
| rats nonalcoholic steatohepatitis | #22 |
| experimental phenotype | #22 |
| 270 | #22 |
| vh j558 | #22 |
| rats loss | #22 |
| animal epitopes humans | #22 |
| 81a | #22 |
| mice independent | #22 |
| cultured hepatic cells | #22 |
| samples onset | #22 |
| ccp negative | #22 |
| induced eae | #22 |
| response myelin | #22 |
| determinant selection | #22 |
| c57bl mice subfamily | #22 |
| identification susceptibility genes | #22 |
| association pv | #22 |
| semiallogenic | #22 |
| antiidiotypic antibody | #22 |
| cells b10 | #23 |
| castration rats | #23 |
| complex influences | #23 |
| citrullinated antigens | #23 |
| peptide activation | #23 |
| phage clones | #23 |
| lymphocytes amino | #23 |
| loss collagen | #23 |
| comp | #23 |
| cells presentation | #23 |
| arthritis type | #23 |
| inflammation absence | #23 |
| experimental chromatography | #23 |
| experimental autoimmune diseases | #23 |
| mace association | #23 |
| cryogel beads | #23 |
| citrullinated epitopes | #23 |
| immunopeptides | #23 |
| 4npa | #23 |
| diseases autoimmunity | #23 |
| onset cia | #23 |
| monoclonal antigens autoimmune | #23 |
| tgfbeta resistance | #23 |
| b10r | #23 |
| antibodies acpa | #23 |
| animal genes | #23 |
| 17 betaoestradiol | #23 |
| rats inbred lew | #23 |
| anti‐cd5 | #23 |
| mbp eae | #23 |
| citrullinated protein | #23 |
| experimental cells | #24 |
| cells c3h | #24 |
| rat induction | #24 |
| new mouse | #24 |
| y35 | #24 |
| severity chronicity | #24 |
| monoclonal anti | #24 |
| loci chromosome | #24 |
| inflammation arthritis | #24 |
| subloci | #24 |
| secondary immune response | #24 |
| mice nox2 | #24 |
| experimental lupus | #24 |
| mediated arthritis | #24 |
| controls anti | #24 |
| animal epistasis | #24 |
| 339 | #24 |
| antinuclear apoptosis | #24 |
| levels comp | #24 |
| chronic autoimmune diseases | #24 |
| severity ali | #24 |
| autoantibodies rheumatoid | #24 |
| ftirm | #24 |
| c57bl 10 mice | #24 |
| flss patients | #24 |
| postpartum flare | #24 |
| mouse models development | #24 |
| production monoclonal | #25 |
| common autoimmune disease | #25 |
| relapsing polychondritis | #25 |
| ros | #25 |
| autoimmune diseases humans | #25 |
| 8 antibodies | #25 |
| monocytes nadph | #25 |
| arthritis experimental arthritis | #25 |
| autoimmune messenger | #25 |
| cell hybridomas | #25 |
| rat mhc | #25 |
| cells immunization | #25 |
| murine lyme arthritis | #25 |
| inbred lew rats | #25 |
| bnda | #25 |
| cix | #25 |
| proteinarginine deiminase type | #25 |
| b6 balb | #25 |
| congenic animals | #25 |
| specific epitopes | #25 |
| complex male | #25 |
| immunodominant epitope | #25 |
| massive infiltration | #25 |
| beta lymphocytes | #25 |
| autoantibody response | #25 |
| rno4 | #25 |
| arginine arthritis | #25 |
| interleukin2 mice receptors | #25 |
| tolerized rats | #25 |
| parasitemia survival | #25 |
| collagen cartilage | #25 |
| immunization development | #25 |
| helperinducer animals antibodies | #26 |
| viable chondrocytes | #26 |
| post translationally | #26 |
| igg2a mice | #26 |
| glutamax | #26 |
| cb11 | #26 |
| polychondritis rp | #26 |
| cells joints | #26 |
| nitrophenylalanine | #26 |
| local exposure | #26 |
| hydrocarbon oil | #26 |
| eae development | #26 |
| mice gammadelta cells | #26 |
| granulocytes cells | #26 |
| anti citrullinated | #26 |
| autoantibodies citrullinated proteins | #26 |
| gene regions | #26 |
| hladrb1 shared epitope | #27 |
| pannus tissue | #27 |
| nonmhc genes | #27 |
| innate interleukin10 | #27 |
| perforin deficiency | #27 |
| interleukin21 tlymphocytes | #27 |
| immunospecific | #27 |
| individuals antibodies | #27 |
| intercrossed | #27 |
| disease immunoglobulin | #27 |
| antibodies type | #27 |
| immunodominant response | #27 |
| ccp2 | #27 |
| trypsination | #27 |
| c1i | #27 |
| physiological level | #27 |
| rheumatoid factor isotypes | #27 |
| pointmutation | #27 |
| ros induction | #28 |
| w3 25 | #28 |
| onset day | #28 |
| protein peptides | #28 |
| mrna ifngamma | #28 |
| rat strain | #28 |
| antibodies mab | #28 |
| antily6g | #28 |
| nr8383 | #28 |
| mediated effects | #28 |
| cia3 | #28 |
| anti rat | #28 |
| lysine position | #28 |
| antigenspecific tolerance | #28 |
| autoimmune inflammatory | #28 |
| chronicity | #28 |
| eae susceptibility | #28 |
| upregulation cytokines | #28 |
| severity day | #28 |
| animal models neurodegeneration | #28 |
| cartilage vivo | #28 |
| chronic dss | #29 |
| mice mab | #29 |
| hiit exercise | #29 |
| presence synovial fluid | #29 |
| rfigm | #29 |
| suboptimal doses | #29 |
| glucose transport capacity | #29 |
| acpa | #29 |
| ros production macrophages | #29 |
| membrane lymphocytes | #29 |
| antibody producing cells | #29 |
| smoking presence | #29 |
| parotid secretory protein | #29 |
| immunopathogenicity | #29 |
| 246trinitrophenyl | #29 |
| absence inflammation | #29 |
| cfa cia | #29 |
| ls2616 | #29 |
| phenomes | #29 |
| peptide anti | #29 |
| metabolic syndrome rats | #30 |
| chain collagen | #30 |
| vivo exercise | #30 |
| paws | #30 |
| treatment raloxifene | #30 |
| disease immunity | #30 |
| ctla4 mice | #30 |
| synovial cells patients | #30 |
| hlase | #30 |
| vpba | #30 |
| adult thymectomy | #30 |
| increased salt | #30 |
| plasminogendeficient mice | #30 |
| translational rats | #30 |
| cultivation cells | #30 |
| variable heavy chain | #30 |
| alphabetat | #30 |
| chronic autoimmune | #30 |
| vgenes | #30 |
| linkage disease | #30 |
| development experimental | #30 |
| dba mice | #30 |
| acpa fine | #30 |
| 11 cells | #30 |
| hiit training | #31 |
| phytol | #31 |
| human type collagen | #31 |
| perpetuated | #31 |
| monoclonal antibody production | #31 |
| common chain | #31 |
| trimolecular | #31 |
| expressing cells | #31 |
| selfprotein | #31 |
| ige cd23 | #31 |
| disease development | #31 |
| pristaneinduced lupus | #31 |
| rats autoimmune | #31 |
| psoriasis model | #31 |
| acute‐phase response | #31 |
| apc development | #31 |
| immunization | #31 |
| synovial fluid blood | #31 |
| littermate controls | #31 |
| drugs addition | #31 |
| nox2 nox1 | #31 |
| comparative genetic analysis | #31 |
| bound peptides | #32 |
| receptor preference | #32 |
| hladrb104 | #32 |
| specificity function | #32 |
| mucosal tolerance | #32 |
| epitope antibodies | #32 |
| type antibody | #32 |
| presence acpas | #32 |
| influence genes | #32 |
| nadph oxidases nox | #32 |
| nonb cells | #32 |
| cell ratio | #32 |
| rt11 | #32 |
| arthritis therapy | #32 |
| congenic mice | #32 |
| caia mice | #32 |
| 11 cell | #32 |
| genomewide genotyping | #32 |
| steen | #32 |
| cells uterus | #32 |
| beta mice | #32 |
| ros rns | #32 |
| role osteoclastogenesis | #32 |
| acpa rheumatoid arthritis | #32 |
| h2aq | #32 |
| polymorphic genes | #32 |
| differentiation arthritis | #32 |
| methods serum samples | #32 |
| ra33 | #32 |
| nodes mice | #32 |
| modified collagen | #33 |
| type cross | #33 |
| induced immunization | #33 |
| tcell receptor | #33 |
| epitopes antibodies | #33 |
| multiplex analysis | #33 |
| arthritic mice | #33 |
| autoantibody activity | #33 |
| autoimmune demyelinating disease | #33 |
| role vav1 | #33 |
| tolerance immunization | #33 |
| rheumatoid joint | #33 |
| antigenpresenting cells cells | #33 |
| cytosolic factor | #33 |
| delayed type | #33 |
| skews | #33 |
| joint pathology | #34 |
| heterogeneous stock | #34 |
| cells dendritic cells | #34 |
| c4bp | #34 |
| interferon activity | #34 |
| natural antibodies nabs | #34 |
| chronic polyarthritis | #34 |
| patients animal models | #34 |
| neurodegeneration role | #34 |
| fpr1 | #34 |
| promiscuous expression | #34 |
| nox2 deficiency | #34 |
| infectious disease models | #35 |
| arthritis disease | #35 |
| complex arthritis | #35 |
| antirat | #35 |
| triple helical | #35 |
| 1xi | #35 |
| vdr cells | #35 |
| monoclonal rheumatoid | #35 |
| hybridomas | #35 |
| phagotope | #35 |
| autoreactive | #35 |
| plasminogen deficiency | #35 |
| patients populations | #35 |
| destructive arthritis | #35 |
| antiarthritis | #35 |
| acs stroke | #35 |
| development chronic | #35 |
| major regulators | #35 |
| accessible sites | #35 |
| psoriasiform skin | #35 |
| nets neutrophils | #35 |
| h2r | #36 |
| nk cells recognition | #36 |
| comparative genetics | #36 |
| protein specific | #36 |
| animals antigen | #36 |
| dth | #36 |
| dinitro1 | #36 |
| flow cytometry expression | #36 |
| induction tregs | #36 |
| oxidases rna | #36 |
| cartilage joints | #36 |
| female histocompatibility | #36 |
| specificity sera | #36 |
| h2g7 | #36 |
| tolerance tlymphocytes | #36 |
| techniques mice | #36 |
| phagocyte | #36 |
| variance animals antibodies | #36 |
| cii cfa | #36 |
| arthritis cartilage | #36 |
| synthetic glycopeptides | #37 |
| joint cartilage | #37 |
| cii protein | #37 |
| genetic control | #37 |
| recombinant vaccine | #37 |
| spontaneous arthritis | #37 |
| c129 | #37 |
| acpa positive | #37 |
| rich lipid | #37 |
| role gamma interferon | #37 |
| susceptibility autoimmune diseases | #37 |
| dba1 | #37 |
| encephalomyelitis | #37 |
| immunopathological features | #37 |
| lymphocytes disease | #37 |
| oxidases oxidation | #37 |
| mif pathogenesis | #37 |
| peptides binding | #37 |
| cochranmantelhaenszel test | #38 |
| sialophorin | #38 |
| human blood neutrophils | #38 |
| innovative tools | #38 |
| cldn4 | #38 |
| snat | #38 |
| animal models pain | #38 |
| target autoantigens | #38 |
| antibodies animals | #38 |
| nitrogen species | #38 |
| autoreactive cells | #39 |
| b6n | #39 |
| endoβnacetylglucosaminidase | #39 |
| benoist | #39 |
| oestrogen treatment | #39 |
| ccia | #39 |
| cell tolerance | #39 |
| nfr | #39 |
| ym1 | #39 |
| resultsrats | #39 |
| wasting syndrome | #39 |
| data myelin | #39 |
| clonal expansion cells | #39 |
| nzw | #39 |
| acpa response | #39 |
| allogeneically | #39 |
| measurement activity | #39 |
| addition impact | #40 |
| rt1c | #40 |
| disease animal models | #40 |
| antigens arthritis | #40 |
| adjuvant induced | #40 |
| positive rheumatoid | #40 |
| polyclonal cell activation | #40 |
| isostere | #40 |
| peptide cell | #40 |
| genetic complexity | #40 |
| ncii | #41 |
| genes loci | #41 |
| rat myelin | #41 |
| aq | #41 |
| congenic mapping | #41 |
| mhc haplotype | #41 |
| autoimmune | #41 |
| rats anti | #41 |
| immunocap isac | #41 |
| priming phase | #41 |
| severity incidence | #41 |
| effects experiments | #41 |
| autoimmune inflammatory diseases | #41 |
| drb1 shared | #42 |
| th17 axis | #42 |
| mhc class class | #42 |
| cartilage bone destruction | #42 |
| pineal gland melatonin | #42 |
| species receptors | #42 |
| antibody isotypes | #42 |
| ptpn22 locus | #42 |
| spleen weight | #42 |
| articular collagen | #42 |
| p38 mapk nfκb | #42 |
| expected onset | #42 |
| fibroblasts mice | #42 |
| arthritis data | #43 |
| type‐ii | #43 |
| anticitrullinated | #43 |
| lew rats | #43 |
| rats sex | #43 |
| spinal glia | #43 |
| kgf treatment | #43 |
| autoreactive cell | #43 |
| cd11bly6g | #43 |
| crosses genetic | #43 |
| lew lymphocytes | #43 |
| mice autoimmune | #43 |
| anticyclic | #43 |
| collagen | #43 |
| treatment autoimmune diseases | #43 |
| congeneic | #43 |
| pc8 | #43 |
| immunodominant epitopes | #43 |
| homozygous form | #44 |
| inflammation animals | #44 |
| chloro23 | #44 |
| provocations | #44 |
| defensins humans | #44 |
| c4bbinding protein c4bp | #44 |
| genetic linkage analysis | #44 |
| neuritis ean | #44 |
| addition order | #44 |
| mice adulthood | #44 |
| mathis | #44 |
| epitopes lymphocyte | #44 |
| mice mice autoimmune | #44 |
| peptide induced | #44 |
| phagotopes | #45 |
| potent suppression | #45 |
| disease histocompatibility | #45 |
| outbred rats | #45 |
| genetic encoding | #45 |
| relapsing disease | #45 |
| chromosome development | #45 |
| susceptibility arthritis | #45 |
| nzb | #45 |
| cocrystallisation | #46 |
| mhc class humans | #46 |
| affinity purified | #46 |
| specific tolerance | #46 |
| posttranslationally | #46 |
| neuritis autoimmune | #46 |
| locus controlling | #46 |
| isosteres | #46 |
| carp antibodies | #46 |
| rat2 | #46 |
| eae mbp | #46 |
| lower severity | #46 |
| disease induction | #46 |
| alphachains | #46 |
| c227 | #46 |
| posttranslational rats receptors | #47 |
| association hladrb1 alleles | #47 |
| antibody reactivities | #47 |
| protective allele | #47 |
| intercrosses | #47 |
| f1 hybrid mice | #47 |
| diagnostic accuracy diagnosis | #47 |
| complex mediated | #47 |
| idiotypic antibody | #47 |
| rheumatoid factors | #47 |
| humanized model | #48 |
| mice nzb | #48 |
| collagen glycosylation | #48 |
| experimental arthritis mice | #48 |
| mice carrying | #48 |
| cia rats | #48 |
| antibody specificity | #48 |
| synovial lining layer | #48 |
| lupus disease | #48 |
| tlr12 | #48 |
| collagen peptide | #48 |
| f1 crosses | #48 |
| peptide recognized | #48 |
| γchains | #48 |
| acetylchitobiose | #48 |
| polyvinylcaprolactam | #49 |
| sex genes | #49 |
| bystander activation | #49 |
| experimental crosses | #49 |
| histone hdacs | #49 |
| immune nervous | #49 |
| class major | #49 |
| mice caia | #49 |
| monoclonal autoimmune diseases | #49 |
| comp levels | #49 |
| tcell stimulation | #49 |
| mouse cartilage | #49 |
| glycosylated form | #50 |
| cytometry analyses | #50 |
| loci animals | #50 |
| alagly | #50 |
| dependent chronic | #50 |
| animal cell culture | #50 |
| disease rats | #50 |
| parathyroid cells | #50 |
| monoclonal epitopes | #50 |
| anticarbamylated protein | #50 |
| ciiia | #50 |
| mice tolerance | #50 |
| antigenantibody | #50 |
| inflammation kynurenine | #50 |
| complex region | #50 |
| glutamine uptake | #50 |
| tracheal cartilage | #51 |
| fewer cells | #51 |
| cells ova | #51 |
| antibodies cells | #51 |
| inbred c57bl autoimmune | #51 |
| lentiviral particles | #51 |
| rheumatoid factor activity | #51 |
| autoantibodies rheumatoid arthritis | #51 |
| aire mice | #51 |
| tolerized | #51 |
| delayed immunization | #51 |
| c57bl 6j background | #51 |
| derived type | #51 |
| evidence animal models | #51 |
| runting | #51 |
| antigenpresenting cells | #52 |
| matrix protein | #52 |
| model collagen | #52 |
| macrophages skin | #52 |
| ptpn22 | #52 |
| xor activity | #52 |
| physiological doses | #53 |
| gastric parietal cell | #53 |
| production reactive | #53 |
| patients rheumatic conditions | #53 |
| lysosomal compartments | #53 |
| protein antibodies | #53 |
| triple helical structure | #53 |
| antibodies epitopes | #53 |
| melatonin day | #53 |
| induced autoimmunity | #53 |
| aged peptides | #53 |
| cartilage erosion | #53 |
| carbamylated proteins | #53 |
| arthritis induction | #53 |
| crossbreeding | #54 |
| rats social isolation | #54 |
| predating | #54 |
| major epitope | #54 |
| strain rats | #54 |
| nodes lymphocyte | #54 |
| imitating | #54 |
| melatonin animals | #54 |
| development individuals | #54 |
| yaa | #54 |
| animals autoimmune | #54 |
| carbamylated protein | #54 |
| antigens myelomonocytic arthritis | #54 |
| macrophage mannose receptor | #55 |
| inflammatory manifestations | #55 |
| autoimmune reactions | #55 |
| complex genetic disease | #55 |
| susceptibility autoimmune disease | #55 |
| arthritis genetic | #55 |
| autoimmune nzb | #55 |
| new animal | #56 |
| mhc | #56 |
| selfreactive cells | #56 |
| alpha1microglobulin | #56 |
| cells salivary | #56 |
| animals antibody | #56 |
| labels superoxide | #56 |
| cd1 mice | #57 |
| vivo depletion | #57 |
| igg abs | #57 |
| animals antirheumatic | #57 |
| antibodies bind | #57 |
| arthritis pathogenesis | #57 |
| development autoimmune | #57 |
| collagen sequence | #57 |
| antibodies | #57 |
| rat type | #58 |
| urokinase activity | #58 |
| oestrogen progesterone | #58 |
| peptide response | #58 |
| schafer | #58 |
| chronic eae | #58 |
| hydroxylase diet | #59 |
| genes mhc | #59 |
| encephalitogenicity | #59 |
| oligoclonal igg bands | #59 |
| anticarp antibodies | #59 |
| cartilage matrix protein | #59 |
| anti cd8 | #59 |
| anti cell | #59 |
| resistance eae | #59 |
| articular joints | #59 |
| hpaaxis | #60 |
| macrophage mannose | #60 |
| protein peptide | #60 |
| immunohistopathology | #60 |
| dichotomous effects | #60 |
| inflammatory cells macrophages | #60 |
| alternative activation macrophages | #60 |
| joint erosions | #60 |
| assay epitopes | #60 |
| epitope spreading | #61 |
| major histocompatibility | #61 |
| serum comp | #61 |
| alpha1m | #61 |
| experimental rats rats | #61 |
| species reactive | #61 |
| incidence severity | #61 |
| cells innate immune | #61 |
| differentiation myelomonocytic arthritis | #61 |
| experimental evoked potentials | #61 |
| antigens class histocompatibility | #62 |
| syngeneically | #62 |
| interferon‐β | #62 |
| cyclic sensitivity | #62 |
| fpr2 | #62 |
| reduced oxidative | #62 |
| adaptive immune | #62 |
| basic characterization | #62 |
| toxin1 | #62 |
| placenta uterus | #62 |
| autoantibody formation | #62 |
| mice susceptibility | #62 |
| mice polyi | #63 |
| delayed interferon | #63 |
| rats strain | #63 |
| glycoprotein myelin | #63 |
| peptide specific | #63 |
| specificity tumor | #63 |
| duval | #63 |
| mog1 | #63 |
| transfer animals | #63 |
| protein disease | #63 |
| igaproducing cells | #63 |
| specific stages | #63 |
| constant darkness | #63 |
| post‐partum | #63 |
| induced experimental | #63 |
| collagen cell | #63 |
| nadph oxidases | #63 |
| hypersensitivity dth | #63 |
| secondary immune | #64 |
| maternal origin | #64 |
| lower capacity | #64 |
| role apc | #64 |
| freund adjuvant | #64 |
| tolerance model | #64 |
| model chronic | #65 |
| autoimmunity humans | #65 |
| weight variation | #65 |
| hindpaws | #65 |
| flss | #65 |
| major subset | #65 |
| histocompatibility complex | #65 |
| induced suppression | #65 |
| acute arthritis | #66 |
| hladr2 | #66 |
| chromosomes mammalian | #66 |
| phagocytosis oxidative burst | #66 |
| rheumatoid synovial cells | #66 |
| multispecificity | #66 |
| thy1 antigen | #66 |
| experimental lymphocytes | #66 |
| resemblances | #66 |
| peripheral joints | #66 |
| negative rheumatoid | #66 |
| spontaneous disease | #66 |
| mice induced | #67 |
| strains susceptible | #67 |
| endos | #67 |
| experimental encephalomyelitis | #67 |
| experimental allergic | #67 |
| key interactions | #67 |
| myelomonocytic arthritis | #67 |
| development cell | #67 |
| fibrinogen genotype | #67 |
| dendritic cells epitopes | #67 |
| rheumatoid arthritis susceptibility | #67 |
| mice cell | #67 |
| frequent infections | #68 |
| individuals positive | #68 |
| sodium diethyldithiocarbamate | #68 |
| tolerized mice | #68 |
| cells mhc class | #68 |
| rheumatoid chromosomes | #68 |
| anti carp | #68 |
| severity periodontitis | #68 |
| class region | #68 |
| female sex hormones | #68 |
| complex class | #68 |
| iggrf | #68 |
| helper phenotype | #68 |
| frequency antibodies | #69 |
| lymphocytes chronic | #69 |
| direct damage | #69 |
| cells mouse | #69 |
| vertebrate immune | #69 |
| relapsing | #69 |
| zap‐70 | #69 |
| rheumatoid disease | #69 |
| presence rheumatoid factor | #70 |
| translationally | #70 |
| prolonged graft survival | #70 |
| mrl mice | #70 |
| role cells | #70 |
| response type | #70 |
| immunoglobulin interferon | #70 |
| susceptibility female | #71 |
| cb10 | #71 |
| cartilage mice | #71 |
| expression pparγ | #71 |
| human psoriasis | #71 |
| ztm | #71 |
| isolated rats | #71 |
| swr | #71 |
| interphalangeal joints | #72 |
| naïve mice | #72 |
| study antibodies | #72 |
| antibodies binding | #72 |
| autoimmunity lymphocytes | #72 |
| dark agouti rats | #72 |
| lathyritic | #72 |
| napdh | #72 |
| delayedtype hypersensitivity dth | #72 |
| species ros | #73 |
| type ifn signature | #73 |
| oxidase complex | #73 |
| treatment stages | #73 |
| membrane animals | #73 |
| mrl lpr | #73 |
| knockout protein processing | #73 |
| bovine type | #73 |
| environmental lighting | #73 |
| pregnancyinduced | #74 |
| antigens class | #74 |
| igarf | #74 |
| hypersensitivity delayed | #74 |
| cartilage explants | #74 |
| peptides sequences | #74 |
| diabetes arthritis | #75 |
| genetic disease models | #75 |
| inbred dba receptors | #75 |
| dth mice | #75 |
| oestradiol | #75 |
| effects development | #75 |
| acpapositive | #75 |
| cell reactivity | #75 |
| rat splenocytes | #76 |
| anti carbamylated | #76 |
| type collagens | #76 |
| disease rheumatoid arthritis | #76 |
| peptide mhc | #76 |
| eae induced | #77 |
| cyp7a1 | #77 |
| pain inflammation | #77 |
| nerve conduction velocity | #77 |
| lpr mrl | #77 |
| development insulitis | #77 |
| inbred mouse strains | #77 |
| rt1n | #77 |
| oligomeric | #77 |
| collagen chains | #77 |
| new animal model | #77 |
| cell deficient | #77 |
| rats eae | #77 |
| regulatory vaccines | #77 |
| clinical arthritis | #78 |
| pythons | #78 |
| autoantigenic | #78 |
| rats respiratory | #78 |
| pathogenesis rheumatoid arthritis | #78 |
| cartilage integrity | #78 |
| mhc expression | #78 |
| inflammatory autoimmune | #79 |
| mononuclear lung | #79 |
| autoimmune experimental epitopes | #79 |
| 1ii | #79 |
| susceptibility disease | #79 |
| shared epitope | #79 |
| erosive arthritis | #80 |
| detection autoantibodies | #80 |
| oxidases | #80 |
| chromosome study | #80 |
| class antigen expression | #81 |
| spleen study | #81 |
| aspartic acid position | #81 |
| dr1 antigen | #81 |
| expression ll37 | #81 |
| sex linkage | #81 |
| type macrophages | #81 |
| mrl mp | #81 |
| induced leukocyte | #81 |
| mog mbp | #81 |
| estrogen suppression | #81 |
| arthritis cells | #81 |
| hnrnpa2 | #81 |
| mhcii expression | #81 |
| inflammatory phase | #81 |
| pannus formation | #82 |
| 14weeks | #82 |
| nadphoxidase | #82 |
| cell independent | #83 |
| tlymphocyte genes | #83 |
| expression mhc | #83 |
| drug encephalomyelitis | #83 |
| mice igg | #83 |
| bcg infection | #83 |
| strains animals | #84 |
| reactive cells | #84 |
| spontaneous development | #84 |
| naïve cells | #84 |
| arthritis day | #84 |
| rat cardiac allografts | #84 |
| multiple sclerosis evidence | #84 |
| epidermal cells | #84 |
| cells recognize | #85 |
| inflammation joint | #85 |
| class molecule | #85 |
| knockout receptors | #85 |
| inflammation joints | #85 |
| homopentamer | #85 |
| antiifngamma | #85 |
| anti cd4 | #86 |
| animal humans | #86 |
| severe eae | #86 |
| contribution genes | #86 |
| preclinical stage | #86 |
| mutant strains | #86 |
| classical humans | #86 |
| gfoger | #86 |
| phagocyte nadph | #86 |
| monoclonal antibodies mab | #86 |
| estrogen induced | #87 |
| alpha1acid glycoprotein | #87 |
| mhc class gene | #87 |
| smash | #87 |
| inbred rat strains | #87 |
| inguinal lymph nodes | #88 |
| narac | #88 |
| thps | #88 |
| levels anti | #88 |
| copy variation | #88 |
| fine specificities | #88 |
| mice antibodies | #89 |
| genetic quantitative | #89 |
| arthritic | #89 |
| peptide immunization | #89 |
| mabs mab | #89 |
| experimental autoimmune | #89 |
| depletion cd8 cells | #89 |
| autoimmune inbred c57bl | #90 |
| rheumatoid arthritis cells | #90 |
| mediated mechanisms | #90 |
| ilc2 activation | #90 |
| monkeys mice | #90 |
| susceptible | #90 |
| genistein treatment | #90 |
| adjuvant arthritis | #90 |
| arthritis compared | #90 |
| pineal hormone melatonin | #90 |
| synovial fluid serum | #91 |
| backgroundan | #91 |
| activation cd4 cells | #91 |
| histological sections | #91 |
| protein induced | #91 |
| cells apc | #91 |
| cattle collagen | #91 |
| nod mhc | #92 |
| abdominal region | #92 |
| difco | #92 |
| humans immunodominant | #92 |
| experimental mouse models | #92 |
| anticitrullinated protein | #92 |
| cellspecific | #93 |
| knockout myelin | #93 |
| 290 patients | #93 |
| animals autoantibodies | #93 |
| xor | #93 |
| mice melatonin | #93 |
| natural polymorphisms | #93 |
| autosomal genes | #94 |
| fcγrs | #94 |
| macrophages development | #94 |
| galactosylated | #94 |
| endosomal acidification | #94 |
| activated cells cells | #94 |
| induced sarcoma | #95 |
| moderateintensity exercise | #95 |
| binding integrins | #95 |
| chronic phase disease | #95 |
| nonglycosylated | #96 |
| pregnancy disease | #96 |
| data rats | #96 |
| fetal rejection | #96 |
| cell alpha | #96 |
| lung emphysema | #96 |
| romani | #96 |
| messenger tolllike receptor | #96 |
| macrophages stimulation | #96 |
| ifnbeta | #96 |
| hydroxylysine | #97 |
| macrophages fibroblasts | #97 |
| il33r | #97 |
| genetic female genes | #97 |
| cathelicidins | #97 |
| citrullinated fibrinogen | #97 |
| rheumatoid lymphocytes | #97 |
| antiimmunoglobulin | #97 |
| complex mice | #97 |
| rheumatoid cartilage | #98 |
| autoimmune experimental | #98 |
| ean | #98 |
| acpa igg | #98 |
| swr mice | #98 |
| autoimmune rats | #98 |
| alternative pathways | #99 |
| interleukin‐4 | #99 |
| collagen cytokines | #99 |
| rat chromosomes | #99 |
| protein antibody | #100 |
| thy1 antigens | #100 |
| cultured crosses | #100 |
| peptides cells | #100 |
| invading pathogens | #100 |
| ccp anti | #100 |
| tap2 | #100 |
| tlymphocyte immunity | #100 |
| inducer animals | #100 |
| rats monoclonal antibodies | #100 |
| safety drugs | #101 |
| fprs | #101 |
| cell determinants | #101 |
| susceptible strain | #101 |
| eira | #101 |
| diarthrodial | #101 |
| bone degradation | #101 |
| singlenucleotide polymorphism | #101 |
| mouse monoclonal antibodies | #102 |
| eae animal encephalomyelitis | #102 |
| findings treatment | #102 |
| candidate autoantigen | #102 |
| brucei infection | #102 |
| oxidative burst | #103 |
| drb10401 | #103 |
| agalactosyl | #103 |
| hla dr1 | #103 |
| ros homeostasis | #103 |
| pathogenesis emphysema | #103 |
| nonarthritic | #104 |
| male mice mice | #104 |
| arthritic disease | #104 |
| mhcii | #104 |
| mutation mice | #104 |
| synchrotron infrared | #104 |
| haplotypes histocompatibility | #104 |
| thelper cells | #104 |
| f1 males | #104 |
| skg mice | #104 |
| development antibodies | #105 |
| autoreactivity | #105 |
| type 22 | #105 |
| osteoclasts mice | #105 |
| hybridoma cell | #105 |
| vivo macrophages | #105 |
| dmaam | #105 |
| fcγr | #105 |
| disease dose | #106 |
| tcell immunity | #106 |
| primed cells | #106 |
| limited cross | #106 |
| proteoglycan loss | #106 |
| arthritis hla | #106 |
| 273 | #106 |
| c3h mice | #107 |
| cells synovial | #107 |
| nzb mice | #107 |
| development autoimmune disease | #108 |
| fpr | #108 |
| littermates | #108 |
| study tolerance | #108 |
| monoclonal igg | #109 |
| type hypersensitivity | #109 |
| structural polymorphism | #109 |
| reactive cell | #109 |
| enthesophytes | #109 |
| presentation cells | #109 |
| delayedtype hypersensitivity | #109 |
| citrullinated proteins | #109 |
| autoantibodies autoantigens | #109 |
| autoimmune encephalomyelitis | #110 |
| carcinoma tumors | #110 |
| cartilage | #111 |
| experimental female | #111 |
| toxic shock syndrome | #111 |
| inbred dba microscopy | #111 |
| streptococcal cell wall | #111 |
| female hypersensitivity | #111 |
| dba 1j mice | #111 |
| mog eae | #111 |
| backcross | #111 |
| alphabeta receptors antigen | #112 |
| anti idiotypic antibodies | #112 |
| amide bond | #112 |
| humoral autoimmunity | #112 |
| extensive literature search | #112 |
| presymptomatic individuals | #112 |
| restricted cell | #113 |
| trait loci | #113 |
| adjuvant properties | #113 |
| mice collageninduced arthritis | #113 |
| autoimmune c57bl mice | #113 |
| xid mice | #113 |
| tcra | #113 |
| db1 | #113 |
| oligoclonality | #113 |
| adjuvantinduced arthritis | #114 |
| ifngammaproducing cells | #114 |
| mice disease | #115 |
| anti mcv | #115 |
| drb10402 | #115 |
| rats collagen | #115 |
| proinflammatory cytokine | #115 |
| autoantigens autoimmunity | #115 |
| transgenic peptides receptors | #116 |
| ccp patients | #116 |
| glycopeptides | #116 |
| pathogenesis autoimmune diseases | #116 |
| glyco | #116 |
| experimental epitopes | #116 |
| lymphocyte female | #116 |
| susceptibility eae | #116 |
| immunosorbents | #116 |
| lutz | #116 |
| fluorescence nf | #117 |
| antiarthritic | #117 |
| encephalomyelitis autoimmune | #117 |
| antibodies reactive | #117 |
| congenic lines | #117 |
| mice type | #117 |
| tolerance induced | #117 |
| rats immunized | #118 |
| psoriasiform dermatitis | #118 |
| pineal hormone | #118 |
| samples individuals | #118 |
| class expression | #118 |
| myelin oligodendrocyte | #118 |
| α enolase | #118 |
| alpha1acid | #118 |
| radiological damage | #119 |
| rheumatoid arthritis review | #119 |
| cd4 tcells | #119 |
| response cells | #119 |
| 05m | #119 |
| psa rheumatoid arthritis | #119 |
| protein mbp | #120 |
| neutrophils nets | #120 |
| vivo animal models | #121 |
| chondrocyte cultures | #121 |
| experimental animal models | #121 |
| t‐lymphocyte | #122 |
| transfer arthritis | #122 |
| transgenic neurons receptors | #122 |
| genes age | #122 |
| pharmacological potential | #122 |
| acpa negative | #122 |
| immune complex deposition | #122 |
| patients acpa | #122 |
| treatment progesterone | #122 |
| symptoms associations | #123 |
| cell monoclonal | #123 |
| alphabeta cells | #123 |
| nox2 activation | #123 |
| c5b | #123 |
| type cytokines | #123 |
| tlr4 stimulation | #124 |
| inbred mouse | #124 |
| cartilage surface | #124 |
| cryogel | #125 |
| preimmunized | #125 |
| blocking antigens | #125 |
| helperinducer | #125 |
| general mechanisms | #125 |
| allelic variations | #125 |
| oxidases neutrophils | #125 |
| disease mechanisms | #125 |
| qtl genes | #125 |
| immunodominant peptide | #125 |
| genetic rats | #125 |
| nzb nzw | #126 |
| female immunization | #126 |
| nonobese diabetic | #126 |
| pnipaam | #126 |
| cyclic polymorphism | #126 |
| microarray detection | #127 |
| atp8 | #127 |
| knockout murine | #127 |
| animal enzyme | #127 |
| absence cells | #127 |
| anticitrullinated peptide | #128 |
| chronic inflammatory disease | #128 |
| dominant epitope | #128 |
| deiminases | #128 |
| lining layer | #128 |
| bxsb | #129 |
| multiple epitopes | #129 |
| spleen rats | #129 |
| rats patients | #129 |
| oestradiol testosterone | #130 |
| psd1 | #130 |
| disease induced | #130 |
| nos2 | #130 |
| vivo absence | #130 |
| cells eae | #130 |
| onset arthritis | #131 |
| epitope specific | #131 |
| lipomannan | #131 |
| kgf | #132 |
| linomide | #132 |
| intercross | #132 |
| mineral oils | #132 |
| disease cgd | #132 |
| pronociceptive | #132 |
| induction regulatory cells | #132 |
| rat chromosome | #133 |
| reduced severity | #133 |
| ggaa | #133 |
| leukosialin | #133 |
| myocellular | #134 |
| mice estrogen | #134 |
| accentuate | #134 |
| interstitial collagens | #134 |
| species animals | #134 |
| eae | #134 |
| plasma synovial fluid | #134 |
| patients cytokines | #134 |
| knockout receptors antigen | #134 |
| peptides cyclic | #135 |
| spinal glial | #135 |
| igg immune complexes | #135 |
| chronic autoimmune disease | #136 |
| macrophages dendritic | #136 |
| intracellular reactive | #136 |
| immunizing | #136 |
| receptor upregulation | #137 |
| innate lymphocytes | #137 |
| stimulated muscle | #137 |
| immunopathological | #137 |
| mice deficient | #138 |
| ditiocarb | #138 |
| dmannitol | #139 |
| autoimmune mice | #139 |
| control development | #139 |
| immunomodulatory drug | #139 |
| tcrdelta | #140 |
| oligoclonal expansion | #141 |
| producing cell | #141 |
| thermoresponsive polymer | #141 |
| rejection tolerance | #142 |
| single subcutaneous injection | #142 |
| gamma lymphocyte | #142 |
| smfish | #142 |
| interferon‐γ | #142 |
| genetic factors development | #142 |
| phadia | #142 |
| or113 | #142 |
| phosphate isomerase | #143 |
| mice beta | #143 |
| tcell alphabeta receptors | #143 |
| cell hybridoma | #143 |
| class haplotypes | #143 |
| rheumatoid arthritis | #144 |
| mhc haplotypes | #144 |
| synovial hyperplasia | #144 |
| rat strains | #144 |
| inbred buf rats | #145 |
| treatment ici | #145 |
| tnf production | #145 |
| tcr gamma delta | #145 |
| severe chronic | #145 |
| syngenic | #145 |
| lyme arthritis | #145 |
| neonatal growth | #146 |
| rats induced | #146 |
| ccp antibodies | #147 |
| pregnancy levels | #147 |
| systemic challenge | #147 |
| function cells | #147 |
| cellular heterogeneity | #147 |
| gammainterferon | #147 |
| α2i | #148 |
| cell surface antigen | #148 |
| redox regulation | #148 |
| interestingly | #148 |
| autoimmune disease | #148 |
| phagocyte nadph oxidase | #148 |
| human autoimmune diseases | #149 |
| complex diseases | #149 |
| drb104 | #150 |
| mhc binding | #150 |
| larsen score | #150 |
| levels antibodies | #151 |
| epicutaneously | #151 |
| mice animals | #151 |
| humans hybridomas | #151 |
| differential gene expression | #151 |
| receptor rats | #151 |
| alphabeta receptors | #152 |
| pepsin | #153 |
| key player | #153 |
| arthritic animals | #153 |
| levels pregnancy | #153 |
| mononuclear cells | #153 |
| male rats rats | #154 |
| selfpeptides | #154 |
| immune priming | #154 |
| c4bbinding protein | #154 |
| expression class | #154 |
| critical event | #154 |
| fcgammar | #154 |
| daf1 | #154 |
| joint inflammation | #154 |
| padi4 | #155 |
| infiltrating cells | #155 |
| arthritis rheumatoid | #155 |
| f1 mice | #155 |
| autoantibodies autoimmune | #155 |
| serum synovial fluid | #155 |
| mace acs | #155 |
| stabilin1 | #156 |
| suppressive role | #156 |
| specificities | #156 |
| mhc region | #156 |
| murine keratinocytes | #157 |
| adjuvanticity | #157 |
| downstream signals | #157 |
| parentals | #158 |
| analysis structure | #158 |
| genetic diabetes mellitus | #158 |
| hypersensitivity reaction | #158 |
| meaib | #159 |
| arthritis infectious | #159 |
| systemic mice mice | #159 |
| inbred c3h mice | #159 |
| animals autoimmunity | #159 |
| consensus motif | #159 |
| gamma interferon | #161 |
| factors anti | #161 |
| benzylated | #161 |
| knockout severity | #161 |
| nursed | #161 |
| specific autoimmunity | #161 |
| day onset | #161 |
| psors1 | #162 |
| βarrestin recruitment | #162 |
| cd152 | #162 |
| binding collagen | #162 |
| epitope | #162 |
| rheumatoid autoantigens | #162 |
| arthritis inflammation | #162 |
| anti ccp | #162 |
| mouse type | #163 |
| onset disease | #163 |
| chains humans | #163 |
| laboratory rats | #163 |
| mrl | #164 |
| progesterone effects | #164 |
| endobetanacetylglucosaminidase | #164 |
| autoantibody responses | #164 |
| striking similarities | #164 |
| agalactosyl igg | #164 |
| rats induction | #164 |
| genes qtl | #164 |
| cells macrophages | #165 |
| animal humans immunity | #165 |
| pathogenic pathways | #166 |
| epitope alleles | #166 |
| tolerance induction | #166 |
| nonimmunized | #166 |
| melatonin mice mice | #166 |
| class mice | #167 |
| human autoimmunity | #167 |
| nox2 | #167 |
| ag7 | #167 |
| seronegative | #167 |
| tlymphocyte humans | #167 |
| cd1 | #168 |
| genetic backgrounds | #168 |
| mice cd4 cells | #168 |
| phase disease | #168 |
| p12 | #169 |
| denoted | #169 |
| oxazole | #169 |
| acpa levels | #169 |
| cryogels | #170 |
| joints male | #170 |
| experimental animal | #170 |
| pathogenesis arthritis | #170 |
| lymph node cells | #170 |
| mirp | #170 |
| inherited disorder | #170 |
| oxazolone | #171 |
| encephalomyelitis eae | #171 |
| ros nitric oxide | #171 |
| rat placenta | #172 |
| rheumatoid | #172 |
| single nucleotide polymorphism | #172 |
| peripheral lymphoid organs | #172 |
| autoimmune eae | #172 |
| lst1 | #172 |
| autoimmunity cell | #172 |
| monoclonal autoantibodies | #173 |
| sod3 | #173 |
| inbred dba models | #173 |
| class gene | #174 |
| studies pain | #174 |
| presence autoantibodies | #174 |
| resistant rats | #174 |
| nasal cartilage | #174 |
| maternal decidua | #175 |
| ifn signature | #175 |
| mice mutation | #175 |
| understanding pathogenesis | #175 |
| new mouse model | #176 |
| strains molecular | #176 |
| secondary challenge | #176 |
| tryptophan catabolism | #176 |
| skin disease | #176 |
| moab | #176 |
| mammalian crosses | #176 |
| lymphotoxinα | #177 |
| histocompatibility | #178 |
| ctla‐4 | #178 |
| hladrb1 alleles | #178 |
| dextran sulphate sodium | #179 |
| nod genes | #179 |
| protein anti | #179 |
| alternative pathway complement | #179 |
| immunized | #179 |
| mice role | #179 |
| cgd patients | #180 |
| arthritis methods | #180 |
| complex disease | #180 |
| epitopes female | #180 |
| molecular adaptations | #181 |
| autoimmunity disease | #181 |
| alleles arthritis | #181 |
| genetic influence | #181 |
| hormone melatonin | #182 |
| arginine deiminases | #182 |
| immunoglobulin mice mice | #185 |
| antigen processing presentation | #186 |
| multistep process | #186 |
| cells lymph nodes | #186 |
| rats reactive | #186 |
| drb1 chains | #187 |
| dba | #187 |
| tcell recognition | #187 |
| b10 | #187 |
| substrains | #188 |
| chondritis | #188 |
| molecular peptide | #188 |
| cells disease | #189 |
| mtec | #189 |
| positionally | #190 |
| hnrnpa2b1 | #190 |
| inflamed joint | #190 |
| synovial membranes | #190 |
| oligodendrocyte glycoprotein | #191 |
| cross‐reactivity | #192 |
| ly1 | #192 |
| autoantibody profiles | #192 |
| passive mice mice | #193 |
| fmlf | #193 |
| glycoprotein peptide | #194 |
| cyclic predictive | #194 |
| proteins myelin | #194 |
| chapter 16 | #195 |
| mice mutant | #195 |
| perpetuate | #195 |
| mhv | #195 |
| tcell response | #196 |
| lewis rat | #196 |
| myelin glycoprotein | #196 |
| oophorectomized | #196 |
| mhc class expression | #196 |
| evidence development | #197 |
| multiplex assay | #197 |
| acutephase response | #197 |
| pannus | #197 |
| igmrf | #198 |
| early appearance | #198 |
| genetic links | #198 |
| swedish patients | #198 |
| interleukin17 | #199 |
| rat genome | #199 |
| dr4 antigen | #199 |
| citrullinated peptide | #200 |
| hla association | #200 |
| cell collagen | #200 |
| pathogenesis autoimmune | #201 |
| myelin proteins myelin | #202 |
| instigation | #202 |
| acpa status | #202 |
| myelin proteolipid protein | #202 |
| dendritic cells macrophages | #202 |
| complete elimination | #203 |
| mice cells | #203 |
| class molecules | #204 |
| 2 complex | #204 |
| immunization immunoglobulin | #204 |
| spleen staining | #204 |
| native collagen | #205 |
| nonparametric tlymphocytes | #205 |
| ides | #205 |
| dth response | #205 |
| macrophages mice | #205 |
| suppresses | #205 |
| defb4 | #206 |
| wild rats | #206 |
| betaestradiol | #206 |
| alternative complement pathway | #207 |
| mice peptide | #207 |
| interleukin4 mice mice | #207 |
| noxs | #207 |
| parental strains | #207 |
| insulitis diabetes | #207 |
| desmoglein 3 | #207 |
| induced upregulation | #207 |
| intranasal challenge | #207 |
| antigen presenting | #208 |
| severity disease | #208 |
| vivo patients | #208 |
| naive mice | #208 |
| immunization mice | #208 |
| highest probability | #208 |
| immunoglobulin vh | #209 |
| cotwins | #209 |
| disease rheumatoid | #209 |
| citrullinated vimentin | #210 |
| vav1 | #210 |
| specific antibodies | #210 |
| susceptible strains | #210 |
| valuable tools | #210 |
| highfatdiet | #210 |
| natural antibodies | #211 |
| hla dr4 | #211 |
| glucose6 phosphate | #211 |
| diseases genetic | #211 |
| purified protein derivative | #211 |
| cells immobilized | #212 |
| large numbers | #212 |
| association rheumatoid arthritis | #212 |
| antibody binding | #213 |
| psoriasiform | #213 |
| mice injected | #213 |
| tsst1 | #214 |
| mhc class antigens | #215 |
| inbred rat | #215 |
| cytofluorometric | #215 |
| triethylsilane | #215 |
| antigen induced | #215 |
| central tolerance | #215 |
| dissect | #216 |
| training hiit | #216 |
| lower level | #216 |
| joints mice | #217 |
| lentiviral vector | #217 |
| resistant strain | #217 |
| cd23 | #217 |
| induced autoimmune | #217 |
| rats immunization | #217 |
| inflammatory infiltrates | #217 |
| antigen tcell | #218 |
| treatment onset | #218 |
| k8 | #219 |
| autoimmunity | #219 |
| peptide antibodies | #219 |
| fcrγ | #219 |
| granuloma formation | #219 |
| peptidylarginine deiminases | #220 |
| hyl | #220 |
| bone erosions | #220 |
| cells autoimmune | #220 |
| redox signaling | #221 |
| rheumatoid factor | #221 |
| pinealectomy | #221 |
| cyclosporin treatment | #221 |
| agouti rats | #221 |
| cells dendritic | #221 |
| fine specificity | #221 |
| targeted deletion | #221 |
| monoclonal antigens differentiation | #222 |
| cybb | #222 |
| thymectomized | #222 |
| wkymvm | #222 |
| cartilage damage | #222 |
| multiplex | #223 |
| experimental autoimmune neuritis | #223 |
| igg2a | #223 |
| carbamylated | #223 |
| inflammation vivo | #224 |
| expressing | #224 |
| clinical scoring | #225 |
| lew | #225 |
| established disease | #225 |
| interleukin‐10 | #225 |
| cells antigen | #225 |
| pathogenic antibodies | #226 |
| disease locus | #226 |
| j1 | #227 |
| macrophagelike cells | #227 |
| delayed type hypersensitivity | #228 |
| presenting cells | #228 |
| arthritis objective | #228 |
| cell selection | #229 |
| presence anti | #229 |
| site inflammation | #230 |
| eae rats | #230 |
| ls1 | #231 |
| human rheumatoid | #231 |
| reactive oxygen | #232 |
| monoclonal immunohistochemistry | #232 |
| ameliorated | #233 |
| production ros | #233 |
| synovial joints | #233 |
| lack expression | #233 |
| role eosinophils | #233 |
| lower numbers | #234 |
| centimorgan | #234 |
| chronic psychosocial stress | #235 |
| chromosome 14 | #235 |
| staphylococcal infection | #235 |
| mhc gene | #235 |
| specificity animals | #236 |
| immune complex | #236 |
| pathological mechanisms | #237 |
| control strain | #237 |
| progression arthritis | #238 |
| autoimmune chronic | #238 |
| c5 | #239 |
| trait locus | #239 |
| inbred dba tlymphocytes | #240 |
| study plasma | #241 |
| strong influence | #242 |
| joint pain | #242 |
| multicomponent | #243 |
| hla drb1 | #243 |
| protected | #243 |
| positive anti | #243 |
| monoclonal antigen | #243 |
| class genetic | #243 |
| inflammation cartilage | #244 |
| crosses | #244 |
| cutaneous infection | #244 |
| estrus cycle | #244 |
| treatment autoimmune | #244 |
| common denominator | #244 |
| binding antibodies | #245 |
| allelic differences | #246 |
| development emphysema | #246 |
| rt1l | #246 |
| normal cartilage | #247 |
| inbred strain | #247 |
| antibodies anti | #247 |
| new model | #247 |
| florescence | #247 |
| antibody response | #247 |
| efficient expression | #248 |
| activity assays | #248 |
| induced chronic | #249 |
| oxygen species | #249 |
| mouse rat | #250 |
| fragments rats | #250 |
| picryl | #250 |
| node cells | #250 |
| arthritic joints | #250 |
| inflammation score | #250 |
| nadph oxidase | #251 |
| conditional knockout mice | #251 |
| hyperinflammation | #251 |
| treatment rats | #251 |
| develops | #251 |
| mice lymphocytes | #252 |
| role model | #252 |
| mice lack | #252 |
| response disease | #252 |
| dark agouti | #252 |
| class mhc | #254 |
| dinitrofluorobenzene | #254 |
| onset clinical | #254 |
| cartilage matrix | #254 |
| lacking | #254 |
| proteins glycoproteins | #254 |
| lpr mice | #254 |
| inbred c3h | #255 |
| autoimmune response | #255 |
| specific neutralizing | #256 |
| anti arthritic | #256 |
| specific subgroups | #256 |
| postmenopausal bone | #256 |
| inflammatory disorder | #256 |
| disease cell | #257 |
| additive interaction | #258 |
| class mhc molecules | #259 |
| chronic granulomatous | #260 |
| mir144 | #260 |
| relationship immunologic | #260 |
| secondary osteoporosis | #261 |
| mediated suppression | #261 |
| mice expressing | #261 |
| lymphocytes helper | #261 |
| autoimmune neuritis | #261 |
| denatured | #261 |
| immunologic animals | #262 |
| selfantigen | #263 |
| primary immunization | #265 |
| crossreactive | #265 |
| tolerance mice | #265 |
| genetic techniques | #265 |
| pregnancy mice | #265 |
| mouse strain | #265 |
| rats animals | #267 |
| vim2 | #267 |
| antigen specific | #267 |
| cysteine proteases | #267 |
| xid | #268 |
| lentiviral gene | #268 |
| posttranslational modifications | #268 |
| pathogenic roles | #269 |
| mann whitney | #269 |
| complement c5 | #270 |
| oxpl | #270 |
| castrated | #271 |
| selfantigens | #271 |
| melatonin effects | #271 |
| monosodium urate crystals | #271 |
| experimental model | #273 |
| amino acid transporters | #273 |
| lewis rats | #274 |
| nasally | #275 |
| synovial lining | #275 |
| hdac1 | #275 |
| inhibitory peptide | #275 |
| tcells | #275 |
| fcgr3b | #276 |
| macrophages dendritic cells | #276 |
| deiminase type | #277 |
| viral female hepatitis | #277 |
| rheumatoid arthritis association | #277 |
| producing cells | #277 |
| recognize | #278 |
| metabolic properties | #278 |
| colon length | #279 |
| interferongamma | #279 |
| gp70 | #279 |
| induced tolerance | #280 |
| dinucleotide phosphate | #280 |
| passive transfer | #281 |
| recipient mice | #281 |
| neonatal mice | #281 |
| inflammatory conditions | #281 |
| immunological receptors antigen | #281 |
| hemiacetal | #282 |
| factor production | #283 |
| disease susceptibility | #283 |
| inbred nod | #283 |
| isoflavone genistein | #283 |
| igg2b | #283 |
| severe colitis | #284 |
| increased serum levels | #284 |
| aire | #284 |
| helper inducer | #284 |
| endophilin | #285 |
| maintained | #285 |
| complete protection | #285 |
| aureus strain | #285 |
| theilovirus | #285 |
| idiotope | #285 |
| publication animals antibodies | #285 |
| emulsified | #286 |
| hla dr2 | #287 |
| melatonin mice | #288 |
| tlr9 mice | #288 |
| antibody production | #288 |
| myelin basic protein | #288 |
| melatonin release | #288 |
| cells autoimmunity | #289 |
| mice immunized | #289 |
| disease cells | #291 |
| synovial cells | #291 |
| ctla4 expression | #291 |
| rheumatic conditions | #292 |
| autoimmune mechanisms | #292 |
| increased copy | #293 |
| cytokines disease | #293 |
| collagen receptors | #293 |
| induced ros | #293 |
| mouse genes | #294 |
| unique model | #294 |
| c57bl 6 mice | #295 |
| c3h | #295 |
| gastric parietal | #295 |
| antigen processing | #295 |
| immunological receptors | #296 |
| tissue‐specific | #296 |
| 6week | #296 |
| nerve conduction | #296 |
| phosphopyruvate | #297 |
| dnfb | #297 |
| murine dendritic cells | #297 |
| helical peptides | #297 |
| gene selection | #298 |
| vivo imaging | #298 |
| ppad | #298 |
| cd19 cells | #298 |
| citrullination | #299 |
| transplantation antigens | #299 |
| solidphase synthesis | #299 |
| tcr beta | #300 |
| neutrophil extracellular traps | #301 |
| posttranslational rats | #301 |
| draining lymph | #302 |
| peptide antibody | #302 |
| alphabeta | #302 |
| extraembryonic tissues | #302 |
| pathogeneses | #303 |
| animals antibodies | #303 |
| strains mice | #303 |
| epidemiological investigation | #303 |
| 1 interferon | #303 |
| autoimmune diseases | #304 |
| igg glycosylation | #304 |
| cgd | #304 |
| conditioned disease models | #304 |
| cartilage development | #305 |
| immunological function | #305 |
| mutant strains mice | #305 |
| cells tcr | #305 |
| gammaifn | #306 |
| αgalcer | #306 |
| immunological studies | #306 |
| murine colitis | #306 |
| hcdr3 | #306 |
| inpp4b | #307 |
| immunisation | #307 |
| class histocompatibility | #307 |
| basal metabolic rate | #308 |
| basal metabolic | #309 |
| chromosome 10 | #309 |
| articular cattle cells | #310 |
| arthritis study | #310 |
| multiple sclerosis eae | #311 |
| perpetuation | #311 |
| inflamed joints | #312 |
| synthetic peptide | #312 |
| disease symptoms | #312 |
| alleles animals | #312 |
| exuberant | #313 |
| epitopes | #313 |
| c3bi | #313 |
| induced colitis | #314 |
| activatory | #314 |
| r620w | #315 |
| intradermally | #315 |
| mice genes | #315 |
| trypanosoma brucei brucei | #316 |
| onset rheumatoid | #318 |
| classical risk factors | #318 |
| genetic interactions | #319 |
| tubule cells | #319 |
| galactosyl | #319 |
| genomewide linkage analysis | #320 |
| spleen bone marrow | #320 |
| mice subjected | #320 |
| deiminase | #320 |
| il21r | #323 |
| cells specific | #323 |
| expressing human | #324 |
| daf2 | #324 |
| impact disease | #324 |
| ccp1 | #324 |
| specific cell | #325 |
| rat gene | #325 |
| expression cells | #325 |
| surprisingly | #326 |
| resembles | #327 |
| mgps | #327 |
| c57bl mice | #328 |
| allelic variant | #328 |
| publication adjuvants | #329 |
| constant light | #329 |
| immunoenzyme | #329 |
| complex genes | #330 |
| early arthritis | #331 |
| glycoprotein mog | #332 |
| nucleotide polymorphism | #332 |
| rheumatoid synovial | #332 |
| fcgammariia | #332 |
| mouse hepatitis virus | #333 |
| anticcp | #333 |
| 35ssulfate | #334 |
| susceptibility genes | #335 |
| joint tissues | #335 |
| mrl lpr mice | #335 |
| autoimmune inflammation | #336 |
| cell response | #338 |
| delayed onset | #340 |
| cells spleen | #340 |
| epitope specificity | #340 |
| ros oxygen species | #341 |
| adjuvants immunologic | #341 |
| erosive | #341 |
| rat | #341 |
| activation macrophages | #341 |
| animal enzyme inhibitors | #342 |
| 6weeks | #342 |
| incident cardiovascular events | #342 |
| specific autoimmune | #342 |
| rats injection | #343 |
| rapid spread | #343 |
| sequence animals | #343 |
| drb1 alleles | #343 |
| diabetic mouse | #343 |
| monoclonals | #344 |
| 182780 | #344 |
| acpa positivity | #345 |
| favor | #345 |
| energetic costs | #346 |
| intraperitoneal injection | #347 |
| pemphigus vulgaris pv | #348 |
| complement activity | #349 |
| neuritis | #349 |
| reduced capacity | #349 |
| igg autoantibodies | #350 |
| phenotype rats | #351 |
| thymic selection | #352 |
| methylcholanthrene | #352 |
| anti cyclic | #353 |
| c3h hej | #353 |
| mice induction | #353 |
| immunoregulation | #353 |
| arthritis synovial | #354 |
| autoantigens autoimmune | #354 |
| mice cd4 | #354 |
| splenic macrophages | #355 |
| dsg3 | #357 |
| cells autoantibodies | #358 |
| tbetarii | #358 |
| adjuvant activity | #358 |
| neuritogenic | #359 |
| injected | #359 |
| enos | #359 |
| tcrbeta | #360 |
| pvg | #361 |
| tlr3 | #361 |
| freund | #361 |
| hla transgenic | #362 |
| murine lupus | #362 |
| determines | #363 |
| identification genes | #363 |
| mouse chromosome | #363 |
| allergic encephalomyelitis | #363 |
| generation ros | #363 |
| cells anti | #364 |
| recognized | #364 |
| hladr4 | #364 |
| european journal | #366 |
| sex chromosomes | #366 |
| glycoproteins mice | #366 |
| immune deviation | #366 |
| antiidiotypic antibodies | #367 |
| psychosocial stress | #367 |
| affinity ligand | #368 |
| 100 micrograms | #368 |
| ncf2 | #368 |
| toxic shock | #368 |
| loci | #368 |
| autoimmune responses | #368 |
| pentameric | #369 |
| histocompatibility antigens | #369 |
| nasal administration | #369 |
| immune pathogenesis | #370 |
| increased production | #370 |
| regulate | #371 |
| clinical onset | #371 |
| serum transfer | #371 |
| newborn antibodies | #372 |
| role mif | #372 |
| alternative activation | #373 |
| autoantigens | #375 |
| rheumatoid cell | #375 |
| undifferentiated arthritis | #376 |
| acutephase proteins | #376 |
| glucose6 | #377 |
| gia | #379 |
| reparixin | #380 |
| mouse monoclonal antibody | #381 |
| induced lupus | #381 |
| oxidase deficiency | #381 |
| fia | #382 |
| fragments immunoglobulin | #382 |
| granulomatous | #383 |
| specific loci | #384 |
| naive rats | #384 |
| c1a | #384 |
| granulomatous disease | #384 |
| shock syndrome | #385 |
| postmenopausal bone loss | #385 |
| pc4 | #386 |
| cell specificity | #386 |
| antioxid | #387 |
| filaggrin | #387 |
| ptpn22 gene | #387 |
| backcrosses | #387 |
| phase response | #388 |
| inbred nod receptors | #388 |
| downregulating | #389 |
| ovulation rate | #390 |
| deficient | #390 |
| greater 50 | #390 |
| peptidylarginine | #391 |
| radiological progression | #391 |
| anaphylatoxin c5a | #391 |
| finetune | #392 |
| il4 il10 | #394 |
| rf1 | #394 |
| ameliorating | #395 |
| autoantibody levels | #397 |
| draining | #397 |
| induced metabolic | #397 |
| juvenile chronic arthritis | #398 |
| regulation animals | #399 |
| protein myelin | #399 |
| immunized mice | #399 |
| reactive oxygen species | #400 |
| inflammatory reactions | #400 |
| genes cells | #401 |
| antibody formation | #401 |
| biacore | #403 |
| inflammation demyelination | #403 |
| immunopeptidome | #403 |
| fcγriib | #404 |
| beta chain | #404 |
| basic protein | #405 |
| experimental | #405 |
| n31 | #407 |
| effects models | #407 |
| rheumatoid case | #407 |
| pam3csk4 | #408 |
| immunogenetics | #409 |
| major locus | #409 |
| 3hproline | #410 |
| intracellular processing | #410 |
| diabetes loci | #410 |
| hladrb1 | #412 |
| cd43 | #412 |
| cell phenotypes | #412 |
| susceptibility loci | #413 |
| titres | #413 |
| reproductive performance | #414 |
| characteristic feature | #414 |
| igk | #415 |
| cultured collagen | #415 |
| female mice | #416 |
| levels autoantibodies | #416 |
| synovial inflammation | #417 |
| lupus mice | #417 |
| spontaneous mutation | #417 |
| genetically modified mice | #418 |
| molecular interactions | #419 |
| class hdacs | #419 |
| wtccc | #419 |
| induced pain | #419 |
| hiit | #420 |
| ameliorate | #420 |
| tcell | #421 |
| lower affinity | #422 |
| dr4 | #422 |
| lipidomic | #423 |
| subsets animals | #424 |
| restricted | #424 |
| hyaline cartilage | #425 |
| regulatory animals | #426 |
| inflammatory cells | #426 |
| congenic strain | #426 |
| carbohydrate moiety | #429 |
| nonimmunogenic | #430 |
| postimmunization | #430 |
| nod mouse | #430 |
| epitopes humans | #430 |
| immunoregulatory | #431 |
| il10 mice | #433 |
| patients healthy individuals | #433 |
| cells antibodies | #434 |
| factor 5 | #435 |
| spontaneous autoimmune | #435 |
| cells beta | #436 |
| reactivities | #436 |
| decalcified | #437 |
| crystallizable | #437 |
| chromosomes chromosome | #437 |
| mass spectrometric analysis | #437 |
| specific antigens | #438 |
| mice effects | #438 |
| helperinducer tlymphocytes | #438 |
| immunised | #438 |
| cells | #439 |
| joint swelling | #439 |
| wildtype mice | #440 |
| nod | #440 |
| female immunoglobulin | #441 |
| vitro techniques leukocytes | #441 |
| normal rats rats | #441 |
| effector functions | #441 |
| patients population | #442 |
| complete adjuvant | #442 |
| mice activation | #442 |
| methylβcyclodextrin | #443 |
| mhc class molecules | #443 |
| tlr2 expression | #444 |
| myelin basic | #444 |
| genomewide scan | #445 |
| skeletal muscle function | #445 |
| mouse models | #445 |
| mice humans | #445 |
| systemic mice | #445 |
| ros production | #447 |
| control mice | #448 |
| induced mice | #448 |
| pain model | #448 |
| inbred strains receptors | #448 |
| complement factor | #449 |
| tcell responses | #449 |
| synovial tissue | #449 |
| innate adaptive | #450 |
| apcs | #451 |
| igg anti | #451 |
| reduced production | #452 |
| heterologous | #452 |
| hybridoma cells | #452 |
| differs | #454 |
| lglutamine | #456 |
| cells chronic | #456 |
| raloxifene | #457 |
| inbred c57bl tlymphocytes | #457 |
| lung macrophages | #459 |
| rheumatoid cells | #459 |
| resembling | #459 |
| eae cns | #459 |
| priming | #459 |
| antibodies monoclonal | #460 |
| neutrophil functions | #462 |
| autoantigen | #462 |
| 256 | #462 |
| gilt | #463 |
| fab fragments | #464 |
| autoantibody production | #465 |
| salivary glands | #466 |
| receptor tcr | #466 |
| cells lymph | #467 |
| titers | #469 |
| earlier onset | #469 |
| antibody mediated | #474 |
| arthritic rats | #474 |
| anticyclic citrullinated peptide | #474 |
| disease mice | #474 |
| cartilage cells | #475 |
| human autoimmune | #476 |
| mice exhibited | #477 |
| cluster genes | #477 |
| mediated inflammation | #478 |
| therapeutic vaccination | #478 |
| female hla | #479 |
| laboratory rat | #479 |
| apoptosis arthritis | #479 |
| aggravated | #480 |
| quantitative trait loci | #480 |
| deacetylase 1 | #480 |
| polymorphonuclear cells | #482 |
| anti idiotypic | #482 |
| immune reactions | #484 |
| immunologists | #485 |
| immunoglobulin male | #486 |
| tcralpha | #487 |
| controlling | #487 |
| jca | #487 |
| oxyntic | #487 |
| insulitis | #488 |
| specific immune | #488 |
| invariant natural | #488 |
| gland animals | #489 |
| normal mice | #490 |
| cytoplasmic calcium | #494 |
| nacetylglucosaminidase | #495 |
| h2b | #496 |
| early rheumatoid | #496 |
| conclude | #496 |
| reactive nitrogen | #496 |
| gammadelta cells | #496 |
| mbp | #498 |
| small effects | #498 |
| receptor 9 | #499 |
| biologicals | #500 |
| nadph | #503 |
| immunoenzyme techniques | #503 |
| autoreactive cd4 | #503 |
| pathogenic | #506 |
| chondrocytes collagen | #507 |
| immunofluorescence analysis | #507 |
| persistent pain | #508 |
| mab mabs | #508 |
| mineral oil | #508 |
| isopropyl | #508 |
| orosomucoid | #509 |
| gingipain | #509 |
| immunization passive | #509 |
| mhc class | #510 |
| mice knockout mice | #510 |
| systemic spread | #511 |
| differential gene | #511 |
| deficient mice | #511 |
| c3h hej mice | #511 |
| 812 | #511 |
| blymphocytes | #512 |
| mrp8 | #515 |
| behavioral alterations | #517 |
| hydroxyquinolines | #517 |
| u1 | #518 |
| antibody complex | #518 |
| suggestive linkage | #519 |
| chronic granulomatous disease | #519 |
| inflammation | #519 |
| tcr recognition | #520 |
| modified form | #521 |
| dextran sulfate sodium | #522 |
| ttg | #522 |
| pcorr | #522 |
| inflammation role | #523 |
| data peptide | #523 |
| encephalitogenic | #524 |
| litter size | #524 |
| p47phox | #524 |
| neutrophil granulocytes | #525 |
| mnc | #526 |
| tconv | #526 |
| mechanical hypersensitivity | #526 |
| maternal antibodies | #527 |
| disease acute | #527 |
| spleen cells | #527 |
| larsen | #528 |
| primed | #528 |
| tolonium | #528 |
| vaccinates | #528 |
| displayed | #529 |
| tolllike receptor tlr4 | #529 |
| ifa | #529 |
| rat rats | #529 |
| autoantibody | #530 |
| cell antibodies | #530 |
| isac | #530 |
| pathogenesis sle | #530 |
| antigen presentation | #530 |
| ratg | #531 |
| epistatic | #532 |
| bred | #532 |
| complex role | #533 |
| lyt2 | #533 |
| posttranslational receptors | #534 |
| spleen lymphocytes | #536 |
| resorptions | #536 |
| translational modification | #536 |
| synovial | #537 |
| urokinase | #537 |
| cells inflammatory | #538 |
| animals | #538 |
| experimental rats | #538 |
| antigen recognition | #540 |
| fibroblast synoviocytes | #540 |
| suppressive | #540 |
| joints | #540 |
| membrane attack complex | #541 |
| rheumatoid humans | #543 |
| specific autoantibodies | #544 |
| protein tyrosine phosphatase | #545 |
| regulating | #545 |
| hypomorphic | #546 |
| shortcut | #547 |
| tlymphocytes | #547 |
| animal gene | #547 |
| immunohistochemical methods | #548 |
| entheses | #548 |
| formyl peptide receptors | #548 |
| mog | #550 |
| immunoglobulin fab | #552 |
| mixed lymphocyte reaction | #553 |
| nox activity | #554 |
| breeder | #555 |
| stronger association | #557 |
| beta animals | #557 |
| cell epitopes | #557 |
| cells control | #558 |
| early onset | #559 |
| healthy mice | #560 |
| elispot assay | #561 |
| transgenic molecular | #562 |
| negative selection | #563 |
| inbred strains | #563 |
| ptdins3p | #563 |
| neutrophil depletion | #564 |
| therapeutic treatment | #565 |
| deeper layers | #565 |
| immunoglobulin heavy chains | #566 |
| target tissue | #566 |
| darkness | #566 |
| earlier | #566 |
| crucial | #567 |
| outbred | #568 |
| disease loci | #568 |
| interferon signature | #568 |
| cells pathogenesis | #569 |
| neutrophilia | #569 |
| mycobacteria | #569 |
| concomitantly | #570 |
| mice compared | #571 |
| btla | #572 |
| transgenic mouse models | #572 |
| keratin8 | #573 |
| col2 | #574 |
| pepstatins | #576 |
| presenting | #576 |
| terpenes | #577 |
| estrogen treatment | #577 |
| keratinocyte growth factor | #578 |
| prolactin prl | #578 |
| ptm | #579 |
| sera patients | #579 |
| triple helix | #580 |
| methotrexate mice | #581 |
| f1 hybrids | #581 |
| production ifngamma | #583 |
| inflammatory joint | #583 |
| hybridoma | #583 |
| time onset | #584 |
| lymphocyte antigens | #584 |
| exaggerated | #584 |
| antibody reactions | #585 |
| traps nets | #590 |
| environmental triggers | #591 |
| antigen antibody | #591 |
| immunological tolerance | #592 |
| lxrα | #592 |
| oligoclonal | #592 |
| transgenic models | #593 |
| noncollagenous | #593 |
| autoimmune disorders | #594 |
| adaptive immunity | #594 |
| macrophages | #594 |
| clonal expansion | #595 |
| th1 cytokines | #595 |
| multiplexing | #595 |
| xanthine oxidoreductase | #596 |
| cells study | #599 |
| tcell activation | #599 |
| develop | #600 |
| augmented | #602 |
| spite | #602 |
| n85 | #602 |
| th2 cytokines | #602 |
| common diseases | #603 |
| pemphigus vulgaris | #603 |
| mouse monoclonal | #603 |
| phagosomal | #604 |
| cells involved | #604 |
| cells male | #604 |
| oxa | #606 |
| animal rats | #606 |
| mice inbred | #606 |
| class humans | #607 |
| frozen sections | #608 |
| genotype hla | #608 |
| spleen animals | #609 |
| regulatory role | #610 |
| inefficiently | #610 |
| naive | #611 |
| production ifn | #611 |
| positive individuals | #612 |
| quantitative trait locus | #615 |
| autoantibodies | #616 |
| idiotypic | #616 |
| th1 type | #616 |
| acetophenones | #616 |
| mutant strains receptors | #616 |
| alpha chains | #616 |
| class antigens | #616 |
| exponential phase | #616 |
| nonobese | #617 |
| oral immunization | #617 |
| beta type | #618 |
| day mice | #619 |
| wistar restraint | #620 |
| promiscuous | #620 |
| consequent | #621 |
| receptor 3 | #621 |
| inflammatory role | #621 |
| nicotinamide adenine | #622 |
| receptors antigen | #624 |
| fluorine18 | #624 |
| chronic stage | #625 |
| loci identified | #625 |
| cytoplasmic ca2 | #628 |
| animal mice | #628 |
| local injection | #629 |
| cross reactions | #630 |
| inflammatory disease | #630 |
| reactive antibodies | #632 |
| healthy rats | #632 |
| development eae | #633 |
| highintensity interval training | #634 |
| fibromodulin | #634 |
| vivo binding | #635 |
| langerhans cells | #635 |
| ifn beta | #637 |
| nabs | #637 |
| cells inhibition | #638 |
| class genes | #638 |
| estrogens female | #640 |
| inflammation autoimmunity | #640 |
| biotinylated | #643 |
| mouse lung | #644 |
| cell binding | #645 |
| immune serum | #646 |
| haplotype | #649 |
| patients sera | #650 |
| antigen specificity | #650 |
| genetic disease | #652 |
| idiotypic antibodies | #654 |
| hexadecane | #654 |
| antibody titres | #655 |
| interphalangeal | #655 |
| new pathway | #658 |
| genetic linkage | #658 |
| axotomized | #659 |
| sialoprotein | #660 |
| cyba | #660 |
| acute inflammation | #661 |
| peptide binding | #661 |
| inbred cba mice | #661 |
| mutated | #662 |
| cartilage destruction | #663 |
| ifng | #664 |
| animal ear | #665 |
| delayed hypersensitivity | #665 |
| reactive | #666 |
| superantigens | #666 |
| receptors igg | #666 |
| lymphoid organs | #666 |
| 264 | #666 |
| activation mice | #669 |
| drb1 | #670 |
| apeced | #670 |
| disease autoimmune | #671 |
| purified proteins | #673 |
| cells induce | #674 |
| treatment protocol | #674 |
| desmoglein | #675 |
| genetic epistasis | #675 |
| pyramidal neurons | #675 |
| strikingly | #676 |
| idiotypes | #677 |
| germinal center | #677 |
| adherent cells | #677 |
| china cohort | #678 |
| igg response | #679 |
| major genes | #679 |
| il12p70 | #679 |
| thelper | #680 |
| cells role | #682 |
| lymphocytes mice | #682 |
| puzzle | #683 |
| inbred c57bl mice | #683 |
| normal animals | #683 |
| specific antibody | #684 |
| helper cell | #684 |
| intradermal injection | #686 |
| transgenic receptors | #687 |
| βarrestin | #688 |
| delayed | #689 |
| subsets | #689 |
| foot joints | #689 |
| early rheumatoid arthritis | #690 |
| rendered | #690 |
| production autoantibodies | #691 |
| disease genes | #692 |
| knockout polymorphism | #695 |
| muscle glucose | #695 |
| igg antibodies | #696 |
| paam | #696 |
| anas | #697 |
| luminex | #697 |
| mice model | #698 |
| disease hla | #698 |
| uterus | #700 |
| heavy chain genes | #701 |
| microspectroscopy | #703 |
| quantitative trait | #704 |
| inbred | #704 |
| complete freund | #706 |
| histopathological analysis | #707 |
| fibroblastlike synoviocytes | #707 |
| extracellular trap | #708 |
| estradiol female | #710 |
| specific cells | #710 |
| igl | #712 |
| posttranslational | #713 |
| predetermined | #716 |
| spleens | #716 |
| mice lacking | #717 |
| acute bout | #718 |
| antibodies patients | #718 |
| lymphocyte depletion | #719 |
| proliferative response | #720 |
| regulatory function | #720 |
| deficiency syndromes | #721 |
| buf | #721 |
| surrounding tissues | #722 |
| th1 th17 | #723 |
| human hand | #725 |
| macrophages mice mice | #725 |
| dmaema | #728 |
| cd1d | #728 |
| ccps | #729 |
| mhc molecules | #729 |
| th2 cytokine | #729 |
| cdk6 | #730 |
| administrated | #732 |
| cholesterol metabolism | #732 |
| cns inflammation | #732 |
| animals antigens antigens | #732 |
| excessive inflammation | #734 |
| finding | #735 |
| rats treatment | #736 |
| net formation | #736 |
| locus | #737 |
| cheeks | #739 |
| operates | #740 |
| c57bl | #740 |
| species specificity | #741 |
| cd5 cells | #741 |
| tissue destruction | #742 |
| nkt | #742 |
| vivo mice | #743 |
| cell responses | #743 |
| immunologic deficiency | #743 |
| treatment anti | #744 |
| role disease | #746 |
| mycobacterial infections | #747 |
| autoantibodies autoimmunity | #749 |
| intensity interval | #749 |
| keratinocyte | #749 |
| nonobese diabetic mice | #749 |
| transferred | #751 |
| preclinical phase | #751 |
| control disease | #753 |
| ere | #755 |
| hapten | #755 |
| tlr activation | #755 |
| metabolomic | #755 |
| mice anti | #757 |
| autoantibodies type | #758 |
| disease protection | #758 |
| phenotypic differences | #758 |
| reacted | #759 |
| hyperinflammatory | #759 |
| knockout tlymphocytes | #760 |
| linkage region | #760 |
| ifngamma production | #761 |
| ccp | #761 |
| polycytidylic | #762 |
| immunocap | #763 |
| gamma ifn | #765 |
| glut4 translocation | #767 |
| periarticular | #772 |
| cells apcs | #773 |
| redox signal | #773 |
| hkexchanging | #773 |
| peripheral tolerance | #774 |
| afflicted | #777 |
| fab fragment | #778 |
| diseases cell | #778 |
| interacted | #779 |
| inbred nzb | #780 |
| acid transporters | #781 |
| pathogenic role | #782 |
| development autoimmunity | #782 |
| arthritis osteoarthritis | #782 |
| nox1 | #782 |
| arthritis psa | #783 |
| chronic colitis | #784 |
| clinical scores | #786 |
| transgenic mutation | #789 |
| inflammatory lesions | #790 |
| peptide fragments | #790 |
| reduced incidence | #790 |
| transgenic receptors antigen | #790 |
| pineal gland | #791 |
| polyarthritis | #792 |
| cell gamma | #793 |
| antibodies directed | #794 |
| cell humans | #794 |
| neutrophil function | #796 |
| interval training | #796 |
| neutrophil extracellular | #796 |
| pathogen free | #797 |
| genes immunoglobulin | #798 |
| lymphocyte proliferation | #798 |
| carbohydrate moieties | #800 |
| matrix proteins | #801 |
| polyi | #801 |
| blymphocyte chain genes | #802 |
| innate adaptive immunity | #802 |
| thy1 | #802 |
| monoclonal binding | #802 |
| count male | #805 |
| induces | #805 |
| helper cells | #805 |
| redox control | #805 |
| multinucleated giant cells | #808 |
| backcrossing | #809 |
| bone erosion | #810 |
| catabolism | #811 |
| function mutation | #811 |
| resident cells | #812 |
| acc1 | #812 |
| strains receptors | #812 |
| febuxostat | #813 |
| nonreceptor type | #815 |
| arginines | #817 |
| ctb | #817 |
| leads | #820 |
| auricle | #820 |
| cd8 antigens | #821 |
| collagen cross | #821 |
| leukocyte infiltration | #822 |
| piece | #823 |
| humoral immune response | #824 |
| electroporated | #824 |
| colocalizes | #824 |
| psoriasis psoriatic arthritis | #825 |
| genetic environmental | #825 |
| prominently | #825 |
| muscle training | #826 |
| response animals | #826 |
| chondroid | #827 |
| class antigen | #829 |
| growth factor beta | #829 |
| producing | #830 |
| effects immune | #830 |
| cross reactivity | #834 |
| lpr | #841 |
| inbred c57bl | #841 |
| peyers patches | #842 |
| immunoglobulin mice | #842 |
| diabetic nod | #844 |
| therapeutic approaches | #844 |
| il25 | #845 |
| chronic active | #845 |
| mice transgenic | #846 |
| inflammatory arthritis | #846 |
| induce | #848 |
| intermingled | #850 |
| macroscopically | #851 |
| lymphocyte | #852 |
| antigen cell | #852 |
| leukocyte migration | #854 |
| new possibilities | #854 |
| ms275 | #855 |
| tcell receptors antigen | #855 |
| importantly | #856 |
| alveolar mice mice | #856 |
| strongest association | #856 |
| mcv | #858 |
| post translational | #861 |
| immune defence | #862 |
| treatment reduced | #865 |
| lyme | #866 |
| knockin mice | #867 |
| factor anti | #867 |
| mediated inflammatory | #867 |
| mice reduced | #867 |
| cross reactive | #868 |
| strongest | #868 |
| lentiviral | #869 |
| hinge region | #869 |
| parietal cells | #869 |
| lnc | #872 |
| immune tolerance | #873 |
| dextran sulfate | #873 |
| parasitemia | #874 |
| lower expression | #874 |
| elisas | #875 |
| cells expressing | #876 |
| granulomas | #877 |
| fcγri | #878 |
| synovial fluid patients | #878 |
| arthritis inflammatory | #879 |
| antigen4 | #881 |
| adoptive | #881 |
| systemic autoimmune diseases | #882 |
| pregnancy animal | #882 |
| testosterone treatment | #883 |
| fluid synovial | #884 |
| cartilaginous | #888 |
| standard therapies | #890 |
| genetic dissection | #891 |
| psoriasis vulgaris | #891 |
| basic | #893 |
| regulator | #895 |
| completely | #896 |
| inflammation mediators | #897 |
| intranasal administration | #897 |
| ctla4 antigen | #898 |
| interleukin1alpha | #898 |
| phosphatase receptor | #902 |
| partly | #904 |
| granulocytes | #904 |
| inception cohort | #905 |
| γδ cells | #906 |
| infiltrations | #906 |
| rats inbred | #907 |
| lipocalins | #908 |
| extracellular traps | #909 |
| immunohistochemical analyses | #910 |
| immunoglobulin levels | #911 |
| liu | #911 |
| single injection | #911 |
| chromosome 16 | #912 |
| lectin pathway | #913 |
| mitochondrial ros | #913 |
| pneumonitis | #914 |
| ciita | #914 |
| proliferate | #915 |
| enolase | #915 |
| allelic variation | #915 |
| immunemediated diseases | #916 |
| cytokine response | #923 |
| antibodies antibody | #924 |
| psoriatic arthritis psa | #924 |
| neutrophil chemotaxis | #924 |
| fluorobenzene | #925 |
| cd200 | #925 |
| chromosome mapping | #925 |
| nkt cells | #926 |
| phenotypic analysis | #926 |
| repertoires | #929 |
| burst | #930 |
| tissue transglutaminase | #931 |
| data role | #932 |
| citrulline | #933 |
| hydratase | #933 |
| alpha animals | #935 |
| macropinocytosis | #936 |
| alters | #937 |
| lymphocyte activation | #938 |
| arthritides | #938 |
| synovia | #939 |
| 1040 | #939 |
| analysed | #940 |
| immune reactivity | #940 |
| rns | #940 |
| disease model | #941 |
| vitro stimulation | #941 |
| collagen structure | #941 |
| genetic analysis | #941 |
| mediated autoimmune | #944 |
| association hla | #945 |
| sciatic nerves | #945 |
| mice mice | #947 |
| fluid patients | #948 |
| inflammatory pathways | #948 |
| clinical observations | #948 |
| humanized mice | #949 |
| riii | #950 |
| vivo | #950 |
| l3t4 | #954 |
| environmental determinants | #955 |
| nos1 | #957 |
| carrying | #958 |
| differentiation tlymphocyte antigens | #959 |
| mhc peptide | #962 |
| levels ros | #962 |
| chronic disease | #963 |
| cellular immunization | #965 |
| animals cytokines | #967 |
| cells lymphocytes | #967 |
| cytotoxic tlymphocytes | #967 |
| monoclonal antigens | #967 |
| lower frequency | #969 |
| cell transfer | #969 |
| chromosome 15 | #971 |
| draining lymph nodes | #972 |
| secreting cells | #973 |
| susceptibility locus | #978 |
| cartilage articular | #979 |
| synovial membrane | #981 |
| w5 | #982 |
| genes chromosome | #982 |
| lymphocytes | #982 |
| binding peptides | #983 |
| pain behavior | #984 |
| tbb | #987 |
| tallele | #988 |
| microspectrophotometry | #990 |
| knockout models | #991 |
| macrophages cells | #991 |
| immunodominance | #992 |
| allergic contact dermatitis | #992 |
| cells reactive | #993 |
| 510 | #994 |
| patients rp | #994 |
| transgenic expression | #994 |
| cartilage bone | #995 |
| hej | #995 |
| spontaneously | #997 |
| formyl peptide | #997 |
| knee joints | #997 |
| laminin fibronectin | #998 |
| antigen expression | #999 |
| immunoglobulin fragments | #1000 |
| lymphocyte subpopulations | #1002 |
| multiple loci | #1003 |
| processing presentation | #1004 |
| expands | #1004 |
| aggravate | #1004 |
| protective role | #1007 |
| igg subclasses | #1011 |
| cyclic peptides | #1012 |
| nrc | #1012 |
| interleukin21 | #1013 |
| 95 stroke | #1013 |
| model multiple | #1015 |
| direct comparison | #1015 |
| igg | #1015 |
| cellular composition | #1016 |
| cells mast | #1016 |
| nerve roots | #1016 |
| aged arthritis | #1017 |
| patients early | #1019 |
| melatonin levels | #1019 |
| cd4 antigens | #1020 |
| immunoglobulin variable | #1022 |
| cysteine protease | #1025 |
| diseases animals | #1026 |
| genetic humans | #1027 |
| innate killer cells | #1028 |
| il4 | #1029 |
| dr1 | #1031 |
| baseline 24 months | #1031 |
| mice treated | #1032 |
| oxidase | #1034 |
| major regulator | #1036 |
| species production | #1039 |
| tramp | #1040 |
| arthritis psoriatic | #1041 |
| expression mrna | #1042 |
| complementary genes | #1043 |
| das28 | #1045 |
| parental strain | #1050 |
| myelin proteins | #1050 |
| patients rheumatoid | #1051 |
| chromosome 5 | #1052 |
| gamma delta | #1055 |
| inflammatory macrophages | #1055 |
| immune defense | #1056 |
| antigens differentiation | #1056 |
| mannans | #1057 |
| rat cells | #1060 |
| lymphocytes cells | #1062 |
| sterile inflammation | #1062 |
| morula | #1062 |
| transgenic | #1063 |
| tarsus | #1066 |
| disease humans polymorphism | #1069 |
| oxazoles | #1069 |
| decidua | #1069 |
| role immune | #1069 |
| synovial fluids | #1071 |
| transgenic cells | #1075 |
| fcγ | #1076 |
| radiological | #1077 |
| peptidylarginine deiminase | #1078 |
| epistasis | #1079 |
| adjuvant cfa | #1080 |
| key steps | #1080 |
| lymphoid cells | #1082 |
| reestablishment | #1082 |
| irf1 | #1086 |
| dependent regulation | #1087 |
| al2 | #1088 |
| haplotypes | #1089 |
| uppsala | #1089 |
| enlarged | #1091 |
| inflamed | #1092 |
| osteoclast formation | #1093 |
| 7 weeks | #1096 |
| oligodendrocyte | #1098 |
| inkt cells | #1102 |
| igs | #1103 |
| effector mechanisms | #1104 |
| cells increased | #1105 |
| arginine deiminase | #1114 |
| fibril | #1115 |
| molecular mimicry | #1115 |
| subdominant | #1115 |
| sclerosis myelin | #1116 |
| clinical disease | #1116 |
| genetic factors | #1117 |
| cd5 | #1117 |
| disulfide | #1117 |
| antitoxin | #1117 |
| animal immunity | #1117 |
| deamidation | #1117 |
| antigenic peptides | #1118 |
| pil | #1121 |
| lymphocytes regulatory | #1123 |
| recognizing | #1126 |
| primary immunodeficiency | #1127 |
| predisposing | #1128 |
| humans lymphocyte | #1128 |
| cells ifn | #1128 |
| foreign antigens | #1128 |
| isomerase | #1128 |
| dissected | #1130 |
| skeletal muscle fibers | #1132 |
| treatment day | #1132 |
| superantigen | #1134 |
| immune response | #1135 |
| cryosections | #1135 |
| overlapped | #1136 |
| vivo administration | #1136 |
| glucosyl | #1136 |
| c57 | #1137 |
| peptide sequence | #1138 |
| underline | #1138 |
| editorial | #1139 |
| anticardiolipin antibodies | #1139 |
| cd4foxp3 | #1142 |
| mice rats | #1146 |
| syntenic | #1147 |
| treatment animals | #1149 |
| helpers | #1149 |
| agonist | #1150 |
| cd4 cells | #1151 |
| subcloned | #1155 |
| disease onset | #1157 |
| antibody affinity | #1160 |
| inactivating | #1161 |
| lxr | #1161 |
| respiratory burst | #1163 |
| prolactin rats | #1164 |
| demonstrating | #1168 |
| stainings | #1168 |
| increased severity | #1170 |
| activated cells | #1171 |
| transduction toll | #1174 |
| gp91phox | #1175 |
| nadph oxidoreductases | #1176 |
| inflamed tissues | #1178 |
| models disease | #1178 |
| 10b | #1179 |
| preponderance | #1180 |
| recombinant interferon | #1180 |
| genetic background | #1181 |
| chemiluminescent | #1182 |
| destructive | #1182 |
| arginine residues | #1184 |
| objective investigate | #1186 |
| disease haplotypes humans | #1186 |
| synovial fibroblasts | #1188 |
| lymphocytes cell | #1188 |
| human type | #1190 |
| ileitis | #1191 |
| splenic cells | #1192 |
| rat human | #1192 |
| antiphospholipid | #1193 |
| primary sjögrens syndrome | #1195 |
| infiltrates | #1195 |
| cells rheumatoid | #1199 |
| antibody | #1200 |
| susceptibility | #1200 |
| basic mechanisms | #1200 |
| antibodies mabs | #1200 |
| somatically | #1201 |
| lung mice mice | #1204 |
| protein arginine | #1208 |
| identified loci | #1210 |
| h2k | #1211 |
| predisposition disease | #1212 |
| onset progression | #1212 |
| c5a | #1213 |
| rationales | #1214 |
| singlecell | #1214 |
| hdacs | #1217 |
| critical issues | #1218 |
| chronic inflammation | #1218 |
| igg subclass | #1220 |
| ilc2 | #1221 |
| compared wt | #1223 |
| mononuclear | #1223 |
| adaptive immune response | #1223 |
| subcellular fractionation | #1224 |
| adaptive immune responses | #1225 |
| tlymphocyte antigens | #1226 |
| chromosome 4 | #1227 |
| antimicrobial peptides amps | #1229 |
| linkage analysis | #1229 |
| analyse | #1230 |
| experimental models | #1231 |
| therapeutically | #1232 |
| subsets lymphocytes | #1233 |
| aps | #1233 |
| host defense | #1238 |
| immunological mechanisms | #1240 |
| human cd4 | #1241 |
| cell lymphocytes | #1244 |
| indel | #1247 |
| mouse | #1250 |
| immune inflammatory | #1251 |
| lining | #1252 |
| animal | #1253 |
| ltb | #1253 |
| dead cells | #1254 |
| animal doseresponse relationship | #1259 |
| mesenteric lymph nodes | #1263 |
| differentiation lymphocyte | #1263 |
| antigen presenting cells | #1264 |
| synovium | #1265 |
| pathogenic mechanisms | #1266 |
| adenine dinucleotide | #1269 |
| suppress | #1269 |
| molecular pathogenesis | #1270 |
| rheumatoid arthritis patients | #1270 |
| suppressive function | #1270 |
| synovial fluid | #1271 |
| rat mouse | #1273 |
| claudin4 | #1274 |
| eae model | #1274 |
| chromosomal regions | #1275 |
| rats mice | #1275 |
| inducer | #1279 |
| rattus norvegicus | #1282 |
| becn1 | #1282 |
| hla molecules | #1283 |
| c4a | #1283 |
| staphylococcal | #1283 |
| rodent models | #1284 |
| spreading | #1286 |
| joint destruction | #1287 |
| attacked | #1288 |
| disease response | #1290 |
| pathological processes | #1294 |
| immunochip | #1295 |
| suppressor cells | #1296 |
| peripheral cells | #1297 |
| serm | #1297 |
| day pregnancy | #1297 |
| nadph oxidase activity | #1299 |
| production anti | #1299 |
| publication animals antigens | #1300 |
| data protein | #1300 |
| restimulation | #1305 |
| hdac3 | #1307 |
| model experimental | #1307 |
| peptide library | #1309 |
| ali | #1310 |
| social isolation | #1310 |
| fab2 | #1312 |
| generated | #1313 |
| phagocytic cells | #1313 |
| introgressed | #1314 |
| permissive | #1315 |
| lymphoproliferation | #1315 |
| increased susceptibility | #1316 |
| detailed characterization | #1316 |
| immune | #1316 |
| protects | #1319 |
| estradiol treatment | #1320 |
| hydrolyzes | #1321 |
| immunoglobulin isotypes | #1321 |
| healthy human subjects | #1322 |
| intrathymic | #1322 |
| phagocytes | #1322 |
| collagen types | #1323 |
| submandibular | #1323 |
| aureus infections | #1325 |
| acute phase proteins | #1327 |
| valuable tool | #1327 |
| therapeutic antibodies | #1328 |
| dietary nitrate | #1329 |
| receptor 2 | #1330 |
| human igg | #1330 |
| immunological memory | #1332 |
| pockets | #1333 |
| identically | #1335 |
| thymectomy | #1335 |
| new therapies | #1336 |
| rats rats | #1336 |
| acute phase response | #1338 |
| cells mice | #1341 |
| induction phase | #1341 |
| adjuvants | #1344 |
| increasing evidence | #1348 |
| knockout mutation | #1349 |
| promiscuity | #1350 |
| galactosylceramides | #1356 |
| allergic contact | #1359 |
| alp | #1361 |
| elimination | #1361 |
| position | #1361 |
| regulatory genes | #1362 |
| believed | #1364 |
| disease activity score | #1364 |
| n44 | #1366 |
| hypersensitivity | #1367 |
| 590 | #1368 |
| bacterial arthritis | #1372 |
| ameliorates | #1374 |
| betad | #1375 |
| membrane glycoproteins | #1375 |
| shared | #1375 |
| trait | #1375 |
| rat spinal cord | #1379 |
| il1r | #1381 |
| immunogen | #1383 |
| abrogates | #1383 |
| surface cells | #1384 |
| exacerbation | #1388 |
| rats humans | #1388 |
| suffer | #1389 |
| variable region | #1389 |
| regulatory treg | #1390 |
| clinical signs | #1390 |
| cd2 | #1390 |
| human patients | #1392 |
| squalene | #1392 |
| phage display | #1393 |
| feto | #1393 |
| cd4cd8 | #1394 |
| effects rats | #1396 |
| inbred mice | #1397 |
| disease outcomes | #1397 |
| positional | #1399 |
| submandibular glands | #1400 |
| early patients | #1403 |
| joint disease | #1403 |
| mononuclear phagocytes | #1406 |
| linkage genetic | #1409 |
| disease phenotypes | #1412 |
| animals disease | #1413 |
| antigens humans | #1415 |
| enzymelinked immunosorbent | #1416 |
| activation neutrophils | #1417 |
| humans immune | #1417 |
| cytokine profile | #1424 |
| class switching | #1425 |
| bacterial infections | #1431 |
| genetic heterogeneity | #1436 |
| gene usage | #1438 |
| stages disease | #1439 |
| cells type | #1440 |
| peptide | #1441 |
| guillainbarré syndrome | #1451 |
| arthritis systemic | #1453 |
| inbred strains mice | #1454 |
| alpha1 | #1458 |
| cell activation | #1458 |
| monoclonal | #1460 |
| proinflammatory responses | #1461 |
| knockout rats | #1461 |
| expression genetic | #1462 |
| lupus | #1464 |
| salt concentrations | #1465 |
| pfp | #1467 |
| opens | #1467 |
| ccr6 | #1467 |
| cell origin | #1468 |
| inflammatory properties | #1469 |
| cells pregnancy | #1472 |
| activation status | #1473 |
| immune deficiency | #1474 |
| cartilage cell | #1474 |
| muscle muscle | #1476 |
| cells activated | #1478 |
| allelic variants | #1479 |
| allotype | #1480 |
| responses animals | #1482 |
| specific gene | #1482 |
| markers genetic | #1483 |
| blisters | #1483 |
| cells lung | #1486 |
| inflammatory diseases | #1486 |
| initiate | #1486 |
| genetic regulation | #1486 |
| stroke 95 | #1487 |
| hormone release | #1489 |
| host defence | #1489 |
| donated | #1490 |
| human cartilage | #1491 |
| mice day | #1491 |
| inbred rats | #1491 |
| humoral immune | #1497 |
| emphysematous | #1499 |
| myelin | #1499 |
| treatment inflammatory | #1504 |
| monocytes neutrophils | #1504 |
| regulatory effects | #1504 |
| vivo vitro | #1505 |
| specific monoclonal | #1505 |
| joint arthritis | #1507 |
| eluate | #1507 |
| mimicking | #1507 |
| fls | #1508 |
| mapped | #1509 |
| inflammatory cell | #1510 |
| hindlimbs | #1511 |
| chromosome 6 | #1512 |
| stimulates | #1515 |
| egfp | #1516 |
| induced ali | #1520 |
| human leukocyte antigen | #1524 |
| earlier studies | #1525 |
| lia | #1525 |
| genes dominant | #1528 |
| knockout mitochondria | #1530 |
| sex steroids | #1531 |
| streptococcus pyogenes | #1533 |
| glutamic acid | #1535 |
| malaise | #1536 |
| lysines | #1537 |
| downregulate | #1540 |
| net release | #1545 |
| protein rna | #1546 |
| unexpectedly | #1547 |
| production macrophages | #1547 |
| increased numbers | #1548 |
| acetylglucosaminidase | #1549 |
| chronic phase | #1554 |
| higher level | #1555 |
| mediated diseases | #1559 |
| intraperitoneally | #1560 |
| neuroimmunomodulation | #1563 |
| 4 humans | #1563 |
| copy variations | #1563 |
| activate | #1564 |
| intradermal | #1565 |
| vsg | #1566 |
| guerin | #1567 |
| matrix components | #1567 |
| immunoglobulin humans | #1568 |
| mammalian embryo | #1568 |
| formyl | #1569 |
| sufficient | #1573 |
| pineal | #1574 |
| cytotoxic lymphocyte | #1574 |
| independent | #1577 |
| cochran | #1577 |
| cathelicidin | #1578 |
| glycolipid | #1580 |
| collagens | #1585 |
| fab | #1592 |
| mac1 | #1593 |
| conserved | #1597 |
| factor beta | #1597 |
| directed | #1597 |
| defines | #1598 |
| cell mediated | #1600 |
| f1 | #1600 |
| twins | #1600 |
| adoptive transfer | #1600 |
| reactive nitrogen species | #1603 |
| autoantibodies biomarkers | #1604 |
| cell receptor | #1605 |
| cells th17 | #1607 |
| estriol | #1607 |
| helical | #1611 |
| stromal cells | #1615 |
| chondrocyte | #1616 |
| chronic inflammatory diseases | #1617 |
| immunity animals | #1617 |
| isosteric | #1619 |
| autoimmune diabetes | #1621 |
| anaphylatoxin | #1622 |
| humans immunoglobulin | #1622 |
| c57bl 6 | #1622 |
| differently | #1625 |
| antigen | #1626 |
| unreactive | #1626 |
| rat spinal | #1629 |
| iggs | #1630 |
| complement component | #1632 |
| immunohistology | #1635 |
| c3b | #1635 |
| collagen fibers | #1639 |
| lund | #1639 |
| type interferon | #1641 |
| mice increased | #1642 |
| abrogated | #1644 |
| p6 | #1644 |
| c4b | #1645 |
| aspartic acid | #1647 |
| intracellular ros | #1651 |
| sjl | #1652 |
| opsonization | #1653 |
| complement activation | #1657 |
| defence | #1658 |
| linked | #1658 |
| complement receptors | #1660 |
| commonly | #1660 |
| staphylococcal enterotoxin | #1661 |
| transporter type | #1661 |
| immune complexes | #1661 |
| enterotoxins | #1662 |
| mice knockout | #1664 |
| tcell receptors | #1665 |
| salt intake | #1668 |
| tumor vasculature | #1669 |
| coincided | #1670 |
| primary sjögren | #1671 |
| isopropylacrylamide | #1672 |
| immunologic epitopes | #1673 |
| pathogenic cells | #1673 |
| gamma production | #1678 |
| single nucleotide | #1683 |
| cd206 | #1686 |
| complement c5a | #1686 |
| cocktail | #1689 |
| auto | #1689 |
| igm antibodies | #1691 |
| method analysis | #1693 |
| ido1 | #1694 |
| agouti | #1694 |
| transgenic mice | #1696 |
| classical pathway | #1696 |
| severity | #1701 |
| triple | #1704 |
| 5 months | #1704 |
| animals autoantigens | #1704 |
| precede | #1704 |
| suppressors | #1706 |
| encoded | #1707 |
| treg cells | #1711 |
| disulfiram | #1711 |
| beta chains | #1712 |
| erosions | #1712 |
| mice neutrophils | #1714 |
| ankylosis | #1719 |
| sjögrens syndrome | #1719 |
| evoke | #1720 |
| pulmonary aspergillosis | #1721 |
| tolerance | #1721 |
| skewing | #1725 |
| oophorectomy | #1727 |
| showing | #1728 |
| mutant mice | #1729 |
| myelin proteolipid | #1729 |
| drug targets | #1732 |
| immune responses | #1734 |
| 369 | #1734 |
| analysis protein | #1734 |
| staphylococcal infections | #1736 |
| phagocytic | #1737 |
| sicca | #1737 |
| fmoc | #1739 |
| intranasally | #1740 |
| arthritis patients | #1742 |
| affinity binding | #1743 |
| prophylactic treatment | #1744 |
| 626 | #1744 |
| cd11 | #1745 |
| osteoclasts | #1746 |
| alternative pathway | #1748 |
| zap70 | #1748 |
| strain mice | #1748 |
| new loci | #1749 |
| responded | #1750 |
| neoplastic disease models | #1753 |
| peroxide | #1758 |
| infiltrating | #1762 |
| endoglycosidase | #1764 |
| dr2 | #1766 |
| inhibitory receptors | #1766 |
| multiple genes | #1770 |
| triggering | #1770 |
| higher frequency | #1770 |
| glycosylation | #1774 |
| peptide antigens | #1775 |
| operate | #1776 |
| blocking | #1781 |
| adoptively | #1782 |
| cnbr | #1783 |
| ll37 | #1784 |
| articular cell | #1784 |
| local administration | #1788 |
| immunohistological | #1789 |
| compartmentalized | #1791 |
| carbohydrates | #1792 |
| pathogenesis | #1793 |
| render | #1794 |
| dogma | #1794 |
| competed | #1797 |
| immune recognition | #1800 |
| polymorphism genetic | #1801 |
| disease pathogenesis | #1801 |
| rat models | #1802 |
| cd19 antigens | #1803 |
| rechallenge | #1803 |
| peyer | #1804 |
| obese diabetic | #1805 |
| aureus infection | #1808 |
| immunogenic | #1810 |
| predisposed | #1810 |
| activated lymphocytes | #1811 |
| elucidation | #1811 |
| complement pathway | #1811 |
| psoriatic | #1813 |
| recovery phase | #1814 |
| nonfunctional | #1817 |
| pregnancy rats | #1817 |
| ossification | #1818 |
| promoting | #1818 |
| il2r | #1818 |
| blymphocyte | #1819 |
| intravenously | #1819 |
| crossed | #1823 |
| katpase | #1824 |
| myelin sheath | #1825 |
| hydroxylated | #1825 |
| neurodegenerative diseases | #1827 |
| deplete | #1830 |
| female sex | #1833 |
| genetic susceptibility | #1836 |
| new treatments | #1839 |
| pathogenesis disease | #1841 |
| trif | #1843 |
| resolution inflammation | #1844 |
| clinical score | #1846 |
| subsequently | #1846 |
| inflammation macrophages | #1847 |
| estrogen | #1848 |
| cultured disease | #1849 |
| pyogenes | #1852 |
| specific immunity | #1854 |
| genetic variance | #1854 |
| cd8 lymphocytes | #1856 |
| macrophages neutrophils | #1856 |
| humoral | #1857 |
| rac2 | #1858 |
| barre | #1858 |
| cocktails | #1860 |
| haenszel | #1862 |
| secreting | #1863 |
| structural basis | #1864 |
| aggravation | #1864 |
| lacrimal apparatus | #1865 |
| silastic | #1871 |
| rats groups | #1871 |
| immunoadsorption | #1873 |
| inkt | #1874 |
| carries | #1875 |
| major | #1876 |
| cartilages | #1879 |
| subsequent development | #1879 |
| candidate | #1883 |
| antigen humans | #1890 |
| inflammation lung | #1892 |
| polyclonal | #1893 |
| bacterial clearance | #1894 |
| ovalbumin | #1897 |
| cyanogen | #1900 |
| striking | #1902 |
| lymphatics | #1903 |
| tcr repertoire | #1903 |
| complexity | #1905 |
| indicating | #1905 |
| proteins rats | #1907 |
| model rats | #1908 |
| gammadelta | #1910 |
| mediated | #1910 |
| enzyme linked | #1911 |
| cell maturation | #1912 |
| cells neutrophils | #1912 |
| interferon gamma | #1914 |
| erythematosus sle | #1916 |
| chromosome | #1916 |
| totally | #1918 |
| 6 hours | #1920 |
| cartilage tissue | #1923 |
| 721 | #1924 |
| anti | #1924 |
| gαq | #1926 |
| pronounced | #1927 |
| ears | #1929 |
| isoantigens | #1931 |
| bcell receptors | #1933 |
| expression cytokines | #1934 |
| animals lymphocytes | #1937 |
| trypanosoma brucei | #1937 |
| sialyltransferases | #1939 |
| mice receptors | #1940 |
| antigen tcell receptors | #1944 |
| type plasminogen | #1945 |
| predisposition | #1949 |
| subclasses | #1950 |
| prevented | #1950 |
| constituting | #1955 |
| cardiac allografts | #1956 |
| snakes | #1957 |
| perforin | #1957 |
| agp | #1959 |
| mmc | #1962 |
| iga igg | #1967 |
| edition | #1967 |
| pinocytosis | #1967 |
| levels serum | #1967 |
| possibilities | #1969 |
| fcγ receptor | #1969 |
| strong | #1971 |
| intravenous injection | #1972 |
| react | #1975 |
| mip | #1977 |
| stimulations | #1978 |
| carp | #1979 |
| synovial tissues | #1979 |
| inbred cba | #1980 |
| ova | #1980 |
| cd154 | #1982 |
| pregnant rats | #1983 |
| cell clone | #1985 |
| disease pathology | #1985 |
| milder | #1988 |
| spans | #1997 |
| mast cell | #1999 |
| cd18 | #2000 |
| transgenic rats | #2001 |
| microglia activation | #2002 |
| presenting cell | #2006 |
| heteroplasmy | #2007 |
| rats effects | #2008 |
| contact dermatitis | #2008 |
| reverted | #2008 |
| prototypic | #2011 |
| abca1 | #2016 |
| response infection | #2016 |
| barré syndrome | #2018 |
| knockout | #2020 |
| tissue inflammation | #2021 |
| immunoglobulin | #2023 |
| genes | #2025 |
| cell | #2027 |
| mabs | #2028 |
| cytokine secretion | #2028 |
| demyelination | #2030 |
| chord | #2031 |
| tetramers | #2032 |
| c5ar | #2033 |
| mesenteric lymph | #2035 |
| conformational epitopes | #2035 |
| beta gene | #2035 |
| factor mif | #2041 |
| 4 tlr4 | #2041 |
| mab | #2042 |
| diethyldithiocarbamate | #2043 |
| immunomodulatory properties | #2044 |
| sex chromosome | #2045 |
| cell immunity | #2047 |
| hypergammaglobulinemia | #2050 |
| oestrogens | #2050 |
| species signal | #2053 |
| castration | #2053 |
| cell function | #2053 |
| coinciding | #2055 |
| emphysema | #2056 |
| glycosylation humans | #2057 |
| innate inflammation | #2058 |
| increased frequency | #2058 |
| dramatically | #2059 |
| activation complement | #2061 |
| vitro vivo | #2061 |
| accompanied | #2067 |
| genetic differences | #2068 |
| dominant | #2070 |
| contributors | #2071 |
| proteomics analysis | #2072 |
| hyaluronoglucosaminidase | #2072 |
| mdsc | #2076 |
| mature cells | #2077 |
| polyradiculoneuropathy | #2077 |
| respiratory tract | #2079 |
| lysine residues | #2080 |
| antiphospholipid syndrome | #2081 |
| cell depletion | #2082 |
| mice pregnancy | #2083 |
| methotrexate mtx | #2094 |
| complement | #2094 |
| conditional deletion | #2095 |
| lysine | #2096 |
| addressed | #2097 |
| αβ | #2100 |
| bioreactor | #2100 |
| suggested | #2102 |
| evokes | #2103 |
| led | #2103 |
| antigens hla | #2104 |
| patients rheumatoid arthritis | #2105 |
| human chondrocytes | #2110 |
| nose | #2117 |
| lentiviral vectors | #2120 |
| pulmonary inflammation | #2122 |
| glycan | #2122 |
| immune functions | #2126 |
| pad4 | #2127 |
| oxidants | #2129 |
| total igg | #2130 |
| secondary receptors | #2133 |
| inducing | #2136 |
| occurring | #2139 |
| histopathological | #2140 |
| target tissues | #2141 |
| selective estrogen | #2141 |
| dissection | #2142 |
| plasminogen | #2143 |
| transduction lymphocytes | #2145 |
| extracellular calcium | #2146 |
| subphenotypes | #2146 |
| h2d | #2147 |
| bound | #2147 |
| circulating monocytes | #2149 |
| immunohistochemical analysis | #2151 |
| 129 strain mice | #2151 |
| reality | #2153 |
| clinical aspects | #2157 |
| periphery | #2161 |
| major histocompatibility complex | #2162 |
| moabs | #2165 |
| rheumatoid biomarkers | #2165 |
| late stages | #2165 |
| prone | #2169 |
| entire | #2174 |
| syringes | #2176 |
| mimics | #2177 |
| animal model | #2179 |
| immune regulation | #2180 |
| human leukocytes | #2181 |
| dynorphins | #2184 |
| psoriatic arthritis | #2184 |
| dnp | #2185 |
| native | #2188 |
| injury ali | #2200 |
| dss | #2203 |
| lps stimulation | #2204 |
| structural requirements | #2211 |
| molecular pathways | #2213 |
| confirming | #2214 |
| 12th | #2215 |
| interleukin2 | #2216 |
| therapeutic effects | #2216 |
| activation cells | #2217 |
| animal mice mice | #2217 |
| naïve | #2219 |
| regulates | #2220 |
| galactose | #2220 |
| suggesting | #2221 |
| wt mice | #2224 |
| immunoreactivity | #2225 |
| mammalian | #2232 |
| shrna | #2232 |
| neutralized | #2233 |
| governs | #2233 |
| presentation | #2234 |
| accelerates | #2236 |
| ctla4 | #2239 |
| autoimmune conditions | #2239 |
| reduced susceptibility | #2239 |
| lacked | #2240 |
| graft rejection | #2244 |
| inflammatory phenotype | #2248 |
| cholera toxin | #2248 |
| cell priming | #2252 |
| exacerbated | #2253 |
| monoclonal antibodies | #2254 |
| cell receptors | #2256 |
| tcell proliferation | #2261 |
| sjögren | #2263 |
| regulation immune | #2265 |
| involved pathogenesis | #2267 |
| hla | #2269 |
| progeny | #2274 |
| mph | #2274 |
| immunospot | #2278 |
| antigenic | #2279 |
| murine | #2279 |
| neutrophil apoptosis | #2280 |
| mice treatment | #2280 |
| lymph nodes | #2281 |
| dependent | #2284 |
| inflammatory | #2288 |
| immunizations | #2289 |
| homologous | #2292 |
| plasmatic | #2293 |
| determining | #2296 |
| modified proteins | #2296 |
| histological evaluation | #2296 |
| cba mice | #2297 |
| regulatory mechanisms | #2299 |
| knockout mice | #2300 |
| apocynin | #2302 |
| segregating | #2308 |
| infiltrating macrophages | #2309 |
| presentation antigens | #2310 |
| wounding | #2312 |
| drastically | #2315 |
| genetic basis | #2315 |
| il10 | #2317 |
| healthy donors | #2318 |
| hydroxylation | #2320 |
| barré | #2320 |
| inflammatory mechanisms | #2321 |
| throughput nucleotide | #2325 |
| sera | #2325 |
| p00002 | #2326 |
| antigens histocompatibility | #2328 |
| wild | #2329 |
| cells induced | #2331 |
| demyelinating disease | #2336 |
| n24 | #2338 |
| lewis | #2345 |
| gk | #2347 |
| reciprocal | #2353 |
| receptor α | #2353 |
| ethylenes | #2358 |
| specific igg | #2358 |
| illness stress | #2361 |
| monosaccharide | #2363 |
| hyaline | #2364 |
| biological agents | #2365 |
| sex hormone | #2366 |
| lectins type | #2366 |
| acrylamides | #2366 |
| degradative | #2367 |
| phosphoproteins | #2369 |
| wf | #2374 |
| eliminated | #2374 |
| lymphotoxin | #2375 |
| peptides derived | #2375 |
| immunogens | #2375 |
| genetic selection | #2376 |
| treatment rheumatoid arthritis | #2376 |
| amps | #2382 |
| cxcl1 | #2382 |
| antinociceptive | #2383 |
| nonalcoholic steatohepatitis | #2384 |
| contaminating | #2386 |
| mouse model | #2386 |
| phenotypes | #2391 |
| sidechain | #2391 |
| receptor transforming | #2392 |
| knock | #2394 |
| syngeneic | #2394 |
| septic arthritis | #2396 |
| systemic lupus erythematosus | #2397 |
| hla genes | #2398 |
| p38 mapk | #2400 |
| inflammatory reaction | #2400 |
| serum autoantibodies | #2408 |
| increased incidence | #2409 |
| mice models | #2411 |
| equina | #2413 |
| intraperitoneal injections | #2418 |
| genetic receptors | #2420 |
| genetic studies | #2420 |
| structure analysis | #2423 |
| realtime pcr | #2424 |
| mice expression | #2426 |
| tlr2 tlr4 | #2429 |
| suggestive evidence | #2430 |
| acute phase | #2430 |
| lentivirus | #2430 |
| unmodified | #2431 |
| cko | #2432 |
| collagen fibrils | #2432 |
| cytokines chemokines | #2432 |
| lymphocytes cd4 | #2432 |
| cells antigens | #2434 |
| early phases | #2440 |
| agents arthritis | #2440 |
| inflammatory activity | #2442 |
| mice multiple | #2446 |
| genetic predisposition | #2449 |
| receptors complement | #2450 |
| b6 | #2450 |
| 551 | #2451 |
| lipoxin | #2458 |
| inflammatory demyelinating | #2459 |
| animal disease models | #2463 |
| exemplified | #2466 |
| idiotype | #2468 |
| antibody responses | #2469 |
| strains | #2471 |
| administration intranasal | #2473 |
| animals cd4 | #2473 |
| translational modifications | #2477 |
| additively | #2477 |
| axotomy | #2477 |
| class | #2480 |
| quantitative | #2480 |
| regulatory | #2487 |
| animal experiments | #2492 |
| specific | #2493 |
| organ specific | #2497 |
| transforming growth factor | #2498 |
| negative feedback | #2501 |
| albeit | #2502 |
| alleviated | #2502 |
| cystatin | #2504 |
| mhc class genes | #2505 |
| multiparous | #2511 |
| transgenic microscopy | #2512 |
| bystander | #2515 |
| il17a | #2516 |
| ppd | #2518 |
| chemokines cytokines | #2519 |
| dichotomous | #2519 |
| contribute | #2522 |
| naturally | #2523 |
| treatment rheumatoid | #2524 |
| hyperostosis | #2525 |
| amiloride | #2526 |
| nod mice | #2527 |
| pathogenicity | #2534 |
| microsatellite markers | #2534 |
| infiltration | #2541 |
| resemblance | #2542 |
| undertaken | #2545 |
| postmenopausal osteoporosis | #2546 |
| proteolipid | #2552 |
| dapsone | #2560 |
| similarities | #2561 |
| igm iga | #2562 |
| kynurenine | #2563 |
| plp | #2563 |
| deprotection | #2564 |
| nox | #2566 |
| succeeded | #2567 |
| transferring | #2573 |
| fine | #2573 |
| passive | #2574 |
| rp patients | #2575 |
| dying cells | #2575 |
| tumor models | #2576 |
| quantitative traits | #2577 |
| incomplete | #2577 |
| complementarity | #2580 |
| peptides | #2585 |
| chick | #2589 |
| calgranulin | #2590 |
| peritoneal macrophages | #2591 |
| antibody levels | #2591 |
| misinterpretation | #2593 |
| interferon type | #2595 |
| sex hormones | #2597 |
| fibrinolysin | #2598 |
| antiinflammatory properties | #2603 |
| onset | #2603 |
| unlinked | #2605 |
| zymosan | #2610 |
| induction | #2611 |
| postulated | #2614 |
| exert | #2615 |
| antimicrobial peptides | #2618 |
| surprising | #2621 |
| interferon beta | #2623 |
| proteolipid protein | #2632 |
| ifn α | #2634 |
| single chain | #2639 |
| sialoglycoproteins | #2643 |
| plasmin | #2647 |
| unable | #2649 |
| asparagine | #2651 |
| tlr9 | #2653 |
| antigens | #2656 |
| disease genotype | #2658 |
| hla antigens | #2659 |
| submandibular gland | #2663 |
| functional impact | #2663 |
| antinuclear | #2663 |
| eluted | #2666 |
| osteonectin | #2667 |
| invading | #2670 |
| brucei | #2670 |
| n22 | #2670 |
| microliters | #2671 |
| biological pathways | #2673 |
| bordetella | #2680 |
| ease | #2683 |
| new therapeutic strategies | #2683 |
| leukocyte antigen | #2688 |
| th1 | #2690 |
| acd | #2696 |
| allelic | #2697 |
| day treatment | #2697 |
| genetic variations | #2698 |
| igg3 | #2698 |
| animal encephalomyelitis | #2702 |
| neutrophils macrophages | #2703 |
| gamma mice | #2711 |
| peptides protein | #2714 |
| γδ | #2716 |
| treatment mice | #2717 |
| rat model | #2718 |
| human complement | #2725 |
| patients anti | #2727 |
| polymorphic | #2729 |
| ifngamma | #2730 |
| lymphocyte subsets | #2730 |
| biased | #2730 |
| post partum | #2731 |
| lamina propria | #2735 |
| fumigatus | #2735 |
| serum anti | #2738 |
| vav | #2743 |
| fragment | #2743 |
| mice exposed | #2750 |
| leucocyte | #2754 |
| resemble | #2762 |
| bromocriptine | #2768 |
| transgenic mouse | #2772 |
| depleting | #2773 |
| human leukocyte | #2774 |
| tyrosine phosphatase | #2774 |
| cytolysis | #2777 |
| qtls | #2777 |
| strong evidence | #2777 |
| detectable | #2780 |
| iga igm | #2780 |
| enigmatic | #2780 |
| genetically | #2782 |
| explanation | #2785 |
| finemapping | #2785 |
| treated rats | #2786 |
| alcoholic steatohepatitis | #2786 |
| intraperitoneal | #2787 |
| tolerogenic | #2789 |
| bone cartilage | #2790 |
| sjogren syndrome | #2791 |
| inbred mrl | #2798 |
| current review | #2798 |
| animal encephalomyelitis autoimmune | #2799 |
| hk | #2801 |
| callithrix | #2804 |
| spleen | #2812 |
| 261 | #2813 |
| neuropathology | #2817 |
| genistein | #2819 |
| alpha | #2821 |
| lack | #2822 |
| activated macrophages | #2825 |
| hyaluronidase | #2830 |
| conventionally | #2831 |
| narrowed | #2832 |
| prl | #2835 |
| olive oil | #2838 |
| demyelinating diseases | #2841 |
| resistant | #2842 |
| hallmark | #2843 |
| glucose uptake | #2846 |
| beta receptor | #2847 |
| beta tgf | #2848 |
| bind | #2848 |
| demyelinating | #2852 |
| th1 response | #2852 |
| polymorphonuclear leukocytes | #2856 |
| phases | #2858 |
| dependent cell | #2859 |
| treg cell | #2859 |
| antibodies antinuclear | #2864 |
| polymorphonuclear | #2864 |
| interleukin receptors | #2864 |
| characterising | #2865 |
| splenocytes | #2865 |
| interleukin33 | #2869 |
| rats inbred strains | #2869 |
| cyanogen bromide | #2874 |
| disease characterized | #2875 |
| guillain | #2875 |
| cells cd8 | #2881 |
| periodontitis | #2882 |
| parvalbumin | #2884 |
| clone cells | #2885 |
| reveals | #2885 |
| exacerbate | #2888 |
| igg iga | #2891 |
| migration inhibitory | #2892 |
| costimulatory molecules | #2895 |
| tgfbeta | #2895 |
| dce | #2896 |
| innate immune responses | #2896 |
| antigens class humans | #2898 |
| dq | #2905 |
| antigen hla | #2907 |
| atp synthase | #2909 |
| linked immunosorbent | #2911 |
| enhancement | #2911 |
| studying | #2918 |
| shortly | #2920 |
| diseases disease | #2920 |
| allogenic | #2921 |
| ergometry | #2921 |
| steadily | #2925 |
| vaccine development | #2925 |
| type lectin | #2926 |
| obvious | #2927 |
| ifn γ | #2931 |
| autoimmune disorder | #2935 |
| dextran | #2939 |
| female flow | #2943 |
| injections | #2944 |
| expression macrophages | #2944 |
| ifn gamma | #2945 |
| proteins peptides | #2946 |
| cd68 | #2947 |
| patients antibodies | #2949 |
| interleukin4 | #2950 |
| cells immune | #2955 |
| eventually | #2956 |
| toll receptor | #2961 |
| cell infiltration | #2962 |
| expressions | #2963 |
| calcium ions | #2964 |
| qtl | #2965 |
| suppressed | #2967 |
| histocytochemistry | #2967 |
| hnrnp | #2980 |
| genetics | #2982 |
| ifn response | #2985 |
| cepacia | #2988 |
| antirheumatic agents | #2993 |
| elusive | #2994 |
| hdac | #2995 |
| thymus gland | #2997 |
| swedish | #2998 |
| respective | #3000 |
| lineage commitment | #3003 |
| time points | #3009 |
| indoleamine | #3009 |
| cells female | #3010 |
| innate | #3014 |
| therapeutic strategies | #3014 |
| illustrating | #3017 |
| anthrax | #3019 |
| interferon ifn | #3020 |
| wild type mice | #3026 |
| defensins | #3027 |
| vdr | #3031 |
| lung inflammation | #3033 |
| accelerating | #3033 |
| macrophage migration | #3036 |
| t‐cell | #3039 |
| endo | #3039 |
| synthetic peptides | #3040 |
| appearance | #3045 |
| quinoxalines | #3047 |
| cd8 | #3048 |
| immunomodulator | #3050 |
| model mice | #3051 |
| longterm treatment | #3052 |
| twin studies | #3053 |
| complex traits | #3055 |
| ppt | #3058 |
| interleukin23 | #3061 |
| profound | #3067 |
| sjögren syndrome | #3069 |
| prevailing | #3073 |
| salivary | #3076 |
| mediated immune | #3077 |
| role cell | #3078 |
| beta | #3080 |
| destruction | #3082 |
| irrespective | #3083 |
| model human | #3083 |
| gene expression profiling | #3086 |
| impairing | #3087 |
| nodes | #3091 |
| glutamic | #3092 |
| inhibitory factors | #3092 |
| parvalbumins | #3093 |
| receptor 4 | #3098 |
| inbred balb mice | #3098 |
| genetic deletion | #3100 |
| detailed description | #3101 |
| postpartum period | #3107 |
| germinal | #3108 |
| antirheumatic | #3109 |
| staphylococcus | #3114 |
| type wt | #3120 |
| neuronal cell | #3123 |
| effects treatment | #3124 |
| suspect | #3127 |
| igm igg | #3130 |
| specificity | #3131 |
| glycans | #3136 |
| monoclonal antibody | #3137 |
| psoriasis | #3142 |
| receptors tlrs | #3142 |
| logarithm | #3146 |
| cd4 cd8 | #3147 |
| preformed | #3151 |
| immune systems | #3152 |
| possibility | #3153 |
| cell activity | #3154 |
| molecule | #3155 |
| propria | #3155 |
| cba | #3164 |
| posttranslational modification | #3167 |
| sjogren | #3171 |
| massively | #3172 |
| accumulated | #3180 |
| cell specific | #3185 |
| precedes | #3185 |
| blockage | #3187 |
| dynorphin | #3191 |
| tissue specific | #3191 |
| pertussis toxin | #3192 |
| adult mice | #3193 |
| cells rats | #3193 |
| keratinocytes | #3194 |
| unravel | #3199 |
| reactivity | #3202 |
| helper | #3204 |
| modified | #3205 |
| ovx | #3208 |
| serum levels | #3210 |
| antiinflammatory | #3211 |
| erbeta | #3211 |
| phagosomes | #3212 |
| nitroarginine | #3212 |
| abs | #3216 |
| publication arthritis | #3224 |
| cells animals | #3224 |
| gpi | #3226 |
| chromosome 1 | #3237 |
| class iii | #3239 |
| clarified | #3242 |
| permitting | #3246 |
| collagenous | #3247 |
| macrophage | #3247 |
| lod score | #3252 |
| bacterial antibodies | #3254 |
| backbone | #3257 |
| nonalcoholic steatohepatitis nash | #3260 |
| female gonadal | #3263 |
| treated animals | #3264 |
| acrylic | #3265 |
| chronic inflammatory | #3267 |
| meps | #3270 |
| immunosorbent assay | #3272 |
| implicate | #3274 |
| proteoglycans | #3278 |
| inflammation interferon | #3278 |
| sch | #3280 |
| arthralgia | #3283 |
| nephritis | #3283 |
| gonadal steroid | #3284 |
| normal rats | #3287 |
| abundantly | #3289 |
| igg1 | #3298 |
| models genetic | #3298 |
| immunoglobulin heavy | #3303 |
| erythematosus | #3305 |
| adaptations | #3309 |
| proteins mice | #3309 |
| characterise | #3314 |
| elicits | #3314 |
| blastocyst | #3315 |
| nociception | #3316 |
| absence | #3318 |
| diseases autoimmune | #3321 |
| beta receptors | #3325 |
| publication animals | #3325 |
| mice protein | #3327 |
| anticardiolipin | #3328 |
| confirmed | #3329 |
| gc cells | #3331 |
| serologically | #3332 |
| suppression | #3338 |
| regional lymph nodes | #3341 |
| macromolecular | #3343 |
| clinical phenotypes | #3345 |
| cd62l | #3353 |
| influenced | #3355 |
| trypanosoma | #3358 |
| akr | #3371 |
| vitamin d3 | #3373 |
| editor | #3377 |
| antinuclear antibodies | #3382 |
| sle | #3384 |
| genetic polymorphisms | #3385 |
| ovariectomy | #3386 |
| macroporous | #3395 |
| levels inflammatory | #3395 |
| mechanistic studies | #3395 |
| explains | #3396 |
| mount | #3397 |
| tubercle | #3402 |
| somatic mutations | #3406 |
| receptors transforming | #3410 |
| early phase | #3413 |
| haptens | #3413 |
| positions | #3418 |
| erythematosus systemic | #3419 |
| nk cells | #3419 |
| reacts | #3421 |
| neutrophil activation | #3421 |
| penetrant | #3425 |
| reply | #3432 |
| proving | #3434 |
| receptor type | #3434 |
| dendritic cells | #3436 |
| serum igg | #3437 |
| alleles | #3440 |
| permitted | #3441 |
| cauda | #3443 |
| 4 months | #3444 |
| injection | #3445 |
| superoxide production | #3446 |
| protein tyrosine | #3447 |
| humans immunization | #3448 |
| obscure | #3448 |
| increased sensitivity | #3449 |
| antimicrobial peptide | #3451 |
| diffusely | #3459 |
| characterised | #3469 |
| h5n1 | #3470 |
| patients sle | #3470 |
| flow cytometry | #3476 |
| modifying | #3477 |
| multimers | #3491 |
| inflammatory mediators | #3491 |
| proteoglycan | #3496 |
| successes | #3497 |
| il21 | #3500 |
| ly | #3501 |
| elucidate | #3503 |
| developed | #3505 |
| classical | #3505 |
| protein processing | #3506 |
| salivary gland | #3507 |
| publication animals animals | #3509 |
| neutrophilic | #3510 |
| pathobiology | #3511 |
| pathological features | #3517 |
| specific cd4 | #3519 |
| globulins | #3526 |
| 267 | #3528 |
| deoxyguanosine | #3528 |
| phenotypically | #3529 |
| germline | #3529 |
| predispose | #3532 |
| micrometer | #3534 |
| lacrimal | #3534 |
| transglutaminases | #3535 |
| radiolabelled | #3539 |
| regulatory cells tregs | #3540 |
| cyclosporins | #3540 |
| mbq | #3541 |
| dominantly | #3548 |
| histological examination | #3554 |
| investigate | #3559 |
| infections staphylococcus | #3561 |
| mast cells | #3563 |
| cultured disease models | #3568 |
| socs1 | #3570 |
| humans interferon | #3571 |
| histological | #3574 |
| homogenate | #3576 |
| interesting | #3580 |
| gamma | #3580 |
| negative patients | #3583 |
| artificially | #3584 |
| role development | #3585 |
| cytolytic | #3589 |
| hindlimb | #3590 |
| il33 | #3593 |
| compared wild | #3597 |
| triggered | #3597 |
| usage | #3601 |
| immunohistochemical staining | #3608 |
| upregulation | #3612 |
| previous findings | #3617 |
| intranasal | #3619 |
| tcr | #3622 |
| cleave | #3624 |
| potential roles | #3624 |
| genetic association | #3629 |
| rp | #3633 |
| attenuate | #3633 |
| mapping chromosomes | #3634 |
| valuable | #3637 |
| genetic | #3637 |
| adhere | #3638 |
| today | #3645 |
| cultured culture media | #3651 |
| allele | #3655 |
| gene deletion | #3657 |
| enhances | #3657 |
| cd4 positive | #3659 |
| exerts | #3663 |
| clinical severity | #3665 |
| tolllike receptor | #3665 |
| luminol | #3667 |
| 95 association | #3671 |
| cd44 | #3678 |
| il23 | #3690 |
| tgf beta | #3691 |
| female genes | #3694 |
| fibronectins | #3697 |
| toll receptors | #3700 |
| igg igm | #3702 |
| heavy chain | #3705 |
| synovitis | #3708 |
| publication animals humans | #3708 |
| cyclohexanecarboxylic | #3709 |
| aggregated | #3717 |
| inbred nod mice | #3730 |
| systemic male | #3735 |
| sequence deletion | #3740 |
| dh | #3742 |
| 378 | #3746 |
| cells produce | #3750 |
| therapeutic benefit | #3752 |
| macrophage cell | #3753 |
| contributing | #3754 |
| mediate | #3754 |
| complement c4 | #3758 |
| immunochemistry | #3759 |
| biomedicine | #3763 |
| type 4 | #3763 |
| lymphocytes tumor | #3766 |
| epitope mapping | #3767 |
| identification | #3771 |
| partum | #3772 |
| mtdna | #3773 |
| d3 | #3775 |
| th17 | #3786 |
| jakob | #3786 |
| reduced expression | #3787 |
| diphtheria | #3803 |
| immunohistochemical | #3805 |
| hind | #3808 |
| skewed | #3820 |
| integrins | #3822 |
| superoxide | #3822 |
| ribonucleoprotein | #3823 |
| new opportunities | #3831 |
| models immunological | #3834 |
| encompassing | #3838 |
| puerperal | #3839 |
| mmp9 expression | #3839 |
| noncoding rna | #3840 |
| unclear | #3847 |
| amelioration | #3854 |
| postulate | #3858 |
| il17 | #3858 |
| identical | #3859 |
| housed | #3861 |
| genetic dna | #3867 |
| cells treg | #3873 |
| genetic promoter regions | #3880 |
| glycoside | #3887 |
| prominent | #3887 |
| kinase2 | #3887 |
| reacting | #3888 |
| dinucleotide | #3894 |
| decreased levels | #3896 |
| synoviocytes | #3900 |
| microsatellite repeats | #3903 |
| superoxides | #3904 |
| dominate | #3907 |
| recognition | #3912 |
| endogenous | #3918 |
| established | #3919 |
| animal studies | #3926 |
| rats messenger | #3931 |
| hladr | #3934 |
| immunophenotyping | #3941 |
| manifestations | #3942 |
| nerves | #3944 |
| toes | #3946 |
| affect | #3947 |
| neutrophils | #3947 |
| polymorphism | #3949 |
| gingivalis | #3957 |
| nets | #3958 |
| mechanisms involved | #3961 |
| involvement | #3973 |
| disrupted | #3975 |
| associate | #3975 |
| 297 | #3982 |
| adult arthritis | #3988 |
| stimulate | #3992 |
| heavy chains | #3992 |
| ifn β | #3999 |
| question | #3999 |
| broader | #4001 |
| patients osteoarthritis | #4009 |
| elevated levels | #4012 |
| sinuses | #4016 |
| chondrocytes | #4018 |
| superoxide dismutase | #4018 |
| individual patients | #4028 |
| ags | #4029 |
| inflammatory processes | #4033 |
| influences | #4034 |
| higher expression | #4034 |
| efficiently | #4050 |
| glycoproteins | #4054 |
| hla alleles | #4059 |
| expression cell | #4063 |
| conferred | #4065 |
| c1q | #4069 |
| produce | #4072 |
| fragments | #4072 |
| hinge | #4074 |
| eliciting | #4075 |
| requirement | #4076 |
| stat4 | #4076 |
| plethora | #4077 |
| glycoprotein | #4077 |
| contrast | #4085 |
| llc | #4089 |
| upregulated | #4090 |
| systemic lupus | #4092 |
| expression type | #4098 |
| fine mapping | #4102 |
| atpases | #4103 |
| leukocyte | #4105 |
| glands | #4107 |
| conferring | #4108 |
| neutrophil | #4113 |
| creutzfeldt | #4115 |
| current concepts | #4116 |
| gelatin | #4120 |
| absent | #4121 |
| therapy genetic | #4122 |
| sclerosis animals | #4124 |
| drives | #4126 |
| regulatory cells | #4126 |
| protect | #4131 |
| mycobacterial | #4133 |
| promoter polymorphism | #4137 |
| stat1 | #4144 |
| functionally | #4147 |
| articular cartilage | #4161 |
| lupus erythematosus | #4162 |
| hla dq | #4165 |
| motor neurons | #4166 |
| polygenic | #4169 |
| placenta pregnancy | #4173 |
| tumour necrosis factor | #4177 |
| stimulatory | #4178 |
| early pregnancy | #4180 |
| immunology | #4183 |
| effector | #4184 |
| systemic disease | #4187 |
| superoxide anion | #4191 |
| infiltrating lymphocytes | #4192 |
| spe | #4193 |
| monocyte | #4201 |
| breeders | #4203 |
| enterotoxin | #4206 |
| porphyromonas gingivalis | #4207 |
| ici | #4207 |
| beads | #4213 |
| antigens cd8 | #4214 |
| animal drug | #4222 |
| depletion | #4223 |
| cytometric analysis | #4224 |
| parathyroid | #4225 |
| long noncoding | #4227 |
| mutant | #4232 |
| inbred balb | #4239 |
| treated mice | #4242 |
| macrophage infiltration | #4244 |
| kidneys | #4244 |
| granulocytic | #4249 |
| continuously | #4250 |
| chondrosarcoma | #4250 |
| witnessed | #4252 |
| conjunction | #4256 |
| immunological | #4257 |
| immunity innate | #4258 |
| bout | #4260 |
| igh | #4262 |
| lymphoid | #4264 |
| cell repertoire | #4268 |
| day1 | #4270 |
| denominator | #4270 |
| complex | #4272 |
| suggestive | #4276 |
| dermatitis | #4285 |
| experimental mice | #4285 |
| clues | #4286 |
| gene targeting | #4290 |
| cd4 | #4291 |
| balb | #4292 |
| disease genetic | #4294 |
| repertoire | #4302 |
| molecular modeling | #4303 |
| provocation | #4303 |
| shares | #4307 |
| sciatic | #4307 |
| tuberculin | #4308 |
| positive cells | #4309 |
| functional role | #4310 |
| receptors interleukin2 | #4317 |
| cell populations | #4317 |
| suppressive effects | #4320 |
| hydroxy2deoxyguanosine | #4331 |
| pparγ | #4350 |
| new insight | #4353 |
| trypanosomiasis | #4358 |
| glutamine | #4364 |
| fungal infection | #4364 |
| peritonitis | #4365 |
| wildtype | #4370 |
| immunoassays | #4373 |
| swelling | #4375 |
| caused | #4381 |
| penetrance | #4381 |
| cell clones | #4396 |
| disease chronic | #4402 |
| mucous | #4402 |
| prevents | #4414 |
| restored | #4417 |
| joint | #4420 |
| modulating | #4426 |
| closer | #4434 |
| receptor beta | #4434 |
| disturbed | #4434 |
| buprenorphine | #4435 |
| model systems | #4443 |
| early | #4453 |
| acute chronic | #4454 |
| aspartic | #4458 |
| parathyroid glands | #4470 |
| confers | #4473 |
| inflammatory pain | #4477 |
| disease duration | #4480 |
| thymocytes | #4481 |
| calmette | #4488 |
| strains rats | #4489 |
| synthase type | #4490 |
| treg | #4493 |
| thickened | #4503 |
| neutralizing antibodies | #4503 |
| human cell | #4505 |
| genetic loci | #4510 |
| extensively | #4516 |
| colitis | #4526 |
| derived cells | #4532 |
| therapeutic implications | #4534 |
| immunotoxins | #4535 |
| beta cells | #4539 |
| cells th2 | #4541 |
| challenged | #4542 |
| lymphocytes cd8 | #4545 |
| 101 | #4546 |
| cytotoxic lymphocytes | #4547 |
| articular chondrocytes | #4553 |
| interleukin5 | #4558 |
| messenger rats rats | #4564 |
| beta cell | #4566 |
| homing | #4576 |
| extracellular ca2 | #4576 |
| hydrolases | #4577 |
| fasl | #4578 |
| cell separation | #4580 |
| proliferative | #4581 |
| neurosecretory | #4585 |
| immunologic | #4592 |
| production inflammatory | #4593 |
| suggests | #4596 |
| inbred shr rats | #4607 |
| modulatory | #4608 |
| ros levels | #4613 |
| igg antibody | #4613 |
| interact | #4613 |
| confer | #4616 |
| depleted | #4639 |
| conditioned medium | #4642 |
| environmental factors | #4643 |
| positive selection | #4658 |
| fashion | #4658 |
| porphyromonas | #4666 |
| visualized | #4667 |
| endorphins | #4669 |
| implicated | #4670 |
| determinant | #4675 |
| causing | #4678 |
| chains | #4681 |
| langerhans | #4681 |
| monocytes macrophages | #4683 |
| animals antigens | #4693 |
| 259 | #4696 |
| female rats | #4699 |
| lymph | #4707 |
| protecting | #4707 |
| inherited | #4709 |
| defined | #4710 |
| destabilization | #4716 |
| facs | #4718 |
| human studies | #4720 |
| orthomyxoviridae infections | #4725 |
| humans inflammation | #4729 |
| cell population | #4734 |
| positive patients | #4736 |
| α1 | #4739 |
| clone | #4741 |
| mediating | #4744 |
| factor 88 | #4750 |
| panel | #4753 |
| gout | #4757 |
| new drugs | #4764 |
| histopathology | #4767 |
| orchiectomy | #4773 |
| cellular localization | #4775 |
| alveolar macrophages | #4776 |
| e4 | #4776 |
| purified | #4778 |
| differing | #4793 |
| eralpha | #4798 |
| male membrane | #4800 |
| rodents | #4801 |
| osteoclastogenesis | #4809 |
| displaying | #4809 |
| hydrolyzed | #4815 |
| tumor antigens | #4816 |
| effector cells | #4819 |
| cytokines | #4821 |
| paw | #4821 |
| cd4 cd8 cells | #4821 |
| cholera | #4822 |
| distinct | #4831 |
| coincides | #4833 |
| litters | #4843 |
| stress rats | #4846 |
| tissue injury | #4847 |
| rats receptors | #4850 |
| matrix ecm | #4852 |
| interferon γ | #4852 |
| stemness | #4860 |
| articular | #4861 |
| venules | #4863 |
| infiltrate | #4868 |
| th17 cells | #4872 |
| tlr2 | #4880 |
| hpa axis | #4882 |
| ifn | #4885 |
| exocrine | #4888 |
| multifactorial | #4889 |
| 116 | #4891 |
| lod | #4892 |
| specific binding | #4893 |
| ige | #4896 |
| humoral immunity | #4897 |
| induced lung | #4899 |
| preimplantation | #4905 |
| essential roles | #4915 |
| discuss | #4916 |
| immunosorbent | #4917 |
| correlating | #4923 |
| interleukins | #4927 |
| deacetylases | #4928 |
| closely | #4932 |
| timepoints | #4940 |
| humans multiple | #4945 |
| deficiency | #4946 |
| disease process | #4962 |
| naturally occurring | #4962 |
| monitored | #4964 |
| elicit | #4966 |
| forelimb | #4967 |
| contradictory | #4975 |
| point mutation | #4976 |
| cell antigen | #4990 |
| understand | #4995 |
| male rats | #4998 |
| kupffer cells | #5001 |
| thymic | #5003 |
| innate immune | #5004 |
| eosinophilia | #5004 |
| modulates | #5011 |
| isotype | #5012 |
| wt | #5012 |
| upa | #5014 |
| opened | #5018 |
| sh3 | #5019 |
| granuloma | #5021 |
| gland | #5024 |
| enhancing | #5026 |
| vimentin | #5026 |
| expand | #5026 |
| poliomyelitis | #5041 |
| explaining | #5042 |
| il5 | #5044 |
| diamines | #5048 |
| heterozygous | #5049 |
| coculture techniques | #5051 |
| cd8 cells | #5055 |
| caveolin | #5065 |
| th1 cells | #5067 |
| linkage | #5067 |
| phospholipid | #5071 |
| arthritis juvenile | #5072 |
| sitedirected mutagenesis | #5076 |
| molecular basis | #5084 |
| cells blood | #5085 |
| bcg | #5086 |
| autologous | #5087 |
| alum | #5087 |
| olive | #5088 |
| new treatment | #5089 |
| multiple sclerosis | #5098 |
| master regulator | #5100 |
| osteopontin | #5109 |
| aged anti | #5110 |
| elispot | #5112 |
| occurs | #5112 |
| sulfasalazine | #5115 |
| isoantibodies | #5120 |
| dq antigens | #5134 |
| contributes | #5139 |
| lesser | #5145 |
| traditionally | #5148 |
| cytosolic | #5152 |
| epidermis | #5158 |
| connection | #5165 |
| cytokines female | #5170 |
| titrated | #5171 |
| preceded | #5175 |
| antigen receptor | #5178 |
| lymphocytes cytotoxic | #5179 |
| binding | #5185 |
| sex characteristics | #5186 |
| transfer | #5187 |
| polymorphism single | #5188 |
| phenotypic | #5191 |
| complement proteins | #5192 |
| molecular level | #5196 |
| ovariectomized | #5210 |
| popliteal | #5224 |
| ers | #5235 |
| beta2 | #5238 |
| serves | #5238 |
| chimeric | #5241 |
| immunosuppressive | #5246 |
| epidermal | #5250 |
| mucus | #5258 |
| cognate | #5258 |
| cd86 | #5261 |
| tested | #5262 |
| deleterious effects | #5266 |
| progenitors | #5270 |
| costimulation | #5275 |
| osteoclast | #5277 |
| detects | #5277 |
| erosion | #5278 |
| therapeutic intervention | #5280 |
| prolactin | #5280 |
| maternally | #5289 |
| gels | #5292 |
| leu | #5294 |
| plasmapheresis | #5298 |
| clinical findings | #5299 |
| drug humans | #5301 |
| key component | #5301 |
| neutralization | #5301 |
| amino | #5310 |
| staphylococcus aureus | #5312 |
| suggestion | #5312 |
| anhydrases | #5315 |
| c57bl 6j | #5320 |
| manner | #5320 |
| spontaneous | #5321 |
| lipopolysaccharides macrophages | #5345 |
| genetic mapping | #5348 |
| ketoglutarate | #5350 |
| opposing | #5352 |
| proinflammatory | #5365 |
| clathrin | #5369 |
| multiplexed | #5371 |
| glomerulonephritis | #5377 |
| modifies | #5379 |
| cultured human | #5386 |
| expansion | #5387 |
| il1α | #5391 |
| tolllike receptors | #5397 |
| oxidation reduction | #5398 |
| new strategies | #5401 |
| mice molecular | #5402 |
| positive lymphocytes | #5402 |
| tnf α | #5411 |
| antiinflammatory agents | #5417 |
| epigenetic mechanisms | #5417 |
| adversely | #5418 |
| fulvestrant | #5420 |
| activation | #5420 |
| dendritic | #5428 |
| antigens surface | #5429 |
| compartments | #5429 |
| signaling molecules | #5432 |
| mif | #5457 |
| cell culture | #5458 |
| wide spectrum | #5473 |
| sideeffects | #5478 |
| multitude | #5482 |
| located | #5499 |
| immunoglobulins | #5500 |
| histological analysis | #5507 |
| reproduced | #5507 |
| lactating | #5515 |
| cytotoxic | #5519 |
| cytokines humans | #5525 |
| balb mice | #5542 |
| therapeutic | #5547 |
| thymus | #5551 |
| immunosuppressive agents | #5559 |
| sexual dimorphism | #5560 |
| pv | #5560 |
| nociceptive | #5565 |
| redox | #5572 |
| cell expansion | #5578 |
| acute lung | #5583 |
| t1d | #5585 |
| percentage | #5588 |
| allergic reactions | #5592 |
| typed | #5596 |
| lipopolysaccharide lps | #5598 |
| potently | #5600 |
| acute lung injury | #5603 |
| oxidase activity | #5613 |
| control animals | #5614 |
| structural homology | #5616 |
| sequence amino | #5621 |
| synthases | #5633 |
| biotinylation | #5642 |
| bead | #5645 |
| pemphigus | #5649 |
| urgent | #5650 |
| type ifn | #5655 |
| proliferative responses | #5658 |
| abolished | #5660 |
| explants | #5660 |
| regarded | #5663 |
| 198 | #5671 |
| directing | #5676 |
| lung mice | #5677 |
| heterotrimeric | #5684 |
| antioxidant defense | #5685 |
| numbers | #5685 |
| aetiology | #5687 |
| triggers | #5689 |
| keratins | #5695 |
| cytokine expression | #5697 |
| progression disease | #5697 |
| skeletal muscle | #5698 |
| experimental animals | #5700 |
| immune mediated | #5710 |
| avenues | #5715 |
| effective treatments | #5735 |
| altogether | #5737 |
| variable | #5759 |
| integrases | #5760 |
| hfd | #5762 |
| ecm | #5776 |
| mechanisms | #5794 |
| mast | #5802 |
| frozen | #5808 |
| b16 | #5808 |
| linking | #5808 |
| inflammatory disorders | #5809 |
| diabetes t1d | #5814 |
| allergic | #5820 |
| splenic | #5829 |
| bal | #5830 |
| hampered | #5832 |
| toxoid | #5835 |
| earliest | #5837 |
| key regulators | #5844 |
| gabapentin | #5847 |
| type receptors | #5850 |
| large proportion | #5851 |
| proteinases | #5862 |
| cfa | #5868 |
| stronger | #5871 |
| disease genotype humans | #5872 |
| hyaluronan receptors | #5875 |
| deleted | #5875 |
| vitro experiments | #5880 |
| microtomography | #5882 |
| single cells | #5896 |
| evidence role | #5898 |
| modulation | #5900 |
| ace2 | #5917 |
| standardization | #5918 |
| abp | #5919 |
| synthetic | #5920 |
| low doses | #5925 |
| bronchoalveolar lavage fluid | #5925 |
| ics | #5932 |
| identifying | #5941 |
| subclass | #5941 |
| depend | #5947 |
| genomic regions | #5947 |
| explain | #5951 |
| interfere | #5953 |
| biobank | #5960 |
| cytokine production | #5962 |
| expression humans | #5965 |
| nerve regeneration | #5966 |
| factor 1 | #5968 |
| avidin | #5970 |
| foxp3 | #5975 |
| costimulatory | #5977 |
| clarify | #5980 |
| symptom onset | #5983 |
| denaturation | #5986 |
| inability | #5988 |
| knee joint | #5990 |
| eosinophils | #5991 |
| cell subset | #6000 |
| immunity | #6010 |
| glyburide | #6010 |
| 88 | #6014 |
| tetanus | #6019 |
| stress induced | #6022 |
| consisting | #6023 |
| fluorescent dyes | #6044 |
| cnvs | #6045 |
| stimulated | #6056 |
| nih | #6065 |
| igm | #6073 |
| cleared | #6074 |
| tumor infiltrating | #6074 |
| laminin | #6075 |
| genetic therapy | #6077 |
| relapsing remitting | #6083 |
| sle patients | #6089 |
| responsible | #6091 |
| undertook | #6097 |
| messengers | #6100 |
| cages | #6103 |
| stat6 | #6105 |
| ligated | #6107 |
| uncoupling | #6115 |
| bone diseases | #6115 |
| telomeric | #6122 |
| infection mice | #6127 |
| unique | #6140 |
| replacing | #6149 |
| plasma cells | #6150 |
| lowers | #6156 |
| inguinal | #6166 |
| responses | #6171 |
| susceptibility gene | #6171 |
| prophylactic | #6183 |
| genomewide association studies | #6193 |
| instances | #6210 |
| cell functions | #6210 |
| models human | #6217 |
| interferon | #6220 |
| translation | #6222 |
| humans lupus | #6235 |
| characterized | #6236 |
| progesterone | #6253 |
| introduction | #6260 |
| cell type | #6265 |
| exclusively | #6269 |
| protective | #6270 |
| microarray | #6272 |
| serum concentration | #6278 |
| sexes | #6280 |
| immune cell | #6285 |
| myelomonocytic | #6286 |
| histone | #6287 |
| biological evaluation | #6290 |
| difficult | #6298 |
| dermis | #6313 |
| sheath | #6316 |
| monolithic | #6318 |
| minor | #6320 |
| allowed | #6320 |
| tracheal | #6322 |
| estrus | #6336 |
| immunomodulatory | #6337 |
| lymphocyte count | #6339 |
| localize | #6347 |
| tumor immune | #6348 |
| borrelia burgdorferi | #6355 |
| remitting | #6355 |
| cell biology | #6355 |
| microsatellite | #6356 |
| virgin | #6356 |
| signs | #6360 |
| tears | #6363 |
| tryptic | #6370 |
| pertussis | #6372 |
| unresolved | #6378 |
| ros generation | #6379 |
| cells cell | #6381 |
| metalloproteinase | #6392 |
| human subjects | #6394 |
| nicotinamide | #6408 |
| registers | #6410 |
| prodromal | #6450 |
| gonadal | #6451 |
| neuropathological | #6454 |
| models molecular | #6455 |
| peritoneum | #6460 |
| express | #6470 |
| biologic | #6473 |
| transgenes | #6474 |
| c4 | #6475 |
| immunity mucosal | #6476 |
| genetic variants | #6477 |
| inoculation | #6477 |
| severe | #6501 |
| gene function | #6502 |
| demonstrates | #6508 |
| organ specificity | #6511 |
| cell numbers | #6513 |
| stages | #6515 |
| chronic | #6523 |
| synergy | #6523 |
| nitrite | #6523 |
| share | #6539 |
| played | #6540 |
| apc | #6559 |
| proteins animals | #6559 |
| antibody titers | #6572 |
| cytotoxicity immunologic | #6575 |
| pace | #6583 |
| proteases | #6588 |
| rheumatic | #6588 |
| expression genes | #6603 |
| toll | #6603 |
| stain | #6604 |
| major source | #6614 |
| translocating | #6615 |
| parturition | #6635 |
| hpa | #6636 |
| whitney | #6639 |
| solid phase | #6644 |
| affinity | #6645 |
| regulation | #6650 |
| parenchyma | #6650 |
| presently | #6651 |
| sclerosis | #6655 |
| memory cell | #6657 |
| cystine | #6658 |
| cells cd4 | #6665 |
| subfamily | #6672 |
| melatonin | #6683 |
| animals antioxidants | #6683 |
| current understanding | #6687 |
| burgdorferi | #6696 |
| macrophages alveolar | #6701 |
| long noncoding rnas | #6715 |
| histone deacetylases | #6742 |
| normal levels | #6747 |
| pups | #6747 |
| estrogens | #6749 |
| demonstration | #6755 |
| relevant | #6761 |
| comparative genomics | #6768 |
| elastase | #6774 |
| cd8 positive | #6776 |
| interleukin18 | #6782 |
| helpful | #6782 |
| cytometric | #6804 |
| demonstrate | #6812 |
| study role | #6813 |
| glucose transport | #6814 |
| crystal structure | #6819 |
| intra articular | #6825 |
| induced acute | #6825 |
| cd19 | #6829 |
| eosinophil | #6829 |
| cterminal | #6829 |
| conflicting | #6830 |
| lname | #6833 |
| antilymphocyte | #6836 |
| molecules | #6840 |
| aspergillosis | #6852 |
| case control | #6852 |
| lymphoid tissues | #6854 |
| periodontal disease | #6855 |
| participates | #6855 |
| vascular endothelium | #6862 |
| sciatic nerve | #6863 |
| alter | #6865 |
| bioreactors | #6867 |
| activating | #6871 |
| facial nerve | #6873 |
| cell communication | #6882 |
| tool | #6883 |
| cytokine release | #6887 |
| lethality | #6889 |
| inflammatory responses | #6893 |
| lung injury | #6900 |
| ankle joint | #6907 |
| harboring | #6908 |
| gastritis | #6915 |
| tumour necrosis | #6921 |
| recessive | #6922 |
| acetaldehyde | #6925 |
| induced pulmonary | #6931 |
| alternative | #6934 |
| microarray analysis | #6937 |
| cyclic | #6951 |
| inflammatory response | #6953 |
| sulfones | #6960 |
| player | #6974 |
| likewise | #6976 |
| exacerbations | #6984 |
| cdr | #6993 |
| equally | #7001 |
| rac1 | #7013 |
| biological function | #7014 |
| mapping | #7016 |
| translational | #7020 |
| degrade | #7020 |
| mimic | #7025 |
| assay elisa | #7033 |
| fewer | #7033 |
| suppressing | #7047 |
| th1 th2 | #7048 |
| histology | #7056 |
| nucleotide | #7060 |
| genome wide | #7063 |
| target cells | #7063 |
| heterogeneous | #7071 |
| subjected | #7072 |
| aureus | #7072 |
| immune cells | #7075 |
| serine proteases | #7082 |
| proportion | #7083 |
| reduced | #7086 |
| glomeruli | #7088 |
| finally | #7092 |
| atherosclerotic lesions | #7094 |
| orthomyxoviridae | #7108 |
| lyme disease | #7115 |
| thp1 cells | #7121 |
| apoptotic cells | #7124 |
| dividing | #7134 |
| mounted | #7137 |
| autophagy | #7144 |
| extracellular | #7153 |
| immunity cellular | #7161 |
| genetic markers | #7162 |
| messenger rats | #7166 |
| cascades | #7175 |
| synteny | #7188 |
| moiety | #7194 |
| promoted | #7198 |
| higher incidence | #7202 |
| lymphoid tissue | #7205 |
| bovine serum albumin | #7219 |
| dependency | #7223 |
| amino acid | #7225 |
| relevance | #7233 |
| mtx | #7237 |
| recognised | #7238 |
| polysaccharides | #7242 |
| sirt1 | #7251 |
| participate | #7253 |
| prevalent | #7262 |
| immuno | #7265 |
| role pathogenesis | #7272 |
| breeding | #7286 |
| inheritance | #7292 |
| rolling | #7300 |
| prime | #7313 |
| dissecting | #7326 |
| avidity | #7332 |
| expressed genes | #7334 |
| adhesins | #7335 |
| inflammasome | #7342 |
| potential targets | #7343 |
| secreted | #7347 |
| disease specific | #7350 |
| uncontrolled | #7353 |
| metalloendopeptidases | #7355 |
| microglobulin | #7363 |
| adulthood | #7369 |
| transduction animals | #7370 |
| oxide nitric | #7377 |
| array | #7387 |
| analyses | #7391 |
| nervous | #7406 |
| transglutaminase | #7410 |
| interleukin6 | #7411 |
| chemokines | #7411 |
| proven | #7418 |
| supernatants | #7428 |
| genotyping | #7446 |
| immunocytochemistry | #7453 |
| fusion protein | #7456 |
| cells peripheral | #7461 |
| β2 | #7467 |
| airways | #7489 |
| adjuvant | #7493 |
| inhibitory factor | #7500 |
| cytotoxic cells | #7518 |
| disease incidence | #7535 |
| anchor | #7536 |
| eliminate | #7540 |
| early disease | #7541 |
| il1 beta | #7545 |
| lesser extent | #7547 |
| interleukin1beta | #7549 |
| necrotic | #7550 |
| activity relationship | #7553 |
| responder | #7562 |
| elevations | #7589 |
| interacting | #7594 |
| micrograms | #7596 |
| hydrocarbon | #7610 |
| appeared | #7610 |
| arginine | #7621 |
| evident | #7628 |
| cytometry | #7630 |
| unexplained | #7632 |
| allogeneic | #7640 |
| peripheral nervous | #7645 |
| sustain | #7654 |
| receptors immunologic | #7659 |
| graft survival | #7661 |
| component | #7661 |
| murine model | #7665 |
| considerable | #7704 |
| histone deacetylase | #7707 |
| placental | #7712 |
| differentially expressed | #7721 |
| chromosomes | #7722 |
| activators | #7728 |
| motifs | #7730 |
| critical roles | #7731 |
| diagnostics | #7735 |
| bacterial toxins | #7735 |
| initiation | #7745 |
| 325 | #7749 |
| rodent | #7751 |
| chain | #7753 |
| granulocyte | #7754 |
| leukocytes mononuclear | #7766 |
| candidate genes | #7769 |
| mer | #7772 |
| activates | #7772 |
| 37°c | #7773 |
| manuscript | #7780 |
| resolving | #7797 |
| carbonic | #7798 |
| cells tregs | #7800 |
| cell surface receptors | #7807 |
| diet fat | #7810 |
| tgf beta1 | #7831 |
| lipopolysaccharides | #7836 |
| patients levels | #7843 |
| strain | #7844 |
| cells pbmcs | #7853 |
| sirtuin | #7854 |
| retinoid | #7862 |
| interleukin1 | #7866 |
| ifnγ | #7872 |
| gene therapy | #7878 |
| amenable | #7895 |
| analyze | #7897 |
| illness | #7901 |
| lymphopenia | #7909 |
| 2nd | #7917 |
| th2 | #7918 |
| fact | #7925 |
| mann | #7929 |
| myocarditis | #7932 |
| discoveries | #7955 |
| cellular immune | #7957 |
| immunodiffusion | #7959 |
| transform infrared | #7960 |
| positive | #7982 |
| nitrites | #7983 |
| candidate gene | #7987 |
| scoring | #7989 |
| direct effects | #7991 |
| tregs | #7991 |
| unknown | #7993 |
| immune function | #7994 |
| oxidative | #7996 |
| fertilized | #8002 |
| identifies | #8007 |
| haplotypes humans | #8011 |
| polymorphisms | #8012 |
| psa | #8015 |
| essential | #8017 |
| hydroxy | #8030 |
| capacity | #8031 |
| raised | #8040 |
| lncrna | #8047 |
| macroscopic | #8049 |
| myeloid differentiation | #8054 |
| respiratory distress | #8063 |
| address | #8064 |
| drive | #8066 |
| evaluation preclinical | #8067 |
| factor signal | #8077 |
| ascertained | #8077 |
| spanning | #8085 |
| hypophyseal | #8087 |
| appearing | #8088 |
| tetramer | #8088 |
| clinical evaluation | #8089 |
| suboptimal | #8101 |
| physiological | #8105 |
| homozygosity | #8108 |
| prolongation | #8108 |
| considerably | #8109 |
| intronic | #8113 |
| prerequisite | #8120 |
| reasons | #8130 |
| nash | #8133 |
| bovine | #8133 |
| latest | #8134 |
| macrophages peritoneal | #8141 |
| definition | #8141 |
| dying | #8148 |
| trachea | #8156 |
| peripheral nerve | #8160 |
| relapses | #8166 |
| elevated | #8167 |
| conditioned | #8167 |
| characterize | #8170 |
| harbor | #8170 |
| bacterial infection | #8176 |
| expression | #8180 |
| member | #8181 |
| induced inflammation | #8186 |
| rescue | #8192 |
| sacrificed | #8197 |
| cassette | #8198 |
| analysing | #8209 |
| underlying | #8214 |
| preferential | #8216 |
| genetic associations | #8225 |
| sulphate | #8225 |
| defective | #8238 |
| ors | #8241 |
| marginal zone | #8244 |
| foster | #8245 |
| wide | #8261 |
| cultured cytokines | #8268 |
| ppar | #8274 |
| fibrinogen | #8275 |
| bone resorption | #8290 |
| clinical manifestations | #8294 |
| differ | #8295 |
| disease genome | #8295 |
| subcutaneous injection | #8300 |
| streptococcal | #8302 |
| oxygen | #8304 |
| combined treatment | #8309 |
| monoester | #8310 |
| remodeling | #8311 |
| aspergillus fumigatus | #8316 |
| 11 | #8316 |
| peptide1 | #8316 |
| genetically modified | #8320 |
| tlr | #8339 |
| cov2 infection | #8349 |
| vh | #8363 |
| boronic | #8363 |
| frequency | #8364 |
| parietal | #8367 |
| firstly | #8379 |
| fibrils | #8388 |
| migrate | #8391 |
| expressed | #8400 |
| residue | #8401 |
| poly | #8401 |
| p001 | #8404 |
| cd11b | #8408 |
| unaffected | #8411 |
| hydrophilicity | #8420 |
| notion | #8424 |
| advancement | #8424 |
| macrophage activation | #8429 |
| highlights | #8433 |
| defense | #8436 |
| viable | #8460 |
| 14 | #8468 |
| lamina | #8472 |
| manifestation | #8482 |
| protein conformation | #8485 |
| damaging | #8500 |
| promotes | #8502 |
| booster | #8512 |
| inflammatory process | #8516 |
| involves | #8520 |
| cells express | #8525 |
| mildly | #8527 |
| drug development | #8539 |
| phenotype | #8539 |
| burkholderia | #8540 |
| forkhead transcription | #8544 |
| human neutrophils | #8545 |
| estradiol | #8546 |
| copy | #8554 |
| tubule | #8558 |
| adaptive | #8568 |
| inflammatory cytokines | #8576 |
| responsive | #8580 |
| cellular functions | #8582 |
| marginal | #8600 |
| productive | #8609 |
| region | #8618 |
| stress reactive | #8622 |
| chickens | #8638 |
| xanthine | #8641 |
| positivity | #8659 |
| uncovered | #8689 |
| inducers | #8705 |
| outline | #8708 |
| experimental mice mice | #8716 |
| vigorous | #8717 |
| constitutive expression | #8717 |
| ccaat | #8720 |
| staphylococci | #8725 |
| regulatory cell | #8734 |
| cytokine | #8750 |
| recovered | #8751 |
| resorption | #8757 |
| rejection | #8759 |
| larynx | #8761 |
| subset | #8775 |
| chemokine receptor | #8777 |
| impaired | #8781 |
| highlight | #8782 |
| promoter | #8789 |
| cells human | #8790 |
| 4 weeks | #8792 |
| homozygous | #8792 |
| generate | #8799 |
| fungal infections | #8807 |
| human serum | #8808 |
| occasionally | #8808 |
| chemically | #8809 |
| parotid | #8809 |
| generates | #8811 |
| female male | #8812 |
| cytokine levels | #8825 |
| correlated | #8830 |
| kupffer | #8836 |
| cell phenotype | #8866 |
| pathway | #8867 |
| precisely | #8877 |
| bovis | #8882 |
| pathways | #8883 |
| unidentified | #8885 |
| frequencies | #8890 |
| deletion | #8893 |
| key regulator | #8903 |
| endopeptidases | #8922 |
| flow cytometric | #8932 |
| strengthen | #8941 |
| hypothalamo | #8941 |
| and or | #8942 |
| staining | #8944 |
| chemiluminescence | #8945 |
| modulate | #8948 |
| pge2 | #8966 |
| subpopulation | #8967 |
| pitfalls | #8967 |
| attack | #8975 |
| neonatal | #8981 |
| gene | #8983 |
| endosomal | #8987 |
| 129 | #8990 |
| vasculature | #9008 |
| rna long | #9017 |
| adrenocorticotropic | #9019 |
| chemoattractant | #9019 |
| discriminate | #9043 |
| thp1 | #9068 |
| leading | #9074 |
| positioned | #9075 |
| specific role | #9081 |
| glut4 | #9084 |
| hl60 | #9115 |
| cd4 cell | #9129 |
| differentially | #9131 |
| human | #9131 |
| cell surface | #9135 |
| pad | #9136 |
| ongoing | #9160 |
| reconstitution | #9166 |
| negative | #9175 |
| causative | #9182 |
| preincubation | #9186 |
| secrete | #9196 |
| tnf | #9198 |
| lethal | #9205 |
| serologic | #9213 |
| respiratory syndrome | #9222 |
| innate immunity | #9233 |
| started | #9233 |
| sequence | #9238 |
| cells isolated | #9241 |
| glomerulus | #9242 |
| immortalized | #9244 |
| severely | #9250 |
| offer | #9255 |
| orphan | #9255 |
| millions | #9268 |
| ubiquitous | #9272 |
| matrix | #9273 |
| killer | #9278 |
| crystal structures | #9313 |
| clear | #9315 |
| smoking status | #9329 |
| sdspage | #9335 |
| copolymers | #9346 |
| carbohydrate | #9368 |
| neutralizing | #9381 |
| immunoblot | #9395 |
| sweden | #9420 |
| functionality | #9425 |
| cysteine | #9458 |
| ifnα | #9459 |
| lacks | #9460 |
| treatment strategies | #9463 |
| immunomodulation | #9473 |
| luminescent | #9474 |
| molecular | #9484 |
| endotoxins | #9487 |
| tlr4 | #9501 |
| immobilized | #9505 |
| immunofluorescence | #9519 |
| cyclosporin | #9519 |
| hormonal | #9519 |
| sensitized | #9523 |
| detrimental | #9524 |
| heritable | #9530 |
| preexisting | #9543 |
| neuroinflammation | #9558 |
| factor beta1 | #9560 |
| interferon regulatory | #9572 |
| regulated | #9576 |
| culture techniques | #9577 |
| analogous | #9593 |
| entering | #9608 |
| affinities | #9614 |
| steroid hormones | #9615 |
| pretreated | #9624 |
| vaccinated | #9638 |
| gestation | #9639 |
| mammalian cells | #9643 |
| attached | #9647 |
| genetic models | #9655 |
| basement membrane | #9657 |
| key | #9658 |
| vehicle | #9670 |
| cell adhesion | #9678 |
| slight | #9694 |
| dramatic | #9694 |
| accessible | #9708 |
| snp | #9709 |
| azathioprine | #9721 |
| ear | #9723 |
| environment interaction | #9730 |
| livers | #9753 |
| humanized | #9753 |
| maintenance | #9756 |
| metabolic syndrome mets | #9758 |
| functional analysis | #9772 |
| blocked | #9776 |
| cleavage | #9781 |
| microscopic | #9784 |
| adhesion cell | #9784 |
| nasal | #9786 |
| plasminogen activator | #9788 |
| structure activity | #9789 |
| infectious | #9804 |
| lowered | #9804 |
| sterile | #9810 |
| driven | #9836 |
| fibronectin | #9846 |
| delineation | #9856 |
| rheumatology | #9870 |
| phage | #9872 |
| memory cells | #9874 |
| nonhuman primates | #9876 |
| pathogens | #9902 |
| serological | #9907 |
| coculture | #9927 |
| interleukin8 | #9936 |
| healthy control | #9938 |
| reactions | #9953 |
| monkeys | #9973 |
| anticipated | #9993 |
| nucleic acids | #10007 |
| flare | #10014 |
| inflammatory cytokine | #10023 |
| genotype | #10053 |
| serum | #10061 |
| leukocytes | #10067 |
| administered | #10070 |
| differentiation factor | #10076 |
| inflammation male | #10091 |
| generating | #10093 |
| surface receptors | #10102 |
| fibrin | #10105 |
| virulence factors | #10110 |
| cells patients | #10110 |
| activated | #10122 |
| ccl4 | #10125 |
| il1beta | #10131 |
| edge | #10132 |
| new strategy | #10136 |
| host cells | #10139 |
| mitogens | #10140 |
| cell signaling | #10143 |
| kappa | #10143 |
| th2 cells | #10147 |
| retroviridae | #10157 |
| postmenopausal | #10172 |
| traps | #10177 |
| hydrogen peroxide | #10184 |
| placenta | #10185 |
| named | #10188 |
| tlrs | #10207 |
| delta | #10218 |
| summarize | #10236 |
| day | #10244 |
| molecular biology | #10259 |
| rats spraguedawley receptors | #10277 |
| arg | #10279 |
| reproducible | #10283 |
| animals anti | #10304 |
| germ | #10305 |
| gene environment | #10307 |
| tendency | #10317 |
| scid | #10324 |
| lectins | #10329 |
| dismutase | #10332 |
| avian influenza | #10343 |
| reductive | #10347 |
| complete | #10365 |
| mediators | #10378 |
| nterminal | #10392 |
| partially | #10400 |
| lasting | #10406 |
| promote | #10424 |
| determine | #10429 |
| cterminus | #10432 |
| refined | #10437 |
| kill | #10441 |
| cattle | #10446 |
| assays | #10447 |
| indirectly | #10460 |
| mediates | #10474 |
| thioredoxin | #10475 |
| occur | #10477 |
| motif | #10479 |
| redundant | #10502 |
| receptor binding | #10504 |
| developing | #10513 |
| behavior animal | #10515 |
| promoter regions | #10545 |
| phosphate | #10548 |
| produced | #10552 |
| exception | #10554 |
| dysregulated | #10557 |
| critical | #10564 |
| influence | #10568 |
| understood | #10572 |
| converting enzyme | #10584 |
| progressive | #10597 |
| rise | #10608 |
| female | #10609 |
| shortened | #10612 |
| small molecule | #10616 |
| nf kappa | #10617 |
| extracellular matrix | #10620 |
| paralysis | #10632 |
| primers | #10636 |
| collectively | #10637 |
| underlie | #10642 |
| testosterone | #10659 |
| macrophage colony | #10664 |
| selective inhibitor | #10667 |
| aged osteoarthritis | #10675 |
| summary | #10684 |
| repeats | #10685 |
| pbs | #10702 |
| respond | #10705 |
| cerebrospinal fluid | #10708 |
| 17 | #10713 |
| disruption | #10729 |
| issue | #10762 |
| conformation | #10767 |
| il18 | #10770 |
| generation | #10781 |
| cleaved | #10800 |
| 103 | #10811 |
| conditional | #10821 |
| capture | #10822 |
| operated | #10824 |
| seropositive | #10826 |
| cellular mechanisms | #10838 |
| belonging | #10857 |
| saline | #10857 |
| restraint | #10864 |
| phosphatase | #10866 |
| immunoblotting | #10872 |
| factor1 | #10880 |
| base | #10885 |
| connective tissue | #10896 |
| multifunctional | #10904 |
| phagocytosis | #10904 |
| avoid | #10909 |
| ineffective | #10909 |
| luciferase | #10915 |
| bronchoalveolar | #10916 |
| promise | #10920 |
| secondary | #10926 |
| pivotal | #10926 |
| mulatta | #10929 |
| mannose | #10934 |
| persisted | #10939 |
| concluded | #10955 |
| methotrexate | #10967 |
| myeloid cells | #10978 |
| airway inflammation | #10982 |
| degrading | #10983 |
| immunoassay | #10984 |
| subcutaneously | #10984 |
| characterization | #10986 |
| governing | #10998 |
| septic | #11000 |
| ethanol | #11000 |
| tnfα | #11003 |
| mpo | #11010 |
| cell subsets | #11012 |
| originally | #11016 |
| 263 | #11027 |
| immunohistochemistry | #11028 |
| scid mice | #11030 |
| occurrence | #11030 |
| messenger | #11037 |
| hyper | #11040 |
| optical imaging | #11045 |
| skin | #11056 |
| establish | #11066 |
| calcitriol | #11067 |
| tumor progression | #11088 |
| paternal | #11094 |
| add | #11096 |
| freezing | #11102 |
| systemic | #11112 |
| infection animals | #11117 |
| focusing | #11144 |
| genetic polymorphism | #11161 |
| innate immune response | #11167 |
| male | #11167 |
| osteoarthritis | #11176 |
| subsequent | #11177 |
| influx | #11177 |
| receptors | #11177 |
| affinity chromatography | #11186 |
| genes involved | #11187 |
| ankylosing spondylitis | #11197 |
| article | #11201 |
| directly | #11208 |
| bsa | #11210 |
| limited | #11223 |
| sorting | #11229 |
| elicited | #11230 |
| interleukin10 | #11232 |
| disulfides | #11233 |
| contributed | #11248 |
| peptidase | #11251 |
| human blood | #11281 |
| ability | #11284 |
| extensive | #11297 |
| humans influenza | #11314 |
| genotyped | #11318 |
| compared controls | #11322 |
| depends | #11323 |
| oxidant | #11344 |
| caution | #11347 |
| addressing | #11351 |
| tissue damage | #11352 |
| correlate | #11354 |
| extra | #11356 |
| histopathologic | #11376 |
| neuroglia | #11384 |
| modifications | #11385 |
| experimental evidence | #11409 |
| increased expression | #11410 |
| pharmacology | #11413 |
| oxidative phosphorylation | #11428 |
| eosinophilic | #11432 |
| interleukin12 | #11437 |
| quantified | #11438 |
| receptor | #11445 |
| hla class | #11447 |
| cell death | #11460 |
| enhance | #11461 |
| reduces | #11466 |
| governed | #11476 |
| initiating | #11479 |
| contrasting | #11480 |
| melanoma cells | #11488 |
| compared healthy | #11489 |
| cd8 cell | #11498 |
| ankle | #11508 |
| serine | #11525 |
| cytosol | #11542 |
| recipient | #11546 |
| ca2 | #11559 |
| therapeutic interventions | #11561 |
| mets | #11566 |
| jurkat | #11569 |
| backgrounds | #11570 |
| inflammatory effects | #11595 |
| culture medium | #11599 |
| differential expression | #11606 |
| frequently | #11627 |
| alteration | #11627 |
| chicken | #11649 |
| swiss | #11652 |
| enhanced | #11661 |
| exerted | #11663 |
| immunologic memory | #11672 |
| transforming growth | #11678 |
| relief | #11691 |
| synergism | #11703 |
| psychotic | #11730 |
| controls | #11730 |
| toxin | #11735 |
| aiming | #11737 |
| innovative | #11751 |
| amyotrophic | #11769 |
| cell lineage | #11773 |
| constitutes | #11774 |
| inoculated | #11781 |
| commentary | #11785 |
| multiple | #11805 |
| selective | #11814 |
| display | #11817 |
| moderately | #11819 |
| altered | #11829 |
| insufficient | #11830 |
| sequence homology | #11840 |
| 9 | #11857 |
| graft | #11866 |
| analogues | #11871 |
| forkhead | #11888 |
| stained | #11890 |
| enzyme | #11942 |
| augmentation | #11943 |
| classic | #11944 |
| supplied | #11946 |
| gastrointestinal tract | #11958 |
| animals bone | #11966 |
| reveal | #11966 |
| maternal fetal | #11968 |
| adherent | #11980 |
| stress response | #11991 |
| contribution | #11998 |
| tgf | #12005 |
| biomarker | #12016 |
| antiserum | #12017 |
| cricetulus | #12021 |
| deacetylase | #12050 |
| encoding | #12051 |
| plasma cell | #12059 |
| aethiops | #12067 |
| propose | #12072 |
| fat diet | #12104 |
| immunologic factors | #12106 |
| downstream | #12107 |
| protection | #12107 |
| il2 | #12111 |
| tyrosine | #12113 |
| lung | #12116 |
| effectively | #12118 |
| replaced | #12144 |
| induced cell | #12147 |
| bromide | #12152 |
| humans | #12155 |
| quiescent | #12181 |
| switched | #12181 |
| genetic vectors | #12203 |
| oligodeoxyribonucleotides | #12204 |
| histologic | #12222 |
| myd88 | #12222 |
| lectin | #12223 |
| therapeutics | #12230 |
| toxic | #12231 |
| mesenteric | #12231 |
| represents | #12233 |
| receptors estrogen | #12236 |
| corticosterone | #12242 |
| noncoding | #12244 |
| diabetic mice | #12257 |
| fibroblasts humans | #12268 |
| recombinant | #12270 |
| splice | #12271 |
| involving | #12273 |
| fluorescent antibody | #12276 |
| mineral | #12297 |
| tnf alpha | #12300 |
| streptococcus | #12310 |
| harmful | #12319 |
| depending | #12361 |
| acid | #12363 |
| leukocyte count | #12369 |
| syndromes | #12371 |
| tradeoff | #12389 |
| interplay | #12412 |
| origin | #12416 |
| clonal | #12420 |
| microfilament | #12423 |
| reversed | #12439 |
| publication adaptor proteins | #12462 |
| weaker | #12464 |
| protein expression | #12503 |
| pain | #12532 |
| hydrochloride | #12535 |
| drug design | #12567 |
| functional | #12573 |
| suppressor | #12596 |
| rats treated | #12596 |
| binding site | #12597 |
| monomeric | #12605 |
| cells natural | #12637 |
| medullary | #12637 |
| explained | #12643 |
| macaca | #12645 |
| notably | #12664 |
| chronic diseases | #12665 |
| fetuses | #12665 |
| adenine | #12679 |
| cdnas | #12679 |
| 6 weeks | #12681 |
| p38 mitogen | #12681 |
| investigation | #12697 |
| instance | #12709 |
| alveolar | #12729 |
| persistent | #12729 |
| receptor alpha | #12743 |
| modulators | #12770 |
| interactions | #12785 |
| aimed | #12791 |
| nature | #12795 |
| influencing | #12800 |
| diminished | #12804 |
| initiated | #12813 |
| tibia | #12813 |
| sole | #12814 |
| metalloproteinases | #12819 |
| thought | #12823 |
| twin | #12854 |
| isolated | #12871 |
| solely | #12882 |
| disadvantages | #12886 |
| sulfhydryl | #12921 |
| sustained | #12922 |
| assay | #12926 |
| breakdown | #12984 |
| cell division | #13004 |
| embryonic development | #13020 |
| damage | #13056 |
| removing | #13067 |
| tryptophan | #13079 |
| tightly | #13087 |
| crystallography | #13101 |
| hyaluronic | #13102 |
| enabling | #13133 |
| time pcr | #13141 |
| publications | #13143 |
| receptors cell | #13145 |
| stereoisomerism | #13158 |
| distress syndrome | #13175 |
| ancestral | #13179 |
| retained | #13203 |
| valine | #13205 |
| division | #13213 |
| suffering | #13215 |
| single nucleotide polymorphisms | #13234 |
| opportunity | #13243 |
| opportunities | #13258 |
| 1 protein | #13270 |
| chemotaxis | #13279 |
| modulator | #13283 |
| lavage fluid | #13293 |
| transgene | #13297 |
| ascending | #13302 |
| regulators | #13320 |
| elucidated | #13323 |
| purity | #13330 |
| bronchoalveolar lavage | #13334 |
| nk | #13353 |
| fisher | #13357 |
| inhibitory effects | #13362 |
| lymphoproliferative | #13372 |
| amyotrophic lateral | #13377 |
| facilitating | #13380 |
| overexpressed | #13383 |
| scattered | #13389 |
| borrelia | #13393 |
| intact | #13410 |
| independently | #13433 |
| thiol | #13434 |
| fibroblast | #13447 |
| oocytes | #13463 |
| embryos | #13465 |
| marrow derived | #13484 |
| spraguedawley receptors | #13488 |
| overcome | #13489 |
| endopeptidase | #13500 |
| aspect | #13523 |
| lateral sclerosis | #13577 |
| tail | #13589 |
| selectively | #13591 |
| lipopolysaccharide | #13598 |
| elisa | #13612 |
| heritability | #13616 |
| vertebrates | #13627 |
| renal disease | #13634 |
| cure | #13674 |
| peripheral | #13689 |
| reproductive | #13755 |
| clones | #13757 |
| requires | #13783 |
| profiling gene | #13808 |
| lavage | #13811 |
| exon | #13822 |
| arising | #13831 |
| secretory | #13835 |
| techniques | #13873 |
| 6 | #13879 |
| killer cells | #13891 |
| exposed | #13917 |
| cloned | #13927 |
| iga | #13936 |
| hepatocytes | #13938 |
| tolerant | #13992 |
| lncrnas | #14002 |
| anti inflammatory | #14010 |
| killed | #14033 |
| selectin | #14034 |
| sensitization | #14035 |
| environmental | #14057 |
| insertion | #14063 |
| recombinant proteins | #14070 |
| neighboring | #14098 |
| reflects | #14102 |
| great | #14120 |
| preclinical | #14123 |
| highlighting | #14145 |
| preventing | #14148 |
| healthy individuals | #14159 |
| administration | #14164 |
| vaccination | #14176 |
| potent | #14183 |
| retroviral | #14208 |
| multigene | #14246 |
| advances | #14275 |
| amino acids | #14298 |
| ester | #14310 |
| oxidative stress | #14315 |
| cord | #14319 |
| incidence | #14322 |
| impairs | #14323 |
| domain | #14325 |
| psychosis | #14326 |
| bovine serum | #14329 |
| p38 | #14329 |
| isolation | #14334 |
| differentiation | #14342 |
| multiprotein | #14366 |
| mineral density | #14406 |
| #14414 | |
| differentiation cells | #14414 |
| resolve | #14420 |
| colony stimulating | #14421 |
| consistently | #14448 |
| kinases animals | #14452 |
| paracrine | #14452 |
| adenoviridae | #14472 |
| chlorocebus | #14481 |
| marrow transplantation | #14485 |
| targeted | #14490 |
| pathology | #14492 |
| il1 | #14500 |
| integrative | #14510 |
| cells vitro | #14537 |
| monocytes | #14540 |
| bone density | #14589 |
| infectious diseases | #14593 |
| biomedical | #14605 |
| nitrate | #14616 |
| nf kappab | #14627 |
| recombinant human | #14632 |
| divergent | #14638 |
| pathological | #14640 |
| enzyme activation | #14658 |
| lupus nephritis | #14661 |
| smoking | #14673 |
| transforming | #14675 |
| gfp | #14681 |
| inborn | #14696 |
| hand | #14698 |
| green fluorescent | #14703 |
| scarce | #14718 |
| risk developing | #14724 |
| substances | #14724 |
| nitrates | #14728 |
| oxide synthase | #14731 |
| p005 | #14732 |
| particulate | #14751 |
| oxidoreductases | #14753 |
| protein binding | #14757 |
| blood vessels | #14759 |
| human cells | #14768 |
| interferon alpha | #14780 |
| il1β | #14800 |
| degenerative | #14815 |
| proteinase | #14817 |
| originating | #14824 |
| vitro | #14829 |
| overlapping | #14835 |
| biocompatible | #14851 |
| prostaglandins | #14881 |
| controlled | #14895 |
| interaction | #14916 |
| chronically | #14923 |
| genomic dna | #14929 |
| potential therapeutic | #14939 |
| colleagues | #14950 |
| plays | #15011 |
| cross | #15041 |
| implications | #15063 |
| escape | #15078 |
| granule | #15079 |
| receptor gene | #15089 |
| phosphoric | #15090 |
| converting | #15126 |
| acute respiratory | #15173 |
| spinal cord | #15185 |
| seroepidemiologic | #15205 |
| bmd | #15213 |
| proliferation cells | #15219 |
| covalently | #15234 |
| preferentially | #15252 |
| adhesion | #15299 |
| fetus | #15300 |
| processed | #15329 |
| allografts | #15337 |
| synthase | #15339 |
| bone mineral density | #15340 |
| accelerate | #15346 |
| neurodegenerative | #15377 |
| pretreatment | #15379 |
| blood mononuclear | #15414 |
| interleukin6 il6 | #15440 |
| comparative | #15474 |
| selected | #15486 |
| antigens bacterial | #15511 |
| cells dcs | #15513 |
| locally | #15521 |
| transcriptase polymerase | #15530 |
| influenza human | #15537 |
| basis | #15540 |
| hormone | #15542 |
| central nervous | #15566 |
| estrogen receptor | #15572 |
| transduction | #15579 |
| vaccines | #15623 |
| responsiveness | #15647 |
| rna interference | #15649 |
| binds | #15651 |
| accelerator | #15673 |
| limitation | #15675 |
| pyruvate | #15682 |
| sequenced | #15696 |
| conformational | #15701 |
| cd28 | #15708 |
| connective | #15748 |
| gastric | #15775 |
| single | #15789 |
| fluorescent | #15793 |
| bone loss | #15832 |
| induced expression | #15835 |
| protein structure | #15849 |
| spinal | #15861 |
| vasculitis | #15884 |
| treating | #15887 |
| kappab | #15894 |
| gcsf | #15908 |
| competitive | #15910 |
| positron emission | #15913 |
| downregulation | #15914 |
| systemic inflammation | #15944 |
| methylated | #15945 |
| neurodegeneration | #15945 |
| involve | #15980 |
| ap1 | #15985 |
| plasmon resonance | #15986 |
| reflected | #15993 |
| chromatographic | #16019 |
| cnv | #16065 |
| oligonucleotide array | #16092 |
| 106 | #16097 |
| responding | #16105 |
| pluripotent | #16135 |
| bone mineral | #16141 |
| undetectable | #16148 |
| skeletal | #16151 |
| neurons | #16154 |
| tissue distribution | #16155 |
| disequilibrium | #16156 |
| beta1 | #16172 |
| exhibited | #16189 |
| response treatment | #16236 |
| grafted | #16238 |
| array sequence | #16239 |
| glandular | #16252 |
| functional studies | #16273 |
| responders | #16278 |
| new class | #16282 |
| subunit | #16293 |
| required | #16309 |
| animals base | #16310 |
| subclinical | #16311 |
| linkage disequilibrium | #16342 |
| receptor signaling | #16351 |
| difference | #16367 |
| remarkably | #16382 |
| molecular structure | #16391 |
| form | #16409 |
| signalling | #16414 |
| molecular mechanism | #16419 |
| publication antibodies | #16433 |
| cd40 | #16468 |
| shr | #16471 |
| capable | #16496 |
| grouped | #16512 |
| subcutaneous | #16522 |
| fibroblasts | #16525 |
| revealing | #16544 |
| targeting | #16552 |
| respiratory | #16585 |
| node | #16585 |
| organs | #16586 |
| tumor cells | #16600 |
| antibodies bacterial | #16603 |
| subunits | #16626 |
| profiling | #16651 |
| necrosis | #16655 |
| establishing | #16709 |
| negatively | #16709 |
| uric | #16743 |
| irradiated | #16757 |
| nick | #16765 |
| intramolecular | #16795 |
| deeper | #16801 |
| instrumental | #16812 |
| detected | #16851 |
| immunoreactive | #16859 |
| clinically | #16859 |
| serve | #16878 |
| inhibitory | #16881 |
| documented | #16904 |
| greatly | #16907 |
| colony | #16928 |
| turn | #16941 |
| immunosuppression | #16942 |
| mmps | #16957 |
| inhibition | #16959 |
| receptor 1 | #16964 |
| additionally | #16970 |
| humans hydrogen | #16982 |
| structurally | #16985 |
| prior | #16994 |
| additional | #17005 |
| binding protein | #17006 |
| recombinant fusion | #17013 |
| sulfate | #17069 |
| b7 | #17077 |
| count | #17083 |
| il12 | #17096 |
| sex factors | #17111 |
| consist | #17113 |
| minimal | #17116 |
| alpha subunit | #17119 |
| lysosomal | #17126 |
| unexpected | #17137 |
| tissue | #17148 |
| pluripotent stem | #17151 |
| receptors tumor | #17172 |
| csf | #17185 |
| activator | #17202 |
| lymph node | #17208 |
| underlying mechanisms | #17217 |
| stimulation | #17249 |
| starting | #17298 |
| peritoneal | #17299 |
| cell proliferation | #17318 |
| fluid | #17330 |
| propensity | #17345 |
| generations | #17377 |
| humans immunity | #17410 |
| constitute | #17425 |
| demonstrated | #17444 |
| membrane | #17466 |
| muscle skeletal | #17479 |
| allowing | #17505 |
| types | #17505 |
| fibrous | #17515 |
| transcriptase | #17515 |
| type iii | #17546 |
| localization | #17547 |
| constitutive | #17559 |
| cytometry humans | #17570 |
| discovery | #17583 |
| treatments | #17596 |
| peripheral blood | #17615 |
| variation | #17616 |
| packed | #17678 |
| differed | #17683 |
| expanded | #17687 |
| proved | #17691 |
| plasmon | #17698 |
| longitudinally | #17713 |
| pbmcs | #17728 |
| stimulating factor | #17743 |
| somatic | #17805 |
| inflammatory bowel disease | #17815 |
| dcs | #17827 |
| relating | #17861 |
| alpha tnf | #17880 |
| neuroendocrine | #17920 |
| oligonucleotide | #17954 |
| homology | #17962 |
| surface plasmon | #17971 |
| pregnancy | #17985 |
| chromosomal | #17994 |
| post | #17998 |
| inhibit | #18002 |
| labelled | #18004 |
| damaged | #18064 |
| osmolar | #18107 |
| 2 4 | #18130 |
| creating | #18142 |
| cytoplasm | #18155 |
| released | #18157 |
| trigger | #18161 |
| corticosteroids | #18164 |
| species | #18168 |
| endocrine | #18192 |
| vertebrate | #18206 |
| labeled | #18208 |
| subcellular | #18231 |
| rna messenger | #18235 |
| protein serine | #18279 |
| limiting | #18281 |
| reverse transcriptase | #18325 |
| evidenced | #18329 |
| truncated | #18336 |
| net | #18345 |
| avian | #18345 |
| males | #18375 |
| critically | #18389 |
| assumed | #18433 |
| modulated | #18444 |
| rats wistar | #18448 |
| pathogen | #18464 |
| immunogenicity | #18486 |
| acids | #18490 |
| reaching | #18494 |
| nonparametric | #18512 |
| constitutively | #18518 |
| hyaluronan | #18609 |
| processing | #18609 |
| sulfonamides | #18643 |
| investigating | #18651 |
| 15 | #18656 |
| 22 | #18658 |
| verify | #18669 |
| signal transduction | #18682 |
| agents steroidal | #18685 |
| remaining | #18721 |
| cerebrospinal | #18788 |
| aim | #18788 |
| created | #18803 |
| cultured | #18823 |
| balanced | #18823 |
| carry | #18829 |
| pathophysiological | #18830 |
| production | #18927 |
| nerve | #18943 |
| nested | #18957 |
| nfκb | #18987 |
| failed | #18988 |
| sequence analysis | #19002 |
| specific antigen | #19050 |
| observations | #19062 |
| provided | #19067 |
| bone marrow | #19084 |
| lungs | #19111 |
| stimulating | #19136 |
| protein | #19164 |
| bearing | #19167 |
| publication administration | #19185 |
| gained | #19200 |
| mitochondrial | #19260 |
| symptoms | #19288 |
| lost | #19298 |
| majority | #19304 |
| intra | #19311 |
| interacts | #19344 |
| hormones | #19441 |
| fatal | #19464 |
| interferons | #19489 |
| analyzing | #19515 |
| exogenous | #19526 |
| cytoskeletal | #19553 |
| adrenal | #19553 |
| rapidly | #19574 |
| inducible | #19616 |
| etiology | #19652 |
| environment | #19668 |
| implanted | #19680 |
| lps | #19681 |
| mice scid | #19683 |
| vesicular | #19701 |
| lineage | #19719 |
| markers | #19789 |
| histologically | #19817 |
| offers | #19826 |
| cutaneous | #19834 |
| precise | #19836 |
| pharmacological | #19854 |
| fetal | #19862 |
| shifted | #19875 |
| newly | #19892 |
| supporting | #19915 |
| vitro techniques | #19945 |
| yielded | #19948 |
| 8 | #19978 |
| 28 | #19979 |
| cns | #19979 |
| response relationship | #20014 |
| transient | #20038 |
| modify | #20055 |
| designated | #20056 |
| reverse | #20057 |
| casecontrol study | #20088 |
| mutagenesis | #20118 |
| illustrated | #20126 |
| downregulated | #20133 |
| ultimately | #20202 |
| κb | #20256 |
| 1 diabetes | #20263 |
| hypothalamic | #20285 |
| primary | #20303 |
| entered | #20310 |
| nitric | #20316 |
| gene expression | #20364 |
| markedly | #20453 |
| genotype humans | #20460 |
| mature | #20491 |
| microglia | #20561 |
| circulating | #20574 |
| overexpressing | #20593 |
| human pair | #20604 |
| polyacrylamide | #20612 |
| marrow | #20651 |
| defining | #20660 |
| pregnant | #20665 |
| equal | #20678 |
| resting | #20729 |
| injured | #20739 |
| mild | #20819 |
| local | #20825 |
| discovered | #20835 |
| cricetinae | #20839 |
| reduction | #20847 |
| illustrate | #20874 |
| lactic | #20908 |
| hypothesized | #20913 |
| tended | #20919 |
| successful | #20952 |
| 10 | #20952 |
| cell derived | #20955 |
| aberrant | #20961 |
| animals biomarkers | #21033 |
| 2 | #21085 |
| attractive | #21228 |
| acute | #21279 |
| produces | #21297 |
| transfected | #21316 |
| marked | #21340 |
| decreased | #21383 |
| maternal | #21389 |
| emerged | #21445 |
| survived | #21524 |
| confirms | #21558 |
| membrane proteins | #21585 |
| forming | #21593 |
| preserved | #21732 |
| contained | #21802 |
| previous | #21805 |
| 16 | #21813 |
| doses | #21835 |
| immunodeficiency | #21852 |
| electrophoresis | #21867 |
| mellitus type | #21871 |
| natural killer | #21877 |
| cell count | #21898 |
| prolonged | #21903 |
| heavy | #21965 |
| increasing | #21979 |
| polymeric | #22042 |
| gradually | #22067 |
| glial | #22202 |
| selecting | #22242 |
| extremely | #22248 |
| 4 | #22274 |
| opportunistic | #22307 |
| accepted | #22356 |
| emission tomography | #22395 |
| enable | #22402 |
| humans models | #22445 |
| initially | #22458 |
| microscopy confocal | #22466 |
| physiologic | #22470 |
| appears | #22488 |
| releasing | #22497 |
| suitable | #22522 |
| humans immunosuppressive | #22529 |
| confirm | #22553 |
| chemokine | #22558 |
| metabolic | #22585 |
| actins | #22597 |
| loss | #22611 |
| nf | #22756 |
| reactive protein | #22834 |
| utilizing | #22899 |
| transformed | #22917 |
| progression female | #22918 |
| detailed | #23005 |
| natural | #23089 |
| cell types | #23132 |
| sex | #23234 |
| null | #23277 |
| untranslated | #23305 |
| signaling | #23324 |
| syndrome | #23335 |
| bone | #23397 |
| necrosis factor | #23407 |
| rich | #23430 |
| cells tumor | #23467 |
| nucleic | #23501 |
| continued | #23663 |
| cellular | #23667 |
| expression gene | #23728 |
| attenuated | #23757 |
| mitogen | #23814 |
| serine threonine | #23835 |
| examine | #23864 |
| fusion proteins | #23968 |
| organ | #23990 |
| remained | #23998 |
| prevent | #24026 |
| confined | #24245 |
| oxidized | #24325 |
| called | #24330 |
| discussed | #24334 |
| genomic | #24394 |
| covering | #24485 |
| embryonic | #24490 |
| interleukin | #24583 |
| varying | #24640 |
| weeks | #24698 |
| mechanistic | #24796 |
| putative | #24897 |
| sarcoidosis | #24963 |
| detect | #24963 |
| remains | #25082 |
| controversial | #25175 |
| implies | #25192 |
| stromal | #25269 |
| type 1 diabetes | #25410 |
| enriched | #25470 |
| relation | #25543 |
| attributed | #25618 |
| 7 | #25632 |
| proteins | #25644 |
| tumor necrosis | #25683 |
| dysregulation | #25711 |
| cytoplasmic | #25732 |
| inflammatory agents | #25735 |
| energetic | #25813 |
| healthy | #25887 |
| representing | #25917 |
| challenging | #25976 |
| threonine | #25988 |
| mechanisms underlying | #26094 |
| signal | #26163 |
| tnfalpha | #26432 |
| frequent | #26487 |
| individuals | #26568 |
| antibodies viral | #26579 |
| growth factor | #26602 |
| validated | #26686 |
| lower | #26708 |
| treat | #26713 |
| 3 | #26751 |
| tolerated | #26780 |
| pathophysiology | #26782 |
| explored | #26850 |
| tumor necrosis factor | #26925 |
| comparable | #26955 |
| normal | #27016 |
| define | #27055 |
| exist | #27121 |
| presented | #27123 |
| consists | #27152 |
| intracellular | #27233 |
| invariant | #27331 |
| animals cells | #27339 |
| adaptor proteins | #27447 |
| chromosomes human | #27524 |
| associations | #27560 |
| kda | #27648 |
| tract | #27680 |
| possess | #27765 |
| exclude | #27824 |
| cell tumor | #27826 |
| attributable | #28018 |
| proteins humans | #28150 |
| heterozygote | #28266 |
| treated | #28436 |
| observe | #28472 |
| remain | #28560 |
| regulation humans | #28667 |
| threonine kinases | #28809 |
| hypothesis | #28819 |
| require | #28838 |
| examined | #29041 |
| infection | #29082 |
| 5 | #29247 |
| animals apoptosis | #29491 |
| intracellular signaling | #29517 |
| easily | #29557 |
| effective | #29656 |
| 005 | #29706 |
| fully | #29936 |
| exhibit | #29947 |
| gtp binding | #29997 |
| intravenous | #30185 |
| cell movement | #30520 |
| oxide | #30546 |
| reached | #30655 |
| active | #30908 |
| versus | #30963 |
| 1 | #31228 |
| cell differentiation | #31374 |
| vary | #31548 |
| blotting western | #31843 |
| free | #32409 |
| expression regulation | #32516 |
| needed | #32543 |
| objectives | #32805 |
| generally | #33368 |
| inhibited | #33394 |
| clinical | #33439 |
| sought | #34008 |
| reduce | #34128 |
| biological | #34247 |
| reflect | #34701 |
| separately | #34818 |
| agents | #34868 |
| assess | #34935 |
| polymerase | #35201 |
| nuclear | #35715 |
| polymerase chain | #36180 |
| formed | #36819 |
| chain reaction | #36949 |
| 001 | #36954 |
| measured | #42007 |
Sacar un reporte | |
Prominent publications by Rikard Holmdahl
KOL-Index: 15284
The purpose of the study was to map the dominant T cell epitope of the CB11 sequence of CII in RTlu haplotype rats and to determine if, when used as a synthetic peptide, it would induce tolerance to protect against CIA. A dominant epitope corresponding to residues 184-198 included in the sequence of the CB11 fragment of bovine CII was identified in proliferation assay using peptides in an epitope scanning system using synthetic peptides of 15 amino acids, overlapping by 12 amino acids. ...
| Conocido por Mucosal Tolerance | Synthetic Peptide | Cell Epitope | Cia Cii | Collagen‐induced Arthritis |
KOL-Index: 14658
An antibody response to defined epitopes located on the triple helical portion of type II collagen (CII) is associated with the development of collagen-induced arthritis (CIA) and rheumatoid arthritis (RA). Monoclonal antibodies to epitopes associated with arthritis, but not antibodies specific for epitopes not associated with arthritis, induce arthritis in mice, the so-called collagen antibody induced arthritis (CAIA) model. We have selected monoclonal IgG antibodies specific for four ...
| Conocido por Collagen Antibody | Induced Arthritis | Monoclonal Antibodies | Mice Inbred | Specific Epitopes |
KOL-Index: 13984
The Aq major histocompatibility complex (MHC) class II molecule is associated with susceptibility to murine collagen-induced arthritis (CIA), whereas the closely related H-2Ap molecule is not. To understand the molecular basis for this difference, we have analyzed the ability of H-2Aq and H-2Ap molecules (referred to as Aq and Ap) to bind and present collagen type II (CII)-derived glycosylated and non-glycosylated peptides. T cell clones specific for the immunodominant CII 256-270 ...
| Conocido por Collagen‐induced Arthritis | Transgenic Models | Aq Molecule | Structural Basis | C3h Mice |
KOL-Index: 13727
BACKGROUND: Autoantibodies to cyclic citrullinated peptides (anti-CCP) are present in most patients with rheumatoid arthritis (RA), and associate with HLA-DRB1 shared epitope (SE) alleles.
OBJECTIVE: To investigate reactivities of anti-CCP to various citrullinated proteins/peptides, which represent potential autoantigens in RA, and to examine the relationship between such antibodies, and their association with genetic variants within HLA-DRB1 SE alleles.
METHODS: Serum samples from 291 ...
| Conocido por Citrullinated Antigens | Rheumatoid Arthritis | Drb1 Alleles | Ccp Patients | Antibody Reactivities |
Localization of a critical restriction site on the I-A beta chain that determines susceptibility to collagen-induced arthritis in mice
[ PUBLICATION ]
Type II collagen-induced arthritis (CIA) in mice is an autoimmune experimental model for rheumatoid arthritis. Susceptibility to CIA is associated with certain major histocompatibility complex class II haplotypes. The two very closely related haplotypes H-2q and H-2p differ in susceptibility to CIA. Only mice of H-2q (DBA/1, B10G strains) but not mice of H-2p-expressing strains (like strain B10P) develop CIA and an autoimmune response to type II collagen (CII) after immunization with ...
| Conocido por Mice Cia | Beta Chain | Rheumatoid Arthritis | H2q Haplotype | Type Collagen Cii |
KOL-Index: 13513
INTRODUCTION: It has previously been shown that an increased number of antibodies against citrullinated peptides/proteins (ACPA) predate the onset of rheumatoid arthritis (RA). Over time antibody positivity expands, involving more specific responses when approaching the onset of symptoms. We investigated the impact of human leukocyte antigen-shared epitope (HLA-SE) alleles and smoking on the development of ACPA, as well as in combination with ACPA during the state of quiescent ...
| Conocido por Citrullinated Peptides | Onset Symptoms | Development Rheumatoid Arthritis | Combination Acpa | Hlase Smoking |
Antibodies to several citrullinated antigens are enriched in the joints of rheumatoid arthritis patients
[ PUBLICATION ]
OBJECTIVE: High titers of specific anti-citrullinated protein antibodies (ACPAs) are frequently present in the serum of rheumatoid arthritis (RA) patients, but their presence in synovial fluid is less well characterized. The purpose of this study was to compare the levels of antibody to 4 well-defined citrullinated candidate RA autoantigens in serum and synovial fluid and to determine whether antibodies to one citrullinated antigen are dominant over another. Furthermore, we studied their ...
| Conocido por Citrullinated Antigens | Synovial Fluid | Rheumatoid Arthritis Patients | Type Collagen | Antibodies Acpas |
Toll-like receptor 3 upregulation in macrophages participates in the initiation and maintenance of pristane-induced arthritis in rats
[ PUBLICATION ]
INTRODUCTION: Toll-like receptors (TLRs) are involved in both innate and adaptive immune responses and are likely to play a complex role in the pathogenesis of human rheumatoid arthritis (RA) and experimental arthritis. The objective of this study was to identify the key TLR in pristane-induced arthritis (PIA), a rat model for RA, and to clarify its roles in the initiation and maintenance of arthritis.
METHODS: Arthritis in DA rats was induced by pristane and the severity was evaluated ...
| Conocido por Induced Arthritis | Tlr3 Expression | Rats Pristane | Receptor 3 | Inbred Strains Severity |
KOL-Index: 12776
Multiple sclerosis (MS) is a complex chronic neurologic disease with a suspected autoimmune pathogenesis1,2. Although there is evidence that the development of MS is determined by both environmental influences and genes, these factors are largely undefined3,4, except for major histocompatibility (MHC) genes. Linkage analyses and association studies have shown that susceptibility to MS is associated with genes in the human histocompatibility leukocyte antigens (HLA) class II region, but ...
| Conocido por Multiple Sclerosis | Transgenic Mice | Hla Dr2 | Humanized Model | Spontaneous Disease |
KOL-Index: 12721
Polymorphism of the major histocompatibility complex (MHC) influences susceptibility to experimental autoimmune encephalomyelitis (EAE) induced by myelin basic protein (MBP) in rats. Current concepts relate such influences to the capacity of class II molecules to present relevant peptides to autoreactive T cells. We have here analyzed the MHC influence on the immune response and the development of EAE after immunization with the immunodominant peptide MBP-63-88. Analysis of MHC-congenic ...
| Conocido por Myelin Basic Protein | Experimental Autoimmune | Major Histocompatibility | Rats Eae | Immune Response |
Multiplex Analyses of Antibodies Against Citrullinated Peptides in Individuals Prior to Development of Rheumatoid Arthritis
[ PUBLICATION ]
OBJECTIVE: The presence of antibodies against cyclic citrullinated peptides has been demonstrated to precede the onset of symptoms of rheumatoid arthritis (RA) by several years. The aim of this study was to analyze antibodies against 10 citrullinated autoantigen-derived peptides for reactivity before the onset of RA symptoms.
METHODS: A case-control study was conducted within the Medical Biobank of Northern Sweden. The study was performed in 409 individuals, 386 of whom donated 717 blood ...
| Conocido por Citrullinated Peptides | Rheumatoid Arthritis | Onset Symptoms | Antibodies Cep1 | Type Collagen |
KOL-Index: 12510
Antibodies against type II collagen (anti-CII) are arthritogenic and have a crucial role in the initiation of collagen-induced arthritis. Here, we have determined the dependence of T and B cells in collagen-antibody-induced arthritis (CAIA) during different phases of arthritis. Mice deficient for B and/or T cells were susceptible to the CAIA, showing that the antibodies induce arthritis even in the absence of an adaptive immune system. To determine whether CII-reactive T cells could have ...
| Conocido por Collagen Type | Arthritis Mice | Antigen Tcell | Antibodies Cii | Adaptive Immune |
KOL-Index: 12427
The nonobese diabetic (NOD) mouse spontaneously develops autoimmune-mediated diseases such as diabetes and Sjögren's syndrome. To investigate whether NOD genes also promote autoimmune-mediated arthritis we established a NOD strain with an MHC class II fragment containing the A(q) class II gene predisposing for collagen induced arthritis (NOD.Q). However, this mouse was resistant to arthritis in contrast to other A(q) expressing strains such as B10.Q and DBA/1. To determine the major ...
| Conocido por Genetic Control | Complement Factor | Induced Arthritis | Locus Chromosome | Mice Inbred |
Gente clave para Rheumatoid Arthritis
Los KOLs mas influyentes del mundo
Seleccione una frase de búsqueda rheumatoid arthritis , rheumatoid arthritis patients , rheumatoid arthritis treatment , rheumatoid arthritis risk , rheumatoid arthritis study
Rikard Holmdahl:Impacto experto
Conceptos para los cualesRikard Holmdahltiene influencia directa:Rheumatoid arthritis, Induced arthritis, Experimental arthritis, Collagen type, Type collagen, Animal models, Reactive oxygen species, Autoimmune diseases.
Rikard Holmdahl:Impacto de Kol
Conceptos relacionados con el trabajo de otros autores para los cualesfor which Rikard Holmdahl tiene influencia:Rheumatoid arthritis, Multiple sclerosis, Autoimmune diseases, Oxidative stress, Animal models, Reactive oxygen species, Nadph oxidase.
Tools
¿Es este tu perfil? Reclama tu perfil Copiar URL Incrustar el enlace a su perfil |